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Summary 
Nociception involves detection of tissue damage by specialized receptors; 
nociceptors. These convey information to the first synaptic relays in the dorsal 
horn of the spinal cord. Within the dorsal horn itself are the dorsal horn neurons 
which can be divided into two broad classes, based on their axonal projections: 
projection neurons and interneurons.  
The neurokinin 1 receptor (NK1r), the main target for substance P, is expressed 
by most projection neurons and many interneurons in the dorsal horn. These 
NK1r-expressing neurons show a bimodal size distribution in lamina I. The 1st 
part of the project tested the hypothesis that large NK1r-immunoreactive cells 
in this lamina are projection neurons, while the small cells are interneurons. 
Rats were anaesthetised and received injections of tracers into two supraspinal 
areas that are likely to label all contralateral lamina I projection neurons. The 
rats were re-anaesthetized and perfused 3 days later and 1341 NK1r-positive 
cells were analysed, of which 441 were retrogradely labelled. Cross-sectional 
soma areas of projection neurons were larger than those of cells that were not 
retrogradely labelled. This difference was highly significant. Nearly all (99.4%) of 
the NK1r-expressing cells that were not retrogradely labelled had soma areas 
<200 µm2, while only 9.8% of the retrogradely labelled NK1r-expressing cells had 
somata <200 µm2. These results provide a means of distinguishing lamina I NK1r-
expressing projection neurons from interneurons based on their soma sizes 
without the need of retrograde tracing surgeries.  
Lamina I contains another population of projection neurons that lack or weakly 
express the NK1 receptor and consists of very large cells: giant cells, which are 
coated with the glycine and gamma-aminobutyric acid (GABA) receptor 
associated protein, gephyrin. There is also a group of large NK1r-expressing 
projection neurons with cell bodies in laminae III-IV and dendrites that pass 
dorsally to enter lamina I. Extracellular signal-regulated kinase (ERK) is 
expressed in dorsal horn neurons and is activated (phosphorylated) by noxious 
stimuli. In the 2nd part of the project, ERK phosphorylation in NK1r-expressing 
neurons as well as in lamina I giant cells was investigated following different 
type of noxious stimuli. Anaesthetised rats received noxious cutaneous, deep or 
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visceral stimuli. They remained anaesthetized for 5 min after the end of the 
stimulus, and were then fixed by perfusion. Spinal cord sections were 
immunoreacted to reveal NK1r, gephyrin and phosphorylated ERK (pERK). Among 
the NK1r-expressing lamina I neurons, pERK was detected in both projection 
(somata >200 µm2) neurons and interneurons, with a significantly higher 
proportion in the larger cells, after all types of noxious stimulation. There was 
no significant difference in the frequency of pERK expression between the three 
morphological classes (fusiform, pyramidal and multipolar) of lamina I NK1r-
expressing projection neurons after these stimuli. Most of the giant cells 
contained pERK after noxious cutaneous stimuli, but few did so following noxious 
deep stimulation. Only a few of laminae III-IV NK1r-expressing projection cells 
contained pERK after noxious deep or visceral stimulation, and the labelling in 
these was very weak. Results from the present study indicate that different 
types of neurons have different roles in conveying nociceptive information.   
The superficial dorsal horn (SDH) is also a vital area for modulating nociception 
and contains large number of excitatory and inhibitory interneurons. Glutamate, 
released by primary afferents and local excitatory neurons, acts on G-protein-
coupled metabotropic glutamate receptors (mGlus). Group I mGlus (mGlu1 and 
mGlu5) are strongly expressed in the SDH. It has been reported that intrathecal 
administration of the mGlu1/5 agonist 3,5-dihydroxyphenylglycine (DHPG) induces 
spontaneous nociceptive behaviours, which are ERK-dependent. In the 3rd part of 
the project, ERK phosphorylation in mGlu5-expressing neurons following the 
administration of DHPG was investigated. Anaesthetized rats underwent a 
laminectomy procedure. DHPG or saline was applied to their exposed lumbar 
cord for 8 minutes after which they were perfused. Sections from the lumbar 
spinal cord were immunoreacted to reveal mGlu5, pERK and one of various 
markers for excitatory or inhibitory interneurons. Following DHPG (but not 
saline), numerous pERK-positive cells were seen in the SDH, particularly lamina 
II, and the great majority of these were mGlu5-positive. ERK phosphorylation was 
detected in both inhibitory and excitatory mGlu5-expressing cells, suggesting 
that type I mGlus have a complex role in nociceptive processing. 
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Pain is among the most complex perceptions, and its research brings together 
elements of many disciplines. It is defined by the International Association for 
the Study of Pain as “An unpleasant sensory and emotional experience 
associated with actual or potential tissue damage, or described in terms of such 
damage”. Nociception on the other hand is defined as “The processes of 
encoding and processing of noxious stimuli, which is an actual or potential tissue 
damaging event, by the nervous system” (Treede, 2009). The SDH of the spinal 
cord represents the first area of the central nervous system (CNS) where 
transmission and modulation of pain-related information occurs.   
1.1 Nociception and the spinal cord 
Nociception involves detection of tissue damage by specialized receptors. Both 
somatic and visceral nociceptors can be activated by noxious chemical, 
mechanical or thermal stimulation in addition to stimuli that only threaten 
damage. Nociceptors convey this information to the first synaptic relays in the 
dorsal horn of the spinal cord. In order to understand the mechanisms of 
nociception and to produce more selective analgesics for use in the treatment of 
both animal and human pain, it is essential to develop various nociception 
eliciting models. These include models of acute and chronic pain such as 
applying noxious or innocuous stimuli to the hindpaw of a rodent, or using 
peripheral nerve injury induced models of pain (Garry et al., 2004).  
The dorsal horn of the spinal cord is a major relay region for nociceptive inputs 
and in the 1950s there was a need to develop a widely accepted scheme that 
divided its grey matter into distinct regions. In 1952, Rexed divided the dorsal 
horn of the cat spinal cord into a series of six parallel laminae based on certain 
cytoarchitectonic characteristics. This scheme was then adapted to other 
species including the rat (Steiner and Turner, 1972; Clark, 1984; Molander et al., 
1984). Lamina I, which is sometimes referred to as the marginal zone, is located 
at the most dorsal aspect of the dorsal horn, and it represents an important 
nociceptive area. Lamina II, which is also known as ‘Substantia Gelatinosa of 
Rolando’ after Luigi Rolando (Caputi et al., 1995) has a very low concentration 
of myelinated fibres, thus it appears translucent under the microscope in thick 
wet sections. Lamina II is further divided into two layers: lamina II outer (IIo) 
with densely packed small cells and predominant primary afferent input from C-
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fibres, and lamina II inner (IIi) with slightly larger neurons and a significant input 
from myelinated fibres. Laminae III and IV are known as the ‘Nucleus Proprius’. 
Most cells in lamina III are small and densely packed with some scattered large 
neurons compared to the more heterogenous lamina IV cells. Laminae V and VI 
are referred to as the neck and base of the dorsal horn, respectively.  
The SDH, which includes laminae I and II, is the main target of nociceptive 
primary afferents. Some nociceptive primary afferents also terminate in deeper 
laminae (III-VI), indicating that this region has an important role in both 
physiological and pathological pain states (Light and Perl, 1979a, 1979b; Cervero 
and Iggo, 1980; Sugiura et al., 1986).  
In addition to the primary afferent input to the dorsal horn, it receives pain 
modulating descending axons from various parts of the brain (Fields et al., 2006; 
Heinricher et al., 2009). The dorsal horn contains neurons which, based on their 
axonal projections, can be divided into two broad classes: interneurons, with 
axons that remain in the spinal cord and projection neurons with axons travelling 
to supraspinal targets such as the brainstem and thalamus. Projection neurons 
are less numerous than interneurons and are known to be excitatory while 
interneurons can be either excitatory or inhibitory (Todd, 2006). In order for us 
to understand the neural circuits that link incoming primary afferents to 
projection neurons, these two broad classes have to be further divided into 
distinct functional populations (Todd, 2010). 
1.2 Primary afferents fibres 
Primary afferent fibres have a remarkable capacity of detecting and transmitting 
sensory information from the periphery to the spinal cord, thus linking external 
and internal environments to the CNS. The somata of primary afferent neurons 
are located in the trigeminal ganglion and the dorsal root ganglia (DRG). A 
central branch from the axons of these neurons travels through a dorsal root to 
enter the spinal cord where it forms axodendritic or axosomatic synapses with 
second-order neurons. Primary sensory fibres are most commonly classified 
based on the conduction velocity of their axons, which is directly related to the 
axonal diameter and whether or not the axon is myelinated. Sensory fibres in 
cutaneous and visceral nerves are routinely divided into Aα/β-, Aδ- and C-fibres. 
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The Aα/β group consists of large myelinated axons that have the fastest 
conduction velocities (25-100 m/s) and most of these are classified as low-
threshold mechanoreceptors (LTM), responding to touch, pressure, stretch or 
hair movement. Aδ-fibres are thinly myelinated and conduct at an intermediate 
velocity (5-25 m/s). C-fibres are the smallest, unmyelinated and most slowly 
conducting fibres (<2.5 m/s). The majority of Aδ [excluding the down (D) hair 
afferents] and most C-fibres are classified as nociceptors or thermoreceptors 
(Todd and Koerber, 2006). Different terminology is used for sensory fibres in 
muscles and joint nerves. Their myelinated afferents are subdivided into groups 
I, II and III, while group IV corresponds to the unmyelinated afferents (Willis and 
Coggeshall, 2004). Figure 1-1 shows Rexed’s laminae and the laminar 
termination pattern of primary afferents in the rat dorsal horn.   
 
Figure  1-1 Rexed’s laminae and the laminar termination pattern of primary afferents. 
The image shows the central terminations of the major primary afferent neurons, the dashed 
lines show laminar boundaries. Modified from Todd (2010). 
Primary afferent fibres are either nociceptive or non-nociceptive and can be 
divided into somatic (cutaneous or deep) or visceral depending on their 
peripheral targets. When a stimulus is applied to a sensory receptor, it elicits a 
response through stimulus transduction, which is the process of converting a 
physical stimulus into a generated potential leading to an action potential. Some 
fibres have specialized response properties since they only respond to one type 
of stimulus, while most nociceptors respond to different sensory modalities 
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including mechanical, thermal and chemical stimuli, and are considered 
polymodal. In most early studies of nociceptors, primary afferents that 
responded to both mechanical and thermal stimulation were referred to as 
mechano-heat-sensitive fibres. These were also considered polymodal 
nociceptors because if an afferent responded to mechanical and heat stimuli, it 
would, in most cases, respond to chemical stimuli as well (Davis et al., 1993).  
The term ‘nociceptive nerves’ was first introduced by Sir Charles Sherrington in 
1906 (Burke, 2007). Nociceptors are specialized primary sensory neurons that 
detect damaging or potentially damaging stimuli, which may result in the 
perception of pain and subsequently initiate protective responses. Nociceptors 
play an important role in this protective function of the pain pathway. They are 
able to: (1) detect various physical and chemical stimuli, (2) set specific 
response thresholds for each stimulus, thus being able to distinguish between 
noxious and innocuous events, and even (3) reset these thresholds in order to 
protect against further damage, a phenomenon known as sensitization (Julius 
and McCleskey, 2006).   
1.2.1 Nociceptive unmyelinated primary afferents  
The majority of cutaneous C-fibres are classified as nociceptors since they can 
be activated exclusively by intense mechanical, thermal or chemical stimuli and 
are typically polymodal (Lynn and Carpenter, 1982; Fleischer et al., 1983). It 
was also reported that some of the small diameter afferents from muscles and 
tendons (Mense and Meyer, 1985) as well as from joints (Schaible and Schmidt, 
1985) are considered nociceptors, while others fall under the low-threshold 
receptor category.  
C-fibres are divided into two major neurochemical groups: peptidergic, which 
innervate various tissues including the epidermis and deeper regions of the skin, 
and non-peptidergic, which innervate mainly the epidermis (Rice et al., 1997; 
Zylka et al., 2005). Peptidergic C-fibres express either one or a combination of 
the following peptides: calcitonin gene-related peptide (CGRP), substance P, 
somatostatin, galanin, cholecystokinin, and vasoactive intestinal polypeptide 
/peptide histidine isoleucine (Ju et al., 1987; Bennett et al., 1996). CGRP is the 
most useful marker for detecting peptidergic afferents for two reasons: first, it 
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appears to be present in all of these, including those that contain substance P or 
somatostatin (Ju et al., 1987), and second, within the dorsal horn, CGRP is 
exclusively present in primary afferents (Chung et al., 1988). Lawson et al. 
(2002) reported that CGRP was detected in less than half of the nociceptive DRG 
neurons of the guinea-pig including those with C-fibres. The majority of 
peptidergic C nociceptors terminate in lamina I and lamina IIo (Figure 1-1).  
Most non-peptidergic C-fibres bind the plant lectin IB4 from Bandeiraea 
simplicifolia (Plenderleith and Snow, 1993). These can be recognized by the 
presence of IB4-binding and the lack of CGRP-immunoreactivity (Sakamoto et 
al., 1999). However, Dhaka et al. (2008) identified a subpopulation of non-
peptidergic C-fibres in the mice that lack peptides and do not bind IB4. Zylka et 
al. (2005) identified another population of IB4-positive non-peptidergic C 
nociceptors that was revealed by axonal tracers targeted to Mrgprd, a Mas-
related gene which is expressed in specific subsets of nociceptive sensory 
neurons in mice (Zylka et al., 2003). These Mrgprd+ fibres exclusively innervate 
the epidermis and project centrally to lamina II of the spinal cord suggesting a 
central topographic segregation of the projection of peptidergic and non-
peptidergic nociceptive sensory neurons to the spinal cord (Figure 1-1).    
The central arborisations of peptidergic primary afferents are concentrated in 
lamina I and the outer half of lamina II (IIo), and also extend to laminae III-IV. 
These peptidergic fibres form simple (non-glomerular) endings that rarely 
receive axo-axonic synapses (Ribeiro-da-Silva et al., 1989). In contrast, the IB4-
binding non-peptidergic C-fibres that correspond to the subpopulation identified 
by Zylka et al. (2005) terminate in a narrow band that occupies the central part 
of lamina II and form central axons of type I synaptic glomeruli (Ribeiro-da-Silva 
and Coimbra, 1982). These axons are postsynaptic to GABAergic boutons at axo-
axonic synapses and therefore are targets to classical presynaptic inhibition 
(Todd, 1996).  
1.2.2 Nociceptive myelinated primary afferents 
Myelinated nociceptors include both the slow Aδ-fibres, which were first 
identified by Burgess and Perl (1967), and a propotion of the fast Aα/β-fibres 
(Djouhri and Lawson, 2004). A-fibre nociceptors respond to external stimulation 
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with higher discharge frequencies, compared to the responses of C-fibre 
nociceptors. This suggests that A-fibre nociceptors provides more discriminable 
information regarding stimulus intensity and they are thought to signal fast 
pricking or sharp pain (Slugg et al., 2000; Lumpkin and Caterina, 2007).  
Although the neurochemistry of myelinated nociceptors is not yet fully known, it 
has been reported that substance P and CGRP are among the neuropeptides that 
are expressed by these nociceptors (Lawson et al., 1997; Lawson et al., 2002). 
The central projections of myelinated nociceptors were initially described in the 
cat and monkey by Light and Perl (1979b). Their study reported that lamina I, 
the most dorsal part of lamina II as well as lamina V of the spinal cord received 
projections from relatively slow conducting myelinated primary afferent 
nociceptors; the Aδ type. More recently, a second type of A-fibre nociceptors 
was identified, which resembled myelinated LTMs in its central projections, 
since these fibres projected to deeper laminae. However, they also projected to 
the SDH, suggesting a more diffuse pattern of central projection (Woodbury and 
Koerber, 2003; Woodbury et al., 2008). 
One of the methods for identifying the central terminals of myelinated primary 
afferents is by their ability to transport peripherally injected cholera toxin B 
subunit (CTb). CTb is a protein that binds specifically to ganglioside GM1, which 
is expressed by most myelinated afferents but not by intact C-fibres in somatic 
nerves of rodents. However, the transganglionic labelling with CTb seen in 
lamina I (which is thought to be contained in terminals of Aδ nociceptors) rarely 
colocalised with CGRP or substance P, suggesting that peptidergic Aδ afferents 
do not normally express the GM1 ganglioside and therefore could not be 
identified with CTb (Shehab and Hughes, 2011).  
1.2.3 Non-nociceptive primary afferents 
Non-nociceptive primary afferents are mostly low-threshold thermoreceptors 
and/or LTMs. Most fibres projecting to the skin and skeletal muscles from the 
DRG are LTMs (Djouhri and Lawson, 2004). Cutaneous LTMs respond to innocuous 
mechanical stimulation such as light brushing of the limb fur, light pressure with 
blunt objects or distortion.  
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LTMs of the fast conducting myelinated type (Aα/β) make up a large proportion 
of cutaneous and muscle fibres. A smaller proportion of fibres in skin and 
muscles are of the slowly conducting Aδ group (Perl, 1992). Cutaneous LTMs of 
the Aα/β type can be divided into rapidly adapting and slowly adapting fibres 
(Willis and Coggeshall, 2004). 
Brown (1981) summarized the findings of numerous studies of LTMs in the cat, 
and reported that these fibres migrate medially within the dorsal columns as 
they move away from their point of entry in the spinal cord. Most of them 
bifurcate to give rostral and caudal branches within the dorsal horn. Collaterals 
from these fibres terminate in dense arborisations that lie within a region 
extending from lamina III to lamina V, with fibres innervating hair follicles 
terminating more superficially than those innervating slowly adapting receptors. 
Shortland et al. (1989) studied the central projections of hair follicle afferents 
in the rat, and reported that these afferents formed narrow sagittal sheets of 
arbors extending from lamina IIi to lamina IV. In addition, Hughes et al. (2003) 
found that in the rat, the termination zone of afferents with hair follicle-like 
morphology extended dorsally into the ventral half of lamina II (Figure 1-1).                                        
LTMs of the Aδ type include D-hair afferents and are found in hairy skin. They 
are sensitive to the slow movements of hairs (Rethelyi et al., 1982). These fibres 
were found to project extensively into laminae IIi and III-IV of the dorsal spinal 
cord (Light et al., 1979; Woodbury and Koerber, 2003). They gave rise to large 
varicosities that formed the central terminals of type II glumeruli (Rethelyi et 
al., 1982).    
LaMotte et al. (1982) reported that the threshold of warm receptors in the 
monkey is below the pain threshold (41-49°C), and these receptors responded 
better to painless heat than to painful heat. The conduction velocity of these 
receptors in the glabrous skin of the monkey is of the Aδ range. The low-
threshold cold receptors, which discharged statically at 20-30°C skin 
temperature, also had a homogenous distribution of conduction velocities of the 
Aδ range in the glabrous skin of the monkey (LaMotte and Thalhammer, 1982).  
  9 
It was reported that in the cat, a fraction of C-fibres responded to both low-
threshold mechanical stimulation and thermal stimulation, and did not respond 
uniquely to noxious stimulation (Bessou and Perl, 1969; Bessou et al., 1971). A 
subclass of these low-threshold C-fibres was recently found to respond vigorously 
to slow and light stroking of the hairy skin in humans (Loken et al., 2009). 
Additionally, selective stimulation of these fibres activated the insular cortex; 
an area known to process positive emotions (Olausson et al., 2002). 
Recently, certain molecular and histological markers of subtypes of 
unmyelinated LTMs (Seal et al., 2009) and rapidly adapting myelinated 
mechanoreceptors (Bourane et al., 2009; Luo et al., 2009) have been identified 
in the mice. Seal et al. (2009) reported that a subset of glutamatergic C-fibre 
LTMs that terminated in laminae I and IIi of the spinal cord of the mice appear to 
be important for the onset of hypersensitivity caused by spared nerve injury. 
1.2.4 Neurochemistry of primary afferents 
Glutamate is the principal excitatory neurotransmitter in the CNS and it is used 
by all primary afferents. Glutamate and substance P, a neuropeptide involved in 
nociception transmission, coexist in many primary afferent terminals in the 
superficial laminae of the spinal cord (De Biasi and Rustioni, 1988) and these will 
be discussed in more detail.  
1.2.4.1 Glutamate  
Glutamate was discovered in 1907 by the Japanese chemist Kikunae Ikeda 
(Kurihara, 2009). After its synthesis in the presynaptic cytoplasm, glutamate is 
transported into the synaptic vesicles for its exocytotic release. Glutamate 
transport requires a specific energy generating system that uses the H+-ATPase 
pump. Certain proteins have been shown to function as vesicular glutamate 
transporters (VGLUTs) and were named VGLUT1, VGLUT2 and VGLUT3 
(Takamori, 2006). VGLUT1 was originally characterized as a brain-specific Na+-
dependent inorganic phosphate transporter I (BNPI) (Ni et al., 1994), while 
VGLUT2 was known originally as differentiation-associated Na+-dependent 
inorganic phosphate transporter I, a protein that highly resembled BNPI (Aihara 
et al., 2000). Subsequently, VGLUT3 was identified and found to be expressed in 
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a more restricted pattern in the CNS in addition to its expression in the DRG 
(Gras et al., 2002). Antibodies against VGLUTs helped in identifying 
glutamatergic axons in anatomical studies. VGLUT1 has been found to be 
expressed by all low-threshold myelinated fibres, while VGLUT2 is expressed by 
lamina I Aδ-fibres as well as by axons of most glutamatergic spinal neurons in the 
rat (Oliveira et al., 2003; Todd et al., 2003; Alvarez et al., 2004). The 
expression of VGLUT2 by unmyelinated primary afferents is found to be weak in 
the rat and the mouse, and these fibres do not express VGLUT1 (Todd et al., 
2003; Brumovsky et al., 2007). VGLUT3, however, is found to be expressed by a 
population of unmyelinated primary sensory neurons projecting to lamina I and 
the inner part of lamina II of the mice dorsal horn (Seal et al., 2009).    
Glutamate acts on both ionotropic and metabotropic receptors. These are the 
most widespread excitatory neurotransmitter receptors in the CNS, thus they 
contribute to both normal and pathological neural activities. Ionotropic 
receptors are subdivided into three groups: AMPA (α-amino-3-hydroxyl-5-methyl-
4-isoxazole-propionate), Kainate and NMDA (N-methyl-D-aspartic acid). AMPA 
receptors are made up from 4 different subunits: GluA1-4 (GluR1-4), with 
receptors lacking the GluA2 (GluR2) subunit being permeable to Ca2+ (Burnashev 
et al., 1992). They are tetramers that exist either as homomeric, containing 
single receptor subtype, or heteromeric receptors. Kainate receptor subtypes 
include GluK1-5 (GluR5-7, KA1 and KA2) (Pinheiro and Mulle, 2006). NMDA 
receptor subunits include GluN1-3 (NR1-3), and GluN2 is further divided into 4 
subunits (GluN2A-D). NMDA receptors are heteromeric complexes, which are 
composed of the GluN1 subunit and one or more of the GluN2 subunits (Matsuda 
et al., 2002). There are 8 cloned metabotropic glutamate receptors (mGlus) that 
are classified into 3 groups. Group I: mGlu1 and mGlu5 (mGluR1 and mGluR5), 
group II: mGlu2 and mGlu3 (mGluR2 and mGluR3) and group III: mGlu4, 6-8 
(mGluR4, 6-8) (Conn and Pin, 1997). mGlus will be discussed in Chapter 5. 
1.2.4.2 Substance P 
Substance P is an undecapeptide that is involved in nociception; it acts on the 
NK1 receptor. Substance P is a member of the mammalian tachykinin group 
which include two other peptides: neurokinin A and neurokinin B, which act on 
the neurokinin 2 and 3 receptors (NK2R and NK3R), respectively (Nakanishi, 
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1991). Substance P and neurokinin A are both derived from the same gene 
(preprotachykinin I), while neurokinin B is derived from a different gene, 
preprotachykinin II (Helke et al., 1990). Substance P and neurokinin A are 
expressed by both primary afferents and dorsal horn neurons, while neurokinin B 
is found in the SDH interneurons of the rat (Ogawa et al., 1985; Moussaoui et al., 
1992). Substance P was discovered by von Euler and Gaddum (1931) and its 
sequence was identified by Chang and Leeman (1970). In the rat, substance P is 
colocalised with CGRP in many of the small DRG neurons. It is packed into the 
large dense-core vesicles at the trans-Golgi network in the cell bodies. It is then 
transported to the peripheral terminals of C-fibres in tissues, and to the central 
terminals in laminae I-II of the spinal cord (Todd, 2002, 2006). Substance P is 
stored in these terminals and can be released into the dorsal horn of the spinal 
cord following intense peripheral stimulation (Duggan et al., 1987; Duggan et 
al., 1988; Liu et al., 1994; Mantyh et al., 1995). Substance P plays a role in 
nociceptive signal transmission by promoting central hyperexcitability and 
increasing sensitivity to pain (Salter and Henry, 1991; Ma and Woolf, 1995). 
Traub (1996) also reported that substance P, released upon peripheral tissue 
insult, contributes mainly to generation but not maintenance of hyperalgesia, by 
facilitating the activation of NMDA receptors, leading to SDH hyperexcitabilty.   
1.2.5 Receptors on primary afferents  
Most studies of receptors on primary afferents have been performed in the DRG, 
since locating these receptors on terminals of primary fibres in the spinal cord 
requires the development of specific antibodies against them (Ribeiro-da-Silva 
and De Koninck, 2009). A number of primary afferent receptors have been 
reported to play a role in peripheral modulation of nociception. These include 
glutamate receptors, opioid receptors, cholinergic receptors, α2-adrenergic 
receptors, somatostatin receptors and transient receptor potential receptors 
(TRPs) (Meyer et al., 2006; Todd and Koerber, 2006). The TRPs, particularly 
TRPV1, will be discussed in more detail since capsaicin, which acts on TRPV1, is 
used in this study as a peripheral noxious stimulus.    
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1.2.5.1 Transient receptor potential receptors (TRPs)  
TRPs are members of a family of transducer protein molecules which are present 
in the surface membranes of nociceptors, thermoreceptors and thermoreceptive 
neurons. These receptors are essential for nociceptive excitation after chemical 
or thermal stimuli. There are four vanillin TRPs that form a group of 
thermosensitive channels in mammals: TRPV1, TRPV2, TRPV3 and TRPV4. Non-
vanilloid TRPs include TRPM8 and TRPA1 (also called ANKTM1).  
In mammals, each of the thermally sensitive TRPs responds to a distinct 
temperature range from cold to noxious heat, and most are expressed in 
cutaneous sensory neurons (Patapoutian et al., 2003). TRPV1, formerly known as 
the vanilloid receptor, is among the earliest proteins that were known to play a 
major role in heat transduction. It is highly expressed on many nociceptive Aδ 
and C-fibres (Caterina and Julius, 2001). In addition to its activation by noxious 
heat (temperatures ≥42°C), TRPV1 is also activated by chemicals such as 
capsaicin [the active substance in chilli peppers (8-methyl-N-vanillyl-6-
nonenamide)] and its agonist resiniferatoxin (Caterina et al., 1997) as well as by 
some endogenous lipids (Vennekens et al., 2008). The function of TRPV1 in the 
peripheral nervous system has been extensively studied. It is specifically 
activated by capsaicin, a lipophillic vanilloid compound found in a wide variety 
of red peppers of the genus capsicum. Binding of capsaicin to TRPV1 activates 
nonselective cation channels, leading to Na+ and Ca2+ influx, which triggers 
action potential firing and the consequent burning sensation associated with 
spicy food (Holzer, 1991). Caterina et al. (2000) reported that TRPV1–/– (knock-
out) mice exhibited no capsaicin/vanilloid evoked pain behaviour and an 
impaired response to noxious thermal stimuli, but responded normally to noxious 
mechanical stimuli. In the spinal cord dorsal horn, the role of TRPV1 in pain 
transmission and modulation is not yet fully understood (Spicarova and Palecek, 
2008). Recently, Cavanaugh et al. (2011) found that during development, a 
substantial percentage of IB4-binding, non-peptidergic neurons lose the 
expression of functional TRPV1 and that in adult mice, TRPV1 expression is 
restricted to a subset of peptidergic primary afferent neurons in the DRG. 
In the periphery, TRPV2 is strongly expressed on a subset of Aδ nociceptors as 
well as in other neuronal and non-neuronal cells (Caterina and Julius, 2001). 
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TRPV2 is only activated by intense noxious heat (temperatures ≥52°C), while 
TRPV3 and TRPV4 respond to lower temperatures. However, TRPV3 responses 
continue to increase with increasing temperatures that reach the noxious range, 
suggesting that it may play a role in nociception (Patapoutian et al., 2003). 
TRPM8 is known to play a role in cold transduction (McKemy et al., 2002; Peier 
et al., 2002). The TRPM8 channel, which is expressed almost exclusively in a 
subpopulation of C-fibres, can be activated by low temperatures (15-30°C) and 
by other chemicals that produce a cooling sensation such as menthol (Lumpkin 
and Caterina, 2007). Further, the exposure to temperatures below 18°C 
activates another member of the TRP family, TRPA1, suggesting that TRPA1 may 
contribute to TRPM8-independent cold transduction of the noxious cold 
temperature range (Story et al., 2003; Lumpkin and Caterina, 2007). 
Thermal or chemical activation of the TRP receptors, which are expressed on C- 
and Aδ-fibres, subsequently results in the release of glutamate and peptides 
including substance P, neurokinin A and CGRP into the dorsal horn, contributing 
to the excitation of second order sensory neurons (Sorkin and McAdoo, 1993; Sun 
et al., 2004; Yan et al., 2006). 
1.3 Dorsal horn projection neurons  
Dorsal horn projection neurons have axons that ascend to various areas of the 
brain. These neurons are not uniformly distributed throughout the grey matter 
of the spinal cord, and this has been shown by injecting retrograde tracers into 
all known supraspinal targets. In the rat, neurons with axons projecting to the 
brain are present in relatively large numbers in lamina I, are largely absent from 
lamina II and are scattered throughout the remainder of the dorsal horn (Todd, 
2010).  
1.3.1 Dorsal horn projection neurons in lamina I  
It has been estimated that projection neurons make up around 5-10% of the 
neuronal population in lamina I (Bice and Beal, 1997a, 1997b; Spike et al., 2003; 
Al-Khater et al., 2008). Many lamina I neurons have axons that remain in the 
spinal cord, and these interneurons are thought to play a major role in 
modulating the process of nociception.  
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Projection neurons in lamina I have axons that cross the midline ascending to a 
variety of supraspinal targets. These include: (1) The caudal ventrolateral 
medulla (CVLM), an area that may play a significant role in modulating 
cardiovascular responses to nociceptive stimulation (Lima et al., 1991; Lima et 
al., 2002; Spike et al., 2003). (2) The dorsal reticular nucleus (DRt) and the 
nucleus of the solitary tract (NTS), which partially but significantly mediates 
cardiorespiratory reflex responses to noxious stimulation (Lima, 1990; Boscan 
and Paton, 2001; Gamboa-Esteves et al., 2004). (3) The lateral parabrachial area 
of the pons (LPb), which in turn projects to areas in the brain involved in 
emotional aspects and autonomic components of pain such as the amygdala and 
hypothalamus (Cechetto et al., 1985; Hylden et al., 1989; Bernard and Besson, 
1990; Bester et al., 1995; Ding et al., 1995; Gauriau and Bernard, 2002). (4) The 
midbrain periaqueductal grey matter (PAG), which forms part of a descending 
analgesic pathway that projects via the rostral ventromedial medulla, 
modulating nociceptive transmission within the spinal cord dorsal horn (Todd et 
al., 2000; Spike et al., 2003; Al-Khater and Todd, 2009; Drew et al., 2009). (5) 
Certain nuclei in the thalamus, which in the rat include the ventral 
posterolateral nucleus that projects to the primary somatosensory cortex and 
the posterior triangular nucleus (PoT) projecting to the 2nd somatosensory area. 
The ventral posterolateral nucleus contributes to the sensory-discriminative 
aspect of pain, while PoT contributes to the affective-motivational aspect of 
pain (Burstein et al., 1990; Gauriau and Bernard, 2004; Al-Khater et al., 2008; 
Todd, 2010).  
Todd (2010) summarized the quantitative data collected from a series of studies 
of projection neurons in the L4 segment of the rat spinal cord. Most of lamina I 
projection neurons can be retrogradely labelled from the CVLM and/or the LPb. 
Almost all lamina I cells projecting to the thalamus, PAG or NTS also project to 
LPb. However, since the region of CVLM is close to the main bundle of ascending 
axons, the tracer injected into this area may be up taken by the fibres of 
passage rather than projection neurons axon terminals.   
Almost a century ago in 1909, Ramon Cajal described the morphology of neurons 
in the nervous system (Garcia-Lopez et al., 2011). Cells in lamina I of the spinal 
cord were known traditionally as the marginal cells of Waldeyer. Lamina I 
contains neurons of different shapes and sizes, and the morphology of these 
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neurons has been examined in various species. Lima and Coimbra (1983, 1986) 
distinguished 4 morphological classes of lamina I neurons in the rat based on 
their dendroarchitecture and cell body shape: (1) Fusiform spiny cells having 
longitudinally-orientated perikarya with bipolar dendrtic trees. (2) Pyramidal 
prismatic wedge shaped cells with 3 to 5 dendritic trunks arising from the apical 
and basal angles of the cell body. (3) Flattened aspiny neurons with a polygonal 
flattened body and horizontal dendritic arbor confined to lamina I. (4) Multipolar 
cells with a cuboidal cell body and dense dendritic trees originating from 
numerous primary trunks. Subsequent studies of projection neurons in lamina I 
of the rat, cat and monkey confirmed the findings of Lima and Coimbra (1983, 
1986) fusiform, pyramidal and flattened cells. However, flattened cells were 
named as multipolar and Lima and Coimbra’s multipolar cells have not been 
further described in the literature (Zhang et al., 1996; Zhang and Craig, 1997; 
Prescott and De Koninck, 2002; Spike et al., 2003; Almarestani et al., 2007). 
Lamina I neurons were also classified based on their soma sizes, and this means 
of classification will be further discussed in Chapter 3. In addition, a substantial 
number of lamina I neurons responded specifically to various forms of noxious 
stimuli, and their responses will be discussed in detail in Chapter 4.  
Lamina I projection neurons have been classified based on the expression of the 
NK1 receptor into NK1r-expressing projection neurons and projection neurons 
that either lacked or weakly expressed the receptor. The NK1 receptor, on 
which substance P acts, is a G protein-coupled receptor consisting of seven 
membrane spanning domains (Yokota et al., 1989).    
1.3.1.1 Lamina I NK1r-expressing projection neurons 
Cells possessing the NK1 receptor are present in all dorsal horn laminae but are 
most numerous in lamina I (Todd et al., 2002). They make up around 80% of 
lamina I projection neurons, and project to the CVLM, NTS, PAG, LPb and 
thalamus (Todd et al., 2000; Spike et al., 2003; Al-Khater et al., 2008).  
Lamina I NK1r-expressing projection neurons selectively receive input from 
peptidergic primary afferents most of which contain substance P (Todd et al., 
2002). These cells also receive glutamatergic input from lamina II vertical 
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interneurons (Lu and Perl, 2005). These glutamatergic vertical cells receive 
peripheral inputs from TRPA1- and TRPV1-expressing C-fibres (Uta et al., 2010), 
as well as from Aδ-fibres, in addition to a central input from neighbouring lamina 
II glutamatergic central interneurons (Lu and Perl, 2005).  
Lamina I NK1r-expressing neurons have been studied extensively in the past few 
years. These cells have attracted attention since they responded specifically to 
noxious stimulation (Salter and Henry, 1991). They also internalized the NK1 
receptor into their cytoplasm following acute noxious stimulation (Mantyh et al., 
1995; Abbadie et al., 1997; Allen et al., 1997). Further, the number of neurons 
with internalized NK1 receptors was proportional to the severity of the noxious 
stimuli (Wang and Marvizon, 2002). These cells also up-regulated fos (the protein 
product of the immediate-early gene c-fos), and phosphorylated ERK after 
noxious stimulation (Doyle and Hunt, 1999; Ji et al., 2002; Todd et al., 2002; 
Polgar et al., 2007). Activation of NK1r-expressing neurons following noxious 
stimulation will be further discussed in Chapter 4.  
It was reported that intrathecal injection of substance P conjugated to the 
cytotoxin saporin (SP-SAP) selectively destroyed NK1r expressing neurons in the 
dorsal horn (Mantyh et al., 1997; Nichols et al., 1999). SP-SAP injected-rats 
showed signs of dramatically reduced hyperalgesia in both inflammatory and 
neuropathic pain models, while their response to acute painful stimuli was 
normal. However, mice that lacked either the NK1 receptor (De Felipe et al., 
1998) or the gene coding for substance P formation (Cao et al., 1998), showed 
little reduction in signs of hyperalgesia in inflammatory models, yet significantly 
reduced responses to acute painful stimulation. These findings suggest that 
although substance P acting on the NK1r-expressing neurons plays a role in 
nociception, there are other substances, such as glutamate released from 
primary afferents (De Biasi and Rustioni, 1988) that are more important in the 
development of hyperalgesia. 
1.3.1.2 Lamina I giant cells 
Lamina I giant cells have been identified by Puskar et al. (2001) as a population 
of very large multipolar lamina I projection neurons that either lacked or weakly 
expressed the NK1 receptor. They are very sparse since there are only around 10 
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of these cells on each side of the L4 segment of the rat spinal cord. They 
therefore make up ~2.5% of lamina I projection neurons. Most of the giant cells 
were retrogradely labelled from the parabrachial area (Puskar et al., 2001; 
Polgar et al., 2008).  
These cells are identified by the presence of gephyrin; the glycine and GABA 
receptor associated protein, on their cell bodies and proximal dendrites. They 
receive extensive inputs from neuronal nitric oxide synthase (nNOS)-containing 
GABAergic internurons (Puskar et al., 2001). They also receive a high density 
input from VGLUT2-containing excitatory interneurons (Polgar et al., 2008). 
However, these cells appear to receive little direct synaptic input from primary 
afferents, suggesting that their responses to noxious stimuli are mainly mediated 
by excitatory interneurons (Polgar et al., 2008; Todd, 2010).  
It was reported that after the injection of formalin to the rat hindpaw, 26 out of 
30 giant cells up-regulated fos (Puskar et al., 2001). Polgar et al. (2008) also 
reported that 38% of the giant cells contained fos after noxious heat. The above 
studies suggest that giant cells, which lack or weakly express the NK1 receptor, 
may contribute to the normal responses to acute noxious stimuli seen after the 
injection of SP-SAP, which selectively destroys NK1r-expressing neurons.   
1.3.2 Dorsal horn projection neurons in laminae III-IV  
Rexed (1952) observed that lamina III of the spinal cord contained numerous 
small cells and scattered larger ones, while lamina IV cells were more variable in 
size. Further, early Golgi studies in the cat identified large laminae III-IV neurons 
with dorsal dendrites extending to superficial laminae (Szentagothai, 1964; 
Rethelyi and Szentagothai, 1969). Schoenen (1982) also reported that in humans, 
laminae III-IV contained a mixed population of antenna-like neurons with 
dorsally oriented dendritic domains. Thereafter, these cells were identified in 
the rat (Todd, 1989) and some were found to express the neurokinin 1 receptor 
(Bleazard et al., 1994; Brown et al., 1995; Littlewood et al., 1995).  
Todd et al. (1998) reported that around 11% of lamina III cells were NK1r-
immunoreactive, while the percentage of NK1r-expressing neurons in lamina IV 
was approximately 28%. However, the population of large NK1r-immunoreactive 
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projection neurons with long dorsal dendrites represents only approximately 
0.1% of all neurons in lamina III (Polgar et al., 2004). These cells have similar 
supraspinal targets to the lamina I projection cells, since they project to the 
CVLM, NTS, LPb, PAG and the thalamus (Marshall et al., 1996; Naim et al., 1997; 
Todd et al., 2000; Al-Khater et al., 2008; Al-Khater and Todd, 2009).  
Laminae III-IV NK1r-immunoreactive cells are densely innervated by substance P-
containing primary afferents, which appear to run ventrally along their dorsal 
dendrites (Naim et al., 1997). In addition, these cells receive a moderate input 
from myelinated LTMs (Naim et al., 1998), but they do not seem to receive any 
significant input from non-peptidergic IB4-binding C-fibres (Sakamoto et al., 
1999). These cells are also densely innervated by GABAergic interneurons that 
contain neuropeptide Y (Rowan et al., 1993; Polgar et al., 1999b). It has been 
recently reported that these neuropeptide Y-positive interneurons constitute 
around 30% of laminae III-IV NK1r-immunoreactive cells’ inhibitory input (Polgar 
et al., 2011).  
Both laminae I and III-IV NK1r-expressing neurons are innervated by descending 
serotoninergic axons from the raphe nuclei that selectively depress the 
transmission of nociceptive information (Stewart and Maxwell, 2000; Polgar et 
al., 2002). This is evidenced by the high density contacts of serotonin-containing 
axons forming synapses with the NK1r-expressing neurons, suggesting that a 
significant part of the descending raphe-spinal inhibitory system is mediated 
directly by serotoninergic axons (Polgar et al., 2002). These cells also receive 
some noradrenergic input from the locus coeruleus and other pontine regions 
(Stewart, 2001; Todd, 2010).  
1.4 Dorsal horn interneurons  
Interneurons have axons that remain in the spinal cord and arborize locally. They 
form the vast majority of neurons in laminae I-III. They include virtually all 
neurons in lamina II and most of laminae I and III neurons. Interneurons can be 
divided into two main functional types: inhibitory cells, using GABA and/or 
glycine as their principal transmitter, and excitatory cells with glutamate being 
their main neurotransmitter (Todd and Spike, 1993). Interneurons are thought to 
play an important role in pain processing. They modify incoming somatosensory 
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information before it is relayed to higher centres. For instance, inhibitory 
interneurons exert a powerful control on spinal nociceptive neurons. A review by 
Sandkuhler (2009) summarized the role of inhibitory interneurons in 4 distinct 
functions. (1) They attenuate the responses of nociceptive neurons during 
nociception. (2) They prevent spontaneous pain by muting nociceptive neurons 
during normal states. (3) They separate nociceptive from non-nociceptive 
information in order to prevent cross-talk between different sensory modalities. 
(4) They also limit the spread of excitation by inhibiting excitatory interneurons 
that cross somatotopic borders.  
Attempts have been made to classify interneurons morphologically, 
electrophysiologically, neurochemically and sometimes by combining two 
methods of classification together. However, there is not a generally accepted 
scheme that applies to all of these cells. Neurochemical classification of laminae 
I, II and III-IV interneruons will be discussed separately, since the expression of 
most dorsal horn neurotransmitters is not confined to one lamina.  
1.4.1 Interneurons in lamina I  
The organisation of lamina I interneurons is not yet fully understood. This may 
be due to the fact that lamina I contains projection neurons and inteneurons 
that are not easily distinguished (Todd, 2010). Three-quarter of lamina I 
interneurons are thought to be glutamatergic since the remaining 25-30% of 
these interneurons contain GABA (Todd and Sullivan, 1990; Polgar et al., 2003).  
1.4.1.1 Morphological and electrophysiological classification 
Grudt and Perl (2002) studied a sample of 13 lamina I neurons, in spinal cord 
slices prepared from hamsters, 8 of which did not project to supraspinal targets 
and were therefore presumed to be interneurons. These cells had ipsilateral 
directed axons in contrast to the axons of the projection neurons that ran 
ventrally and medially toward the contralateral cord. The axonal arborisation of 
lamina I interneurons was mainly limited to lamina I with few cells having axons 
that arborized in adjacent lamina IIo. These cells had relatively sparse 
dendrites, which were confined mainly to laminae I and IIo. The study also 
reported that all lamina I interneurons produced a sustained discharge in 
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response to injecting a depolarizing current. In addition, Ruscheweyh and 
Sandkuhler (2002) reported a laminar difference in membrane and discharge 
properties of neurons of the rat dorsal horn in vitro. Although the study did not 
differentiate between lamina I projection neurons and interneurons, it showed 
that most neurons in lamina I, but not in lamina II, discharged action potentials 
at regular intervals throughout the current pulse (tonic discharge). However, 
delayed firing neurons, which showed a delayed onset of firing in response to 
current injection, were encountered in both laminae I and II. Prescott and De 
Koninck (2002) also identified 4 physiological cellular classes of lamina I neurons 
in the rat in vitro: tonic, delayed, phasic (firing a high frequency burst of 
variable duration) and single spike (firing only one spike in response to strong 
depolarisation). The study also reported the existence of at least three 
morphological cellular classes in lamina I, which correlated with the 
electrophysiological properties of these cells. Tonic cells were typically 
fusiform, phasic cells were pyramidal and multipolar cells fired in a delayed 
and/or single spike patterns.   
1.4.2 Interneurons in lamina II  
Most of the studies regarding dorsal horn interneurons were conducted in lamina 
II, since the majority of neurons in this lamina are interneurons. In lamina II of 
the rat, it was found that approximately 30% of the neurons were inhibitory, 
containing GABA and/or glycine (Polgar et al., 2003). The remaining neurons are 
thought to be glutamatergic (Todd et al., 2003; Maxwell et al., 2007).    
1.4.2.1 Morphological classification 
Lamina II interneurons can be classified morphologically using different 
techniques. Gobel (1975, 1978) studied the cat substantia gelatinosa and 
identified certain morphological types of cells that have distinct characteristics 
using the Golgi technique. Cells were identified based on certain criteria: 
dendritic and axonal branching patterns, dendritic spine distribution, geometric 
shape of the dendritic tree and the laminar distribution of the dendrites and 
axons. Three morphological types were identified in this study: islet, stalked and 
spiny cells. Islet cells, mostly found in clusters, had fusiform or rounded cell 
bodies with axons and dendrites arborising longitudinally. Stalked cells on the 
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other hand were found individually with cone-shaped cell bodies and dendrites 
emitting numerous fine stalked-like branches and dendritic spines. Spiny cells 
were found singly between the islet cell clusters with extensive dendritic trees 
spanning rostrocaudally and mediolaterally. These spiny cells have not been 
further mentioned in the literature that described interneuron morphology. In 
the rat, Todd and Lewis (1986) recognised two main types of Golgi stained 
neurons in lamina II: islet and stalked cells with a description that almost 
resembled the cells identified by Gobel (1975). Todd and Lewis (1986) also 
identified a group of ‘unclassified’ cells that represented over one-third of 
lamina II neuronal population.   
Cells can also be classified morphologically after being revealed by intracellular 
injection in vivo. Bennett et al. (1980) studied the responses of a population of 
22 lamina II neurons of the cat to both natural and electrical stimulation of their 
receptive fields. These neurons were then filled intracellularly with horseradish 
peroxidase and their morphology was studied. Twenty of them were recognised 
as being either islet or stalked cells. There was also a clear correlation between 
the location of the neurons’ dendritic arborisations and their responses to 
natural and electrical stimulation. For instance, all stalked cells and those islet 
cells with dendritic trees located superficially (lamina IIo) responded either 
specifically to noxious stimulation or to both gentle mechanical and tissue-
damaging stimulations (wide dynamic range neurons). On the other hand, islet 
cells with deeply located dendritic trees responded to low-threshold mechanical 
stimulation, suggesting that different layers have different functional roles. In 
agreement with Bennett et al. (1980), Rethelyi et al. (1989) reported a relation 
between the laminar location of neuronal dendritic trees and the nature of 
primary afferent excitation in the cat. However, there was no clear relation 
between the morphology of these cells and their responses to various types of 
noxious and innocuous stimuli. Additionally, in the rat SDH, there was no 
correlation seen between function and either the cellular configuration or the 
distribution of the dendritic trees (Woolf and Fitzgerald, 1983).   
A third morphological means of classification was developed in the hamster by 
combining whole cell recording in slices obtained from in vitro preparations with 
neuronal labelling using biocytin from the patch pipette (Grudt and Perl, 2002). 
Four main classes were identified based on different dendritic morphology: islet, 
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central, radial and vertical cells. Islet cells had elongated (>400 µm) dendritic 
trees in the rostrocaudal axis. Central cells resembled islet cells but with shorter 
(<400 µm) dendritic trees. Unlike the islet and central cells, radial cell dendrites 
were compact and extended in several directions in the parasagittal plane. 
Vertical cell dendrites fanned out ventrally from a dorsally placed soma located 
in lamina IIo. Some of the vertical cells were morphologically similar to Gobel’s 
stalked cells but others did not show all the features of stalked cells. Similar 
results were seen in the rat dorsal horn (Maxwell et al., 2007; Yasaka et al., 
2007; Yasaka et al., 2010). Despite the identification of the above 4 cellular 
classes, approximately one-third of the studied neuronal populations did not fall 
under any of them, and were considered as ‘unclassified’ (Grudt and Perl, 2002; 
Maxwell et al., 2007; Yasaka et al., 2007; Yasaka et al., 2010).  
Using the Golgi method, Todd and McKenzie (1989) reported that islet cells were 
GABAergic while none of the stalked cells were immunoreactive to GABA. More 
recently, Maxwell et al. (2007) and Yasaka et al. (2010) immunocytochemically 
stained axons of populations of lamina II neurons that were obtained in vitro 
preparations (whole cell patch clamp) with VGLUT2 and the vesicular GABA 
transporter (VGAT). The two studies concluded that all islet cells were 
GABAergic while radial and most vertical cells were glutamatergic, and central 
cells could be either excitatory or inhibitory. In addition, all islet cells received 
monosynaptic excitatory inputs exclusively from C-fibres and primary afferent-
evoked inhibitory inputs only from Aδ-fibres, while vertical and radial cells 
received excitatory and inhibitory primary afferent-evoked inputs from both C- 
and Aδ-fibres (Grudt and Perl, 2002; Yasaka et al., 2007). This suggests that 
morphology may correlate with different patterns of excitatory and inhibitory 
inputs to lamina II interneurons. Moreover, within the dorsal horn, certain 
specific circuits between the interneurons have been identified. Lu and Perl 
(2003) performed simultaneous whole cell recordings from pairs of cells in vitro 
preparation and identified a specific inhibitory pathway between islet and 
central cells in which islet cell axons formed GABAergic synapses onto central 
cells. Lu and Perl (2005) also reported that lamina II central cells excited 
vertical cells monosynaptically through glutamatergic synapses. Vertical cells in 
turn excited neurons in lamina I that were presumed to be projection neurons.    
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1.4.2.2 Electrophysiological classification 
Dorsal horn neurons can be classified electrophysiologically based on their action 
potential discharge during the injection of a depolarizing current. During the 
injection of a current, most lamina II neurons either discharged tonically 
(repetitive action potential discharges), fired transiently (initial bursting after 
which adaptation occurs), displayed a prominent single spike or exhibited a 
delayed action potential discharge (Grudt and Perl, 2002; Graham et al., 2007). 
Yoshimura and Jessell (1989) studied the membrane properties of the substantia 
gelatinosa neurons in vitro. Their study found that the discharge properties of 
these neurons are modified by the expression of various types of voltage-gated 
currents. It has been suggested that a tonic firing pattern is mainly generated by 
a combination of a voltage gated Na+ current with a pronounced delayed inward 
rectifier K+ (KDR) current (Ruscheweyh and Sandkuhler, 2002; Melnick et al., 
2004). In addition, it was suggested that the response of delayed firing neurons 
to sudden depolarisation was caused by the transient outward rectifying current 
(IA) that served to delay the onset of the first action potential. This A current is 
a transient voltage-dependant outward potassium current that counteracts fast 
depolarisations leading to the delay to the appearance of the first action 
potential (Yoshimura and Jessell, 1989; Ruscheweyh and Sandkuhler, 2002). 
Furthermore, Hu et al. (2006) reported that in the SDH,  the IA current is 
mediated by the Kv4-containing potassium channel particularly Kv4.2, and that 
genetically eliminating the Kv4.2 channel subunit increased the number of 
tonically firing neurons.   
Grudt and Perl (2002) studied the responses of certain morphological populations 
of lamina II neurons to depolarising current injections. It was observed that all 
islet cells studied responded with a sustained repetition of action potentials 
(tonically), while the action potentials of the radial neurons were delayed from 
the onset of the depolarising step. Central cells acted in two different ways, one 
group went silent when depolarised while the other group responded to the 
depolarising step in a sustained (tonic) fashion. The vertical cells had either 
tonic or delayed response patterns. 
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In a recent study, Yasaka et al. (2010) reported that the morphology and 
neurotransmitter type of lamina II interneurons were related to the firing 
patterns of these neurons. Most excitatory neurons including vertical and radial 
cells but few inhibitory cells including islet cells had delayed, gap or reluctant 
pattern of firings, which was associated with A-type potassium (IA) currents.  
1.4.3 Interneurons in lamina III-IV  
Laminae III-IV contains variety of cells of different sizes and shapes including 
both projection neurons and interneurons. A limited number of studies have 
focused on laminae III-IV interneurons, for instance, Schneider (2008) studied 
the local circuit connections between neurons in lamina III and IV of the 
hamster. Whole cell recordings between synaptically connected pairs of neurons 
in laminae III and IV showed that these connections were mostly unidirectional 
inhibitory connections. Subsequentely, Schneider (2008) processed the biocytin 
filled-cells histochemically and described their morphology. Intracellular 
labelling suggested that the recording was made from local axon interneurons, 
since the neurons were relatively small in size and located within laminae III-IV. 
Each interneuron had 2 to 4 tapered dendrites and a thin cylindrical axon that 
terminated within the dorsal horn. Polgar et al. (2003) also reported that around 
40% of lamina III interneurons were GABAergic in the rat. Further, Ruscheweyh 
and Sandkuhler (2002) obtained whole cell patch-clamp recordings from 27 
lamina III-IV neurons (projection neurons and/or interneurons). The study 
reported that some of these deeper neurons generated tonic firing after the 
injection of a depolarizing current, and none showed delayed firing. 
1.4.4 Neurochemical classification of the SDH interneurons  
Interneurons can be classified alternatively based on their expression of 
neurochemical markers, including various proteins and neuropeptides (Todd, 
2010). Despite the complexity of the SDH in term of its neurochemistry, specific 
populations of excitatory and inhibitory interneurons can be identified when 
using combinations of neurochemical markers (Sardella et al., 2011b).  
Certain proteins are expressed in the dorsal horn of the spinal cord including the 
calcium-biding proteins: calbindin, calretinin, parvalbumin (Ren and Ruda, 1994) 
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and the γ-isoform of protein kinase C (PKCγ) (Mori et al., 1990). Apart from 
parvalbumin, the above proteins are largely restricted to glutamatergic cells 
(Todd, 2010). Calbindin and calretinin expression patterns in the SDH are 
known to partially overlap and most of the calbindin- calretinin-containing 
neurons were not reactive for either GABA or glycine (Albuquerque et al., 1999). 
Moreover, Antal et al. (1991) reported that the majority of the calbindin-
immunoreactive cells in the SDH were negative for GABA-immunostaining, 
suggesting that these neurons are more likely to be glutamatergic. The calcium 
binding protein Parvalbumin is expressed by a subpopulation of neurons that are 
found mainly in laminae IIi and III and ~70% of these showed both GABA and 
glycine immunoreactivity, while ~30% were non-GABAergic (Antal et al., 1991; 
Laing et al., 1994).  
Several protein kinase C isoenzymes have been identified in the SDH including 
α, βI, βII and γ (Mori et al., 1990; Polgar et al., 1999a). Among these, PKCγ  is 
thought to play an important role in nociceptive processing, evidenced by the 
reduction of signs of neuropathic pain in mice lacking the PKCγ isoform 
(Malmberg et al., 1997). Polgar et al. (1999a) reported that the great majority 
of PKCγ-containing neurons, which are concentrated mainly in lamina IIi (Mori et 
al., 1990), were likely to be excitatory, since they were neither GABA- nor 
glycine-immunoreactive. Polgar et al. (2011) recently reported that lamina IIi 
PKCγ-expressing interneurons receive input from a subset of NPY-expressing 
inhibitory interneurons.  
Furst (1999) reported that nitric oxide, which is synthesized by nitric oxide 
synthase in pre- and post-synaptic sites, is involved in certain spinal functions 
such as mediating nociception. Nitric oxide activates the enzyme guanylyl 
cyclase which in turn increases the production of the second messenger cGMP 
(Schmidt et al., 1992). Nitric oxide synthase possesses a nicotineamide adenine 
dinucleotide phosphate (NADPH) reduction capacity. This reduction capacity is 
called NADPH diaphorase (NADPH-d) activity. NADPH-d is known to colocalise 
with nitric oxide synthase in some areas in the CNS including the spinal cord 
(Bredt et al., 1991; Reuss and Reuss, 2001). neuronal nitric oxide synthase 
(nNOS) is one of three nitric oxide synthase isoforms which is found in neurons 
that synthesise nitric oxide and is thought to immunocytochemically correspond 
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to NADPH-d (Valtschanoff et al., 1992a). NADPH-d was used in early studies to 
identify nNOS-containing neurons. NADPH-d/nNOS-positive neurons are 
concentrated mainly in lamina II of the spinal cord and they were most likely 
GABAergic and glycinergic (Valtschanoff et al., 1992b; Spike et al., 1993). Puskar 
et al. (2001) also reported that GABAergic axons containing nNOS selectively 
innervate lamina I giant cells of the rat dorsal horn.  
The dorsal horn also contains certain neuropeptides that are found exclusively in 
glutamatergic neurons such as substance P, neurokinin B, somatostatin and 
neurotensin (Todd, 2010). Somatostatin-expressing interneurons are found 
throughout lamina II (Kiyama and Emson, 1990; Proudlock et al., 1993; Todd and 
Spike, 1993). Most of the somatostatin-containing axons (in laminae I and II) are 
thought to be derived from somatostatin interneurons along with a minor 
contribution from primary afferents (Ribeiro-da-Silva and Cuello, 1990). 
Neurotensin is thought to be present mainly in cells in the ventral part of 
lamina II (Seybold and Elde, 1982; Todd and Spike, 1993) and these neurotensin-
containing neurons were found to be GABA-negative (Todd et al., 1992a). 
Further, Todd et al. (2003) reported that the great majority of axons that are 
likely to be derived from neurotensin- and somatostatin-containing interneurons 
were VGLUT2-immunoreactive.  
It has been shown that certain neuropeptides are restricted to GABAergic 
neurons, such as neuropeptide Y (NPY) and galanin (Todd, 2010). Neuropeptide 
Y is found exclusively in GABAergic neurons in laminae I-III (Rowan et al., 1993). 
It has been reported that lamina III NK1r- expressing projection neurons receive 
a substantial inhibitory input from a set of NPY-containing GABAergic 
interneurons (Polgar et al., 1999b). In a recent study, Polgar et al. (2011) 
reported that lamina IIi PKCγ-containing interneurons also receive input from a 
presumably different subset of NPY-expressing neurons. Galanin is another 
neuropeptide which is found mainly in laminae I and IIo (Todd and Spike, 1993). 
It has been reported that all of laminae I and IIo galanin-containing cells are 
GABAergic (Simmons et al., 1995; Zhang et al., 1995) and recently, Tiong et al. 
(2011) reported that these cells represent a distinct population of inhibitory 
interneurons.  
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Among the opioid peptides that are expressed by both excitatory and inhibitory 
interneurons are dynorphin and enkephalin. Dynorphin-immunoreactive neurons 
are concentrated mainly in laminae I and IIo (Todd and Spike, 1993). They can 
be clearly revealed immunocyochemically with antibodies against dynorphin 
precursor proteins: prodynorphin and preprodynorphin. Preprodynorphin is also 
present in dynorphin–containing axon terminals (Li et al., 1999). Prodynorphin 
and preprodynorphin are expressed in glutamatergic (Marvizon et al., 2009) and 
galanin-containing GABAergic neurons (Sardella et al., 2011a), respectively. 
Enkephalin-containing neurons are present throughout the dorsal horn but are 
concentrated in lamina II (Todd and Spike, 1993). They are found in both 
excitatory (Todd et al., 2003; Marvizon et al., 2009) and inhibitory (Todd et al., 
1992b) interneurons. 
1.5 Markers of neuronal activity 
Markers of neuronal activity provide an approach for studying the functions of 
the spinal cord neurons. Neuronal markers such as fos and ERK are up-
regulated/phosphorylated by variety of noxious stimuli, and have been used 
widely in basic research. Fos, a protein encoded by the cellular immediate-early 
gene c-fos (Hunt et al., 1987) and more recently, ERK (a mitogen activated 
protein kinase, MAPK) (Ji et al., 1999), are recognised as useful markers of 
neuronal activation. Immunocytochemical labelling of these markers has enabled 
researchers to investigate their colocalisation with other cellular markers, 
making it possible to study the characteristics of positively-labelled neurons. 
1.5.1 Fos 
Almost two decades ago, Hunt et al. (1987) reported that fos is up-regulated in 
nuclei of neurons in the dorsal horn of the rat after noxious stimulation. Since 
then, this neuronal marker of activity has been extensively used in pain studies. 
The c-fos messenger ribonucleic acid (mRNA) is typically identified using either 
northern blot analysis (Draisci and Iadarola, 1989) or in situ hybridization (Elliott 
et al., 1995), while its protein product fos is identified immunocytochemically 
(Hunt et al., 1987). It has been shown that noxious stimulation increased c-fos 
mRNA levels in the spinal dorsal horn within 30 minutes of stimulation (Draisci 
and Iadarola, 1989). The nuclear protein fos is transported from the cytoplasm, 
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where it is synthesized, and it accumulates in the nuclei of the spinal neurons, 
reaching its maximal detectible levels approximately 2 (1-3) hours after the 
application of the stimulus (Presley et al., 1990). Following noxious thermal and 
chemical stimulation, Williams et al. (1990) reported that fos expression 
reached its peak 2 hours later, mainly in laminae I and II of lumbar spinal 
segments ipsilaterally, with more fos-positive neurons in laminae III-IV after 
formalin injection than after noxious heat. The study also showed that 8 hours 
after formalin injection, there was no fos-immunoreactivity in the spinal cord, 
while numerous fos-positive cells appeared, mainly in the contralateral side of 
the deep dorsal horn, 8 hours following noxious heat. Fos-immunoreactivity 
lasted for 24 hours and became more diffuse and symmetrical, suggesting a 
complex role of fos in nociception transmission. Bullitt (1991) also reported that 
during the first few hours after the peripheral stimulation of one side of the 
body, fos-positive neurons appeared in the appropriate spinal segments.  
Fos expression after somatic noxious stimulation is mostly localised to laminae I 
and IIo of the spinal cord (Harris, 1998). This neuronal distribution differs if the 
stimulus was innocuous, since fos-immunoreactive neurons were seen mainly in 
deeper laminae (IIi-IV) in response to hair brushing, gentle joint manipulation 
(Hunt et al., 1987) and tactile stimulation (Jasmin et al., 1994). It was also 
reported that itch, which was induced either by topical application of histamine 
to the skin of the rat (Nakano et al., 2008) or by the injection of histamine-
independent itch mediators to the mouse hindpaw (Akiyama et al., 2009), led to 
the expression of fos in the superficial laminae (I and II). Thus, it could therefore 
be suggested that spinal transmission of both itch and pain sensations may have 
a lot in common (Ross, 2011).  
1.5.2 pERK 
In this study, phosphorylation of ERK was used as the marker of neuronal 
activity, and it will therefore be discussed in more detail. In the past few years, 
the MAPK family of signalling cascades has received a great deal of attention. 
This family includes 3 major members: extracellular signal-regulated kinases 
(ERK, including ERK1/2), p38 (including p38α, p38β, p38γ and p38δ) and c-Jun N-
terminal kinases (JNK, including JNK1, JNK2, and JNK3) (Ji et al., 2009).  
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ERK1 (also known as p44 MAPK) and ERK2 (p42 MAPK) belong to a group of 
serine/threonine protein kinases. They are both activated by dual 
phosphorylation on their regulatory tyrosine and threonine residues by the 
upstream MAPK kinases: MEK1 and MEK2 (Boulton et al., 1991; Seger and Krebs, 
1995). Both ERK1 and ERK2 are usually referred to as ERK since they resemble 
each other structurally and are often activated together, as they have similar 
sensitivities to activation by MEKs (Zheng and Guan, 1993). In addition, neither 
MEK inhibitors nor pERK antibodies distinguish between ERK1 and ERK2 (Ji et al., 
2009). However, ERK1 knock-out mice are viable, fertile and of normal size 
(Pages et al., 1999), while ERK2 knock-out mice die before embryonic day 8.5, 
indicating that ERK2 can compensate for ERK1 loss but not vice versa (Hatano et 
al., 2003). 
Both p38 and JNK are stress-regulated protein kinases that play a role in 
inflammatory responses and neuronal survival, while the ERK/MAPK cascade is 
known to regulate cellular proliferation and differentiation (Xia et al., 1995). In 
addition to its role in regulating a variety of cellular functions, the ERK/MAPK 
cascade is also involved in neuronal plasticity such as that involved in learning 
and memory (Impey et al., 1999) and in pain hypersensitivity (Ji et al., 2009). 
Ruan et al. (2010) suggested the involvement of all three members of the MAPK 
family in nociception. Their study reported that activation of ephrin receptor 
tyrosine kinases in the spinal cord induced hyperalgesia in mice, which was 
accompanied by phosphorylation of p38 and JNK in both spinal neurons and 
astrocytes, whereas pERK appeared in spinal neurons only.  
1.5.2.1 The role of ERK in nociception  
In the nervous system, ERK pathway activation occurs in a variety of situations, 
including painful conditions. Activation of ERK produces short-term functional 
changes by phosphorylating kinases, receptors and ion channels as well as long-
term transcriptional changes (Ji et al., 1999). After exposure to a noxious 
stimulus, the ERK pathway is activated at different neuraxis levels, including 
DRG, spinal and supraspinal centres, leading to modulatory changes in the 
nervous system (Cruz and Cruz, 2007). Ji et al. (1999) provided the first 
indication of pERK involvement in nociception in the spinal cord. Their study 
showed that ERK phosphorylation was specific to noxious stimulation and that 
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noxious stimuli of different types led to the appearance of many pERK-positive 
neurons in the SDH of the spinal cord of the rat.  
The ERK/MAPK cascade is activated by various pathways, including for instance 
those that involve activation of certain receptors or neurotransmitters. NMDA 
receptor-dependent phosphorylation of ERK occurs after the removal of the Mg2+ 
blockade of the NMDA channels, thus opening these channels and allowing the 
entry of Ca2+. On the other hand, NMDA receptor-independent mechanisms 
involve the GluA2-lacking AMPA receptors that allow the influx of calcium, which 
produces lasting facilitation of synaptic transmission (Woolf and Salter, 2000). It 
also involves group I mGlus, for instance, Karim et al. (2001) reported that 
mGlu1 and mGlu5 are required for phosphorylation of ERK in the SDH. It was also 
suggested that group I mGlu-induced ERK activation are of importance in 
maintaining longer lasting forms of inflammatory pain. Adwanikar et al. (2004) 
showed that group I mGlus activation led to nociceptive behaviours as well as 
pERK expression in the SDH, both of which were enhanced after the injection of 
complete Freund’s adjuvant (CFA) into the mouse hindpaw.  
Substance P also plays an important role in the MAPK/ERK cascade, as evidenced 
by the induction of pERK mainly in lamina I neurons of the SDH of the rat after 
both intrathecal injection of substance P in vivo and application of substance P 
to a spinal cord slice preparation in vitro (Kawasaki et al., 2004). Wei et al. (Wei 
et al., 2006) reported that the bath application of substance P into spinal cord 
slices activated ERK in the SDH in both rat and mouse. Further, both capsaicin- 
and substance P-induced ERK activation were inhibited after the application of a 
selective NK1r antagonist (Kawasaki et al., 2004; Wei et al., 2006). However, it 
was reported by Lever et al. (2003) that after stimulating C-fibres in the mouse 
dorsal horn in vitro, ERK was phosphorylated mainly in the SDH, and this 
phosphorylation was NMDA and mGlu1 but not AMPA or NK1 receptor dependent. 
Their study also reported that the brain-derived neurotrophic factor (BDNF) 
signalling through the tropomyosin-related kinase B (TrkB) receptor, but not 
substance P signalling through the NK1 receptor, may contribute to ERK 
activation in the dorsal horn neurons in this model. This discrepancy may be 
attributed to different nature of stimuli applied in each study as well as to 
different pharmacological degrees of NK1r inhibition (Ji et al., 2009).  
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It has been also shown that noxious stimulation led to the release of BDNF in the 
dorsal horn after its anterograde transport from the DRG (Zhou and Rush, 1996). 
It was suggested that following nociceptive stimulation, BDNF is released at the 
synaptic cleft in the dorsal horn and binds to its high affinity postsynaptic 
receptor: TrkB (Pezet et al., 2002), activating the MAPK/ERK cascade (Slack et 
al., 2004). Subsequently, Slack et al. (2005) reported that dorsal horn neurons 
that projected to the thalamus (spinothalamic tract, STT neurons) expressed the 
TrkB receptor, and that both exogenous and induced-endogenous release of 
BDNF led to ERK phosphorylation in TrkB-containing STT neurons.  
Activation of the MAPK/ERK cascade leads to short term changes in the dorsal 
horn, such as phosphorylating receptors or channels, as well as long term 
changes, altering the expression of neuronal genes (Ji et al., 2003). It was 
hypothesized that the activating ERK phosphorylates the GluN1 subunit of the 
NMDA receptor, thus increasing dorsal horn neuronal excitability (Slack and 
Thompson, 2002; Slack et al., 2004). Recent studies have also demonstrated the 
involvement of activated ERK in phosphorylating the pore-forming subunit of the 
potassium channel Kv4.2, which is a major contributor to A-type K+ currents that 
modulate nociceptive behaviours and pain plasticity and in the dorsal horn 
(Adams et al., 2000; Hu et al., 2003; Ji et al., 2003; Hu et al., 2006).  
The MAPK/ERK cascade is also involved in regulating neuronal gene expression, 
which is involved in induction and maintenance of inflammatory pain. Ji et al. 
(2002) reported that two days following noxious stimulation, which was induced 
by the injection of CFA into the hindpaw of the rat, pERK-positive neurons were 
concentrated in the SDH. Both prodynorphin and NK1r were up-regulated in 
these SDH neurons and their up-regulation was prevented by blocking ERK 
activation. Recently, Matsuoka and Yang (2012) reported that selectively 
activating ERK1/2 led to nerve growth factor (NGF)-induced up-regulation of 
BDNF mRNA in cultured DRG neurons. The study also showed that the application 
of AZD6244, a MEK1/2 specific inhibitor, to the rat spinal cord attenuated 
pathological pain, which was induced by either chronic constrictive injury or 
spared nerve injury. AZD6244 also decreased the expression of pERK in the DRG 
and BDNF in the SDH. In addition to the above study, several studies have used 
inhibitors of ERK phosphorylation, which block its upstream kinase MEK, in order 
to reverse pERK-induced pain state. For instance, intrathecal application of the 
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MEK inhibitor PD98059 reduced the 2nd phase of formalin-induced pain behaviour 
in mice (Choi et al., 2006). This 2nd phase is thought to result from central 
sensitization, a nociceptor-mediated activity-dependent increase in the 
excitability of spinal neurons (Woolf and Costigan, 1999).  
It is often assumed that spinal ERK phosphorylation is exclusively dependent on 
sensory afferent input from the periphery. However, supraspinal input may 
contribute to either facilitating or inhibiting spinal ERK activation (Cruz et al., 
2006; Svensson et al., 2006). For example, Svensson et al. (2006) reported that 
formalin injection to the hindpaw of the rat evoked the activation of spinal ERK. 
This ERK expression was facilitated by input from an excitatory serotonergic 
descending pathway, which arose from the brainstem medullary 5-
hydroxytrytamine-containing nuclei of the raphe. It was shown that the 
intrathecal administration of a spinal 5-hydroxytrytamine 3 receptor antagonist 
decreased ERK activation in the spinal cord. However, Cruz et al. (2006) 
reported that in animals with spinal cord injury, which was induced by spinal 
transection at the thoracic level, spinal ERK phosphorylation was enhanced at 
the L6 spinal cord segment, and this enhancement was more intense after 
stimulating the bladder. This suggests that supraspinal input through different 
mediators may play a complex role in both inhibiting and stimulating spinal ERK 
activation (Cruz and Cruz, 2007).  
Phosphorylation of ERK in the dorsal horn following various types of noxious 
stimuli will be discussed in more detail in Chapter 4. Figure 1-2 shows examples 
of mechanisms of ERK activation in the spinal cord after noxious stimulation. 
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Figure  1-2 Examples of mechanisms of ERK activation in the spinal cord. 
Following noxious stimulation, glutamate, BDNF and substance P are released onto the 
spinal cord and bound to their receptors activating ERK in the cytoplasm. Activated ERK 
then phosphorylates specific subunits or subsequently leads to gene expression, 
modulating different cellular functions. From Cruz and Cruz, (2007).  
1.5.3 Fos and pERK: pros and cons 
In 1987, fos was first used as a marker of neuronal activity in the SDH (Hunt et 
al., 1987), yet 12 years later, it was shown that pERK is specifically induced by 
noxious stimulation (Ji et al., 1999). Since then, both fos and pERK have been 
extensively used as markers of neuronal activation following noxious stimulation.  
There are several advantages to using fos as a marker of neuronal activity, such 
as the fact that its expression in the SDH is very robust and requires high 
threshold stimuli. In addition, it can be easily revealed and quantified 
immunocytochemically. However, the direct role of fos in nociception is not yet 
fully understood. Fos expression is thought to be due to monosynaptic activation 
of spinal cord neurons following small-diameter high-threshold primary afferents 
stimulation (Hunt et al., 1987). It is usually assumed that fos is related to 
nociceptive processes, since its expression leads to long term intracellular 
changes in spinal nociceptive neurons, producing either hyperalgesia or allodynia 
(Morgan and Curran, 1991; Harris, 1998). This link between nociception and fos 
expression in the dorsal horn is further strengthened by the finding that fos 
expression is decreased after treating animals with variety of analgesics, such as 
kappa1-opioid receptor agonists and non steroidal anti-inflammatory drugs 
(Catheline et al., 1999; Buritova and Besson, 2000). However, dissociation 
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between the sensation of pain and fos expression has also been reported. For 
instance, morphine abolished pain-related behaviours in rats injected with 
formalin, yet failed to significantly decrease the expression of fos in the SDH 
(Presley et al., 1990). This suggests that in addition to the direct relation 
between fos expression in the dorsal horn and nociception, spinal fos expression 
may reflect processes that contribute indirectly to pain transmission. It is also 
essential to consider that the absence of fos expression does not always indicate 
the absence of neuronal activity, since it is expressed only in certain neurons 
following peripheral stimulation. For instance, pinching the hindpaw of lightly 
anesthetised rats led to positive withdrawal reflexes, indicating the activity of 
ventral horn motor neurons. However, there was no fos-immunoreactivity in the 
ventral horn (Bullitt, 1990). Additionally, there is a risk of false positive results, 
for instance Bullit (1990) reported that at least few supraspinal neurons 
expressed fos in the absence of noxious stimulation, such as following prolonged 
inhalational anaesthesia. This may be due to the time lag between the induction 
and expression of fos, making it difficult to determine which precise events were 
directly responsible for the gene induction (Cruz and Cruz, 2007). It was also 
reported that walking for an hour on a rotating rod induced fos expression in 
spinal and supraspinal areas in the rat. However, the pattern of this expression 
differed from fos up-regulation following noxious stimulation, since fos was 
expressed in laminae IIi, V-VII as well as in motor neurons in the ventral horn 
following this innocuous stimulus (Jasmin et al., 1994).  
Like fos expression, ERK activation requires high-threshold stimuli. pERK 
expression is also topographically specific, and predominantly induced in 
somatotopically appropriate neurons (Ji et al., 1999). Unlike fos, the expression 
of pERK is more rapid and occurs in various cellular and subcellular regions. In 
addition, ERK phosphorylation is more likely to be only associated with noxious 
stimulation. Importantly, the availability of specific inhibitors of the MAPK/ERK 
pathway has led to a clear demonstration of the role of pERK in central 
sensitization (Karim et al., 2001).  
Although it was reported that fos expression in supraspinal neurons may occur 
without the participation of ERK (Johnson et al., 1997), it was shown that the 
situation may differ in the spinal cord (Cruz and Cruz, 2007). It was reported 
that spinal fos expression, induced by both noxious somatic and visceral 
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stimulation, was almost completely suppressed upon ERK blockade (Kawasaki et 
al., 2004; Cruz et al., 2007). In addition, Kominato et al. (2003) reported that 
after the injection of a MEK inhibitor in a rat model of neuritis, the increase in 
fos expression seen in the SDH neurons was significantly suppressed, while fos 
expression in deep dorsal horn neurons was ERK independent. This suggests that 
fos expression in the SDH may have been the result of activation of the 
MAPK/ERK cascade. It was also shown that formalin-induced fos expression in 
the SDH of the rat was almost blocked after intrathecal injection of a p38 
inhibitor (Svensson et al., 2005). Ruan et al. (2010) also reported that p38, JNK, 
ERK and fos were phosphorylated/up-regulated in the mouse SDH following the 
activation of ephrin receptor tyrosine kinases, which also led to hyperalgesia. 
Their study also showed that inhibition of any of the three MAPKs pathways 
almost prevented fos expression and reversed pain behaviour. This therefore 
suggests that blocking any of the interactions in this signalling molecules 
network will result in a decreased activation of the whole network and pain 
behaviour relief as a result.  
The specificity, distribution and time course of fos and pERK are compared in 
Table 1-1, which is partially adapted from a review by Gao and Ji (2009). 
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Table  1-1 Comparison of the specificity, distribution and time course of fos and pERK 
 Fos pERK 
Mechanism of action Gene expression phosphorylation 
Induction by noxious stimuli Yes Yes 
Induction by innocuous stimuli Sometimes  No 
Stimulus intensity-dependent Yes Yes 
Subcellular distribution in neurons Nucleus Nucleus, cytoplasm, 
dendrites, and axons 
Lamina localization in the SDH            
I-II 
III-IV 
V-VI 
               
Strong 
Weak 
Medium 
                       
Strong 
Weak 
Weak  
Time course after formalin injection  
Onset 
Peak induction 
Return to base 
                    
>30 minutes 
1-2 hours 
8-24 hours 
                             
1-3 minutes 
2-10 minutes 
1-2 hours  
Correlation to pain behaviour Partially  Closely 
Involvement in central sensitization Unknown Yes 
Specific inhibitors No Yes 
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1.6 Aims of the project  
The overall aim of the project is to investigate the role of different populations 
of spinal cord projection neurons and interneurons in nociception.  
The project initially starts with examining whether NK1r-expressing projection 
neurons can be distinguished from NK1r-expressing interneurons, in lamina I of 
the spinal cord, based on their soma sizes. The results from the first part of the 
project are then used to assess the responses of ‘putative’ lamina I NK1r-
expressing interneurons and projection neurons (categorized based on their 
soma sizes) to various noxious stimuli. The 2nd part of the project also 
investigates the responses of other populations of projection neurons in the SDH 
to various noxious stimuli. These include laminae III-IV NK1r-expressing neurons 
and lamina I giant cells (both are previously known, from retrograde studies, to 
be projection neurons). Finally, and since it was reported that spinal activation 
of group I mGlus induced hyperalgesia, the role of mGlu5-expressing neurons in 
nociceptive modulation is further investigated. 
The individual aims of each part of the project will be discussed in further detail 
in the relevant Chapters. 
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2. General Methods 
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This Chapter deals with the general methods that are used in order to pursue the 
three principal aims of the project. Specific experimental procedures that are 
applied in each part of the project are explained in detail in the corresponding 
Chapters. Overall, the following procedures are similar in every Chapter: animal 
perfusion, tissue processing and immunocytochemistry in addition to confocal 
microscopy and analysis. All experiments were approved by the Ethical Review 
Process Applications Panel of the University of Glasgow, and were performed in 
accordance with the UK Animals (Scientific Procedures) Act 1986. 
2.1 Perfusion of the animals 
Following the appropriate survival time for each experimental protocol 
(retrograde tracing, noxious or pharmacological stimulation), pentobarbitone- or 
urethane-anesthetized rats were perfused intracardially with a fixative at 4°C, 
preceded by a wash with Ringer’s solution* for couple of seconds. The fixative 
that was used contained 4% freshly de-polymerised formaldehyde* in 0.1 M 
phosphate buffer* (PB). After completion of the perfusion process, the 
appropriate spinal segments were removed and put into the same fixative 
solution and stored at 4°C overnight. In those experiments that involved 
retrograde tracing, in order to identify the injection sites, the brain tissue was 
removed and put in 30% sucrose overnight. Detail of handling the brain tissue is 
mentioned in the next Chapter.    
2.2 Tissue processing and immunocytochemistry 
On the following day after perfusing the animals, appropriate thoracic, lumbar 
or sacral spinal segments were cut into 60 µm thick horizontal, parasagittal or 
transverse sections with a Vibratome. The choice of the plane of cutting the 
*Ringer’s solution typically contains sodium chloride, potassium chloride, calcium chloride and 
sodium bicarbonate (to balance the pH). Other additions can include chemical fuel sources for 
cells, including ATP and dextrose, as well as antibiotics and antifungals. 
 
*4% formaldehyde is made in a fume hood by heating distilled water to 68°C and adding 40 g of 
paraformaldehyde. Few drops of 1 N NaOH are added at a time till the paraformaldehyde is 
completely dissolved. 0.2 M phosphate buffer is then added and topped up with distilled water to 
make one litre of the solution, which is then filtered. 
 
*0.1 M phosphate buffer  is made by adding 1120 ml of solution A to 2880 ml of solution B and 
mixing well after adjusting the pH to 7.4. 3000 ml distilled water is then added to the solution. 
Solution A: NaH2PO (2H2O) 37.4 g in 1200 ml H2O 
Solution B: Na2HPO4           84.9 g in 3000 ml H2O 
40 
segments depended on the orientation of the cells of interest as well as on the 
purpose of processing these cells. Horizontal sections are ideal for viewing and 
assessing the morphology of lamina I neurons, since the branches of their 
dendritic trees are oriented mainly rostrocaudally and/or mediolaterally with 
very limited ventral spread (Cheunsuang and Morris, 2000). On the other hand 
laminae III-IV neurons posses dorsally-directed dendrites that arborize toward 
the superficial laminae (Todd, 1989) making them more visible in parasagittal 
sections. Transverse sections are useful for showing the laminar distribution of 
cells of interest. Prior to cutting the segments, some blocks were notched at one 
side in order to orientate the free-floating sections. Spinal blocks from animals 
that were unilaterally injected with a tracer to the brain were notched 
ipsilateral to the injection site. Blocks from the stimulated animals were 
notched contralateral to the side of stimulation. After cutting the segments, 
sections were immersed in 50% ethanol for 30 minutes in order to enhance the 
penetration of the antibodies (Llewellyn-Smith and Minson, 1992). These 
sections were then rinsed in phosphate buffer saline (PBS) that contained 0.3 
M NaCl* three times over a period of half an hour, unless otherwise stated. They 
were then incubated at 4°C for three days in a cocktail of primary antibodies. 
Antibodies that were used in this project are listed in Table 2-1. The sections 
were then rinsed again in PBS three times over a period of half an hour followed 
by their reaction with species-specific secondary antibodies for 24 hours. These 
secondary antibodies (anti-IgG) were raised in donkey and conjugated to Alexa 
488 (Invitrogen, Paisley, UK), Rhodamine Red, Cy5 or DyLight 649 (Jackson 
ImmunoResearch, West Grove, PA, USA) and were used at 1:500 (Alexa 488 and 
DyLight 649 conjugates) or 1:100 (Rhodamine Red and Cy5 conjugates).  
All antibodies were made in PBS that contained 0.3% Triton® X-100* (PBST) 
unless otherwise stated. Sections were then rinsed three times with PBS, 
mounted on glass slides, covered-slipped with anti-fade medium (Vectashield; 
Vector Laboratories, Burlingame, CA, USA) and stored at -20°C.  
*phosphate buffer saline that contained  0.3 M NaCl  is composed of 100 ml of 0.2 M PB in 
1900 ml of distilled water with 36 g of NaCl. It is found that this concentration of NaCl reduces the 
non-specific binding of antibodies and avoids need for the addition of other proteins, such as 
blocking sera.  
 
*PBS that contained 0.3% Triton® X-100  is made up with 3 ml of Triton® X-100 in 1000 ml of 
PBS. 
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Tyramide signal amplification (TSA) was used in some reactions where two of the 
primary antibodies were raised in the same species (Shindler and Roth, 1996). 
The amplification was performed with a TSA kit (PerkinElmer Life Sciences, 
Boston, MA) according to the instructions of the manufacturer and will be 
explained further in the appropriate Chapter. 
2.3 Antibody characterisation 
Specificity of the CTb and Fluorogold antibodies is shown by the lack of staining 
in regions of the CNS that did not contain neurons that had transported the 
tracer, and by the presence of immunostaining in populations of neurons that 
are known to project to the injection sites.  
The NK1r antibody is raised in rabbit against amino acids 393-407 of the rat NK1 
receptor conjugated to keyhole limpet haemocyanin. It has been shown that 
there is no immunostaining with this antibody in sections of medulla and cervical 
spinal cord from knock-out mice compared to wild-type mice (Ptak et al., 2002).  
The mouse monoclonal antibody against gephyrin (mAb 7a) was generated 
against an extract of rat spinal cord synaptic membranes (Pfeiffer et al., 1984), 
and has been shown with Western blots to bind to a 93-kDa peripheral 
membrane protein (gephyrin) in extracts of rat brain membranes (Becker et al., 
1989; Kirsch and Betz, 1993).  
The monoclonal pERK antibody detects both ERK1 and ERK2 that are dually 
phosphorylated at Thr202 and Tyr204 sites, and does not cross-react with JNK or 
p38 MAP kinase that are phosphorylated at the corresponding residues.  
Specificity of the mGlu5 antibody is shown by the lack of staining in regions of 
the brain in knock-out mice, as well as the lack of cross-reactivity with the 
mGlu1 antibody (manufacturer’s specification).     
The calbindin antibody (CB-28kD) detects a single protein band at 28-kDa 
(manufacturer’s specification). The specificity of the calretinin antibody is 
shown by the absence of staining in the cerebral cortex of knock-out mice.         
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The GABA antibody was raised against GABA conjugated with glutaraldehyde to 
porcine thyroglobulin, and shows negligible cross-reactivity against other amino 
acids, including glutamate, aspartate, glycine or taurine (Pow and Crook, 1993). 
2.4 Confocal microscopy and analysis 
Two confocal laser scanning microscopes were used in this project. For the first 
two parts of the study, sections were scanned with a Bio-Rad Radiance 2100 
confocal system equipped with blue diode (405 nm) argon multi-line, green HeNe 
(543 nm) and red diode (637 nm) lasers (Bio-Rad, Hemel Hampstead, UK), and 
connected to a Nikon Eclipse E600 microscope (Nikon UK Ltd, Surry, UK). The 
sections were scanned through dry (10×, 20×) objective lenses and a 40× oil-
immersion lens (numerical aperture [NA] 1.3). Z-series of various numbers of 
optical sections at 2 µm z-separation were produced.  
For the 3rd part of the study, a Zeiss LSM710 confocal microscope equipped with 
argon multi-line, 405 nm diode, 561 nm solid-state and 633 nm HeNe lasers was 
used (Carl Zeiss MicroImaging, Germany). Sections were scanned through a 40× 
oil-immersion objective lens (NA 1.3) to produce z-series consisting of optical 
sections at 1 µm z-separation.  
Scans that were produced using both the Bio-Rad Radiance 2100 confocal system 
and the Zeiss LSM710 confocal microscope were saved in the form of raw images 
(Bio-Rad pic and Zeiss lsm), and viewed using Neurolucida for Confocal software 
(MicroBrightField Inc., Colchester, VT, USA). Figures were composed with Adobe 
Photoshop (CS) software and in some cases, the brightness and contrast of the 
images was adjusted.  
2.5 Statistical analysis  
For statistical comparison between different groups of data, the following tests 
were used: Kruskal–Wallis test, Post-hoc Mann–Whitney U-tests with sequential 
Bonferroni correction and Chi-square test. A P value of less than 0.05 was 
considered significant.  
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3. Soma size distinguishes lamina I NK1r-
expressing projection neurons from 
interneurons 
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3.1 Introduction  
Lamina I is supplied mainly by Aδ- and nociceptive peptidergic C-fibres as well as 
by thermoreceptive fibres (Light and Perl, 1979b; Todd and Koerber, 2006; 
Todd, 2010). It contains neurons that are activated by noxious and/or thermal 
stimuli (Christensen and Perl, 1970; Han et al., 1998). These can be either 
projection neurons, which convey nociceptive, thermoreceptive and itch 
information to higher brain centres (Craig, 1995; Willis and Coggeshall, 2004) or 
interneurons. Lamina I interneurons play a major role in modulating nociception, 
yet they are not easily distinguished from projection neurons in the same 
lamina. As described previously, projection neurons make up around 5-10% of 
the neuronal population in lamina I, and these neurons project to various 
supraspinal targets. 
Lamina I neurons of the rat that project to the LPb respond to noxious 
stimulation, as evidenced by immunocytochemical (fos up-regulation) (Lanteri-
Minet et al., 1994; Bester et al., 1997) and electrophysiological (Bester et al., 
2000; Andrew, 2009) studies, suggesting the importance of this area in 
processing nociception. Craig (1995) reported that the CVLM; specifically the 
area between the lateral reticular and spinal trigeminal nuclei, is a major target 
for axons of lamina I neurons in the cat and the monkey. It was also reported 
that large numbers of lamina I neurons in the rat were retrogradely labelled 
from the CVLM (Lima et al., 1991; Spike et al., 2003). It was shown that in the 
rat, the thalamus (including its PoT) received fewer projections from lamina I 
neurons that were located in the lumbar region, compared to neurons in the 
cervical area (Burstein et al., 1990; Al-Khater et al., 2008). It was also found 
that in the lumbar cord of the rat, the largest numbers of labelled lamina I 
neurons were seen following tracer injections into the CVLM or LPb, compared to 
the smaller number of cells observed after the injection of a tracer into the 
PAG. In each case, most labelled cells were located in the contralateral dorsal 
horn with some cells having bilateral projections (Todd et al., 2000; Spike et al., 
2003; Polgar et al., 2010). In addition, Al-Khater and Todd (2009) reported that 
almost all (>95%) lamina I spinothalamic neurons in both lumbar and cervical 
enlargements were labelled from the LPb.  
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Many lamina I neurons express the NK1 receptor, on which substance P acts. It 
was estimated that in the rat, around 45% of lamina I neurons express the NK1 
receptor (Todd et al., 1998), and a large number of these do not project to 
supraspinal areas. Approximately 80% of lamina I neurons that were retrogradely 
labelled from various supraspinal regions, expressed the NK1 receptor in the rat. 
NK1r-expressing neurons are of particular interest, since they are activated by 
noxious stimuli (Doyle and Hunt, 1999) and their ablation leads to a dramatic 
reduction of hyperalgesia in inflammatory and neuropathic pain models (Mantyh 
et al., 1997; Nichols et al., 1999).    
Attempts have been made to classify lamina I NK1r-expressing neurons. For 
instance, Cheunsuang and Morris (2000) identified two distinct populations of 
NK1r-expressing neurons in lamina I. These included small cells, which stained 
weakly for the receptor and had fusiform somata, with a mean value of their 
cross-sectional area of 81 µm2 (in a horizontal plane), and large multipolar cells 
that were described as strongly immunoreactive (mean of the soma cross 
sectional area was 288 µm2). Cheunsuang and Morris (2000) also suggested that 
many of the larger neurons may project to the thalamus and have polymodal 
nociceptive characteristics, thus being a part of a system that evaluates the 
severity of an injury, and then initiates the appropriate response for protection 
and endogenous suppression of this pain. In contrast, the study showed that 
smaller neurons had a very distinctive fusiform morphology, which has been 
suggested to be characteristic of nociceptive specific neurons (Han et al., 1998). 
Subsequently, Polgar et al. (2002) reported that a sample of 45 NK1r-
immunoreactive lamina I neurons that were labelled from the CVLM had soma 
sizes that were similar to those of the large cells identified by Cheunsuang and 
Morris (2000). However, the study could not determine whether all of the large 
cells were projection neurons, since not all projection neurons in this lamina 
would have been labelled from the CVLM (Spike et al., 2003).  
It was reported that morphology of lamina I neurons correlated with functional 
properties in the rat, cat and monkey. For instance, pyramidal cells that lacked 
the NK1 receptor responded to innocuous cooling only, while multipolar and 
fusiform cells were activated by noxious stimuli (Han et al., 1998; Yu et al., 
1999; Almarestani et al., 2007). Almarestani et al. (2007) also reported that 
47 
most of the spinoparabrachial NK1r-expressing neurons in the rat were either 
multipolar or fusiform, while the pyramidal projection cells were seldom NK1r-
immunoreactive. However, it was shown that in the rat, there was no difference 
between the morphological classes of NK1r-expressing projection neurons in 
either the density of contacts from substance P-containing afferents or the 
percentage of cells that up-regulated fos after noxious chemical stimulation 
(Todd et al., 2002; 2005). 
The main aim of this part of the study was to test the hypothesis that all of the 
large lamina I NK1r-immunoreactive cells identified by Cheunsuang and Morris 
(2000) are projection neurons, while the small cells are interneurons. To achieve 
this, tracers were injected into both the LPb and the CVLM, since it has been 
shown that virtually all lamina I projection neurons can be labelled from these 
sites (Spike et al., 2003). It has been reported that a large number of lamina I 
pyramidal projection neurons lacked the NK1 receptor, and these cells tended to 
be smaller than the NK1r-expressing projection neurons (Almarestani et al., 
2007). Therefore, an additional aim of this study was to further investigate the 
retrogradely labelled pyramidal cells that were NK1r-negative, and compare 
them with the NK1r-expressing projection neurons of the pyramidal class.  
3.2 Experimental procedures 
3.2.1 Animals and operative procedures 
Three adult male Wistar rats (250–280 g; Harlan, Loughborough, UK) were used 
for this part of the study. The rats were anaesthetized with Isofluorane (1.5-4%). 
They were then placed on a heating pad in order to maintain their body 
temperature. Their heads were fixed in a stereotaxic frame, after which the 
anaesthetic was administered through a mask attached to the frame. The level 
of anaesthesia was monitored throughout the procedure by occasionally pinching 
the hindpaw and observing the appearance of any withdrawal reflexes. In order 
to prevent the rat corneas from drying during the surgery, their eyes were 
covered with Vaseline petroleum jelly. The points in the skull that corresponded 
to the LPb and the CVLM were determined using a standard rat brain atlas 
(Paxinos and Watson, 2005). Under aseptic conditions, the two areas of interest: 
the LPb and the CVLM were made accessible by performing a craniotomy with a 
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fine drill after separating the underlying fascia. Each rat received two 
injections: (1) 50 nl of 4% Fluorogold (Fluorochrome Inc, Englewood, CO, USA) 
targeted on the left LPb, and (2) 200 nl of 1% CTb (Sigma-Aldrich, Poole, UK) 
into the left CVLM. Injections to the CVLM were aimed to regions between the 
lateral reticular nucleus and the adjacent part of the spinal trigeminal nucleus 
(Spike et al., 2003). The injections were made under pressure using two 
different glass micropipettes, one for each area. In order to prevent the 
backflow of the tracers after injecting them, the micropipettes were left in 
place for 5 minutes. At the end of the procedure, the incision was sutured and 
the rats were allowed to recover from anaesthesia after which they were 
subcutaneously injected with 5 mg/kg carprofen; an analgesic. Following a 3 day 
survival period, the rats were re-anaesthetized with pentobarbitone (40 mg/kg 
ip) and perfused with 4% formaldehyde as described in the previous Chapter.  
3.2.2 Tissue processing and immunocytochemistry 
The brain and the lumbar spinal cord were dissected out and post-fixed at 4°C 
for 24 hours. The brain fixative contained 30% sucrose as a cryoprotectant, 
preventing large ice crystal formation. The regions of the brainstem that 
contained the injection sites were cut into 100 µm thick coronal sections with a 
freezing microtome. The brain sections were cut serially into 5 bottles and the 
series in one of the bottles was used for further analysis. Sections through the 
Fluorogold injection were mounted on slides with a glycerol-based antifade 
medium (Vectashield, Vector laboratories, Peterborough, UK) and viewed with a 
fluorescent microscope. For detection of CTb, sections from one of the bottles 
were incubated for 3 days in goat antiserum to CTb (1:50,000). On the 3rd day, 
the sections were rinsed 3 times in PBS over a period of half an hour, and then 
they were incubated overnight in biotinylated anti-goat IgG (Jackson 
ImmunoResearch, West Grove, PA; 1:500). On the 4th day, and after the sections 
had been rinsed 3 times in PBS for 30 minutes, they were reacted for 3-4 hours 
with streptavidin-horseradish peroxidase (Sigma-Adrich, Poole, UK; diluted in 
PBS, 1:1000). Peroxidase activity was revealed with 0.025 M diaminobenzidine in 
the presence of 0.001% hydrogen peroxide. The sections were then rinsed 3 
times in PBS over a period of half an hour and mounted on gelatinized slides and 
air dried. On the following day, sections were rinsed in water, dehydrated in 
49 
ascending concentrations of alcohol, cleared in Histo-Clear and mounted with 
Histomount.  
The spread of the tracers was plotted onto drawings of the LPb and the CVLM 
(Paxinos and Watson, 2005) and representative examples were photographed. 
The spinal L4 segment from each animal was initially notched on the left side 
(ipsilateral to the injection side), and cut into 60 µm horizontal sections with a 
Vibratome. The sections were then treated for 30 minutes with 50% ethanol. 
These were rinsed 3 times with PBS for half an hour, and then incubated free-
floating at 4°C for 3 days in a cocktail of antibodies. The primary antibodies 
consisted of guinea-pig anti-Fluorogold (1:500), goat anti-CTb (1:5000) and 
rabbit anti-NK1r (1:10,000). The sections were rinsed 3 times with PBS for 30 
minutes, reacted with fluorescent labelled species-specific secondary antibodies 
that were raised in donkey and conjugated to either Alexa 488, Rhodamine Red 
or Cy5. The sections were then rinsed 3 times with PBS, mounted and stored at -
20°C. Characteristics and suppliers of antibodies used in this part of the study 
are described in the previous Chapter.   
3.2.3 Confocal microscopy and analysis 
Horizontal sections from the L4 spinal segments were used to analyze the soma 
sizes of lamina I NK1r-expressing neurons that projected to the LPb and/or the 
CVLM, as well as the soma sizes of the NK1r-expressing neurons that were not 
retrogradely labelled.   
Sections were initially examined with a 20× objective lens using a fluorescent 
microscope. All of those on the contralateral (right, un-notched) side that 
contained lamina I were identified by the presence of numerous retrogradely 
labelled cells, as well as a relatively high density of NK1r-immunoreactivity 
compared to lamina II. In this way, between one and three sections from each 
animal were selected for further analysis. These sections were scanned with a 
Bio-Rad Radiance 2100 confocal system through a 40× oil-immersion lens to 
produce image stacks with a 2 µm z-separation. Since the area covered by this 
lens was approximately 300×300 µm2, several overlapping fields (between 5 and 
7 from each section) were scanned in order to include most of the medial two-
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thirds of lamina I. The lateral part of the dorsal horn was not analysed, as the 
orientation of the lamina is different in this region. Scans were performed 
sequentially with each laser line to avoid fluorescent bleedthrough.  
Confocal image stacks were analysed with Neurolucida for Confocal software. 
Initially, and to avoid selection bias, only the channel corresponding to NK1r-
immunoreactivity was viewed and this was used to identify lamina I. NK1r-
immunoreactive cells in lamina I were then selected and the outlines of their 
cell bodies were drawn by examining all of the optical sections through each 
cell. Preliminary observation confirmed that there was a large population of 
small cells (<200 µm2 soma cross-sectional area) that showed weak NK1r-
immunoreactivity, and these were found to be far more numerous than the 
larger NK1r-immunoreactive cells. For this reason, all of the larger cells (>~200 
µm2 soma cross-sectional area) together with a sample of small cells were 
selected for analysis. For each of the selected cells, the maximum cross-
sectional area of the soma was measured from projected confocal images of NK1 
receptor staining with Neurolucida for Confocal (Puskar et al., 2001). In 
addition, the intensity of NK1r-immunostaining in the plasma membrane was 
assigned a score ranging from 4 (strong) to 1 (very weak), as described 
previously (Al-Khater and Todd, 2009). This scoring system was used because 
variation in immunofluorescence intensity at different depths of the Vibratome 
sections makes it difficult to use a more objective measure (Spike et al., 2003). 
When all of the selected cells in a field had been analysed, the channels 
corresponding to Fluorogold and CTb were examined, and the presence or 
absence of these tracers in each of the selected cells was determined. In 
addition, any retrogradely labelled cells that had not been included in the 
selected sample were identified and analysed in the same way. These additional 
cells included those that were NK1r-negative as well as some that showed very 
weak immunostaining and had not been recognized in the initial survey. Cells 
were excluded from the analysis if part of the soma had been removed from the 
Vibratome section in such a way that the cross-sectional area would be 
underestimated. 
As described previously, Almarestani et al. (2007) reported the presence of a 
distinctive population of pyramidal spinoparabrachial neurons that lacked the 
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NK1 receptor. In order to further investigate this, the morphology of all 
retrogradely labelled cells that were not NK1r-immunoreactive was analysed by 
examining confocal image stacks with Neurolucida software. Cells were 
classified into multipolar, pyramidal or fusiform based on the criteria described 
by Zhang et al. (1996) and Zhang and Craig (1997). The soma size of these 
neurons and the number and orientation of their primary dendrites were clearly 
defined, since it has been suggested that these features are particularly 
important for classification (Almarestani et al., 2009). 
3.3 Results 
3.3.1 Injection sites 
The extent of spread of Fluorogold from the LPb and of CTb from the CVLM was 
plotted for each experiment. Drawings, which were based on those of Paxinos 
and Watson (2005), are illustrated in Figure 3-1. Photomicrographs of 
representative injection sites are shown in Figure 3-2.  
The Fluorogold injection, which targeted the LPb covered almost all of it in each 
case, with variable spread into surrounding structures, such as the superior 
cerebellar peduncle, medial parabrachial area, cuneiform nucleus, and inferior 
colliculus.  
The CTb injection, which was targeted on the CVLM filled the lateral part of the 
lateral reticular nucleus in all three cases, with spread into surrounding regions, 
including the area between this nucleus and the spinal trigeminal nucleus and 
the ventrolateral white matter. 
3.3.2 NK1r-immunoreactivity in lamina I 
The highest densities of NK1r-immunostaining, for both cell bodies and 
dendrites, were seen in lamina I (Figure 3-3). This finding is in agreement with 
previous studies (Bleazard et al., 1994; Nakaya et al., 1994; Littlewood et al., 
1995; Todd et al., 1998). Lamina I NK1r-immunoreactive cells appeared to have 
a bimodal size distribution, with one group consisting of large neurons of various 
shapes, and the other group consisted of many smaller fusiform cells that 
resembled what was described by Cheunsuang and Morris (2000). The large cells 
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showed different somatodendritic morphology (including fusiform, pyramidal and 
multipolar types), and were also much more variable in regard to their strength 
of NK1r-immunoreactivity. This ranged from strong to very weak in contrast to 
the small cells, which were generally weakly immunoreactive. In regard to the 
smaller NK1r-expressing cells, it was observed, but not systematically analysed, 
that these cells were particularly numerous in the ventral part of lamina I (as 
reported by Cheunsuang and Morris, 2000).  
Altogether, 1341 NK1r-immunoreactive cells were identified in lamina I in 
sections from the three experiments. Of these, 441 neurons were retrogradely 
labelled from the CVLM, LPb, or both. The 900 remaining cells were not labelled 
from either the CVLM or the LPb.  
3.3.3 Retrograde labelling  
In addition to the 441 NK1-immunoreactive projection neurons, 101 NK1r-
negative retrogradely labelled cells were identified. The total number of lamina 
I projection neurons that were selected for analysis from the 3 experiments was 
therefore 542, (156–206 per experiment). Of these, 83–88% contained both 
tracers, while 5–6% was labelled only with CTb injected into the CVLM and 5–12% 
was labelled only with Fluorogold injected into the LPb (Table 3-1, Figure 3-4a).  
From the three experiments, between 76 and 86% (mean 81%) of the 
retrogradely labelled lamina I cells were NK1r-immunoreactive. The strength of 
NK1r expression on these cells varied from very weak to strong (Table 3-2). 
Examples of retrogradely labelled neurons that were NK1r-immunoreactive and 
those that lacked the NK1 receptor are shown in Figures 3-3 and 3-4.  
Of the 441 NK1r-immunoreactive retrogradely labelled neurons, 420 had been 
identified in the initial surveys of NK1r immunoreactivity in the confocal image 
stacks, as described in the experimental procedures section. The remaining 21 
(most of which showed weak NK1r-immunoreactivity) were identified only after 
the channels corresponding to CTb and Fluorogold were observed. 
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3.3.4 Soma cross-sectional areas 
As described previously, the total number of lamina I NK1r-immunoreactive 
neurons that had been selected in this study is 1341. Of these, 900 cells were 
not retrogradely labelled (214–390 from each experiment). The remaining 441 
NK1r-immunoreactive neurons were retrogradely labelled. Regarding the 
strength of the NK1r immunoreactivity, the great majority of un-labelled cells 
(784, 87%) were assigned a score of 1, while 106 (12%) were given a score of 2, 
and 10 (1%) a score of 3.  
Figure 3-5 shows the frequency distributions of soma cross-sectional areas for 
the different groups of neurons based on both their NK1r expression and 
retrograde labelling. The histogram for all NK1r-immunoreactive neurons shows 
a clear bimodal distribution with two peaks. The first one corresponds to soma 
cross-sectional area values between 50 and 200 µm2, and the second broader 
peak extends from 200 to 600 µm2 with fewer cells having larger soma cross-
sectional areas (up to 1200 µm2).  
Figure 3-5 also shows the cross-sectional areas of cell bodies for the NK1r-
immunoreactive cells that were not retrogradely labelled. These ranged from 61 
to 568 µm2, with a median value of 124 µm2 (n=900), and they corresponded to 
the first peak of the combined NK1r-immunoreactive group.  The cross-sectional 
area values for the retrogradely labelled NK1r-immunoreactive cells were 128–
1198 µm2, with a median of 298 µm2 (n=441), and these corresponded to the 
second peak of the combined group. The retrogradely labelled cells that lacked 
the NK1 receptor had soma cross-sectional area values that ranged between 137 
and 1129 µm2 with a median of 272 µm2 (n=101).  
Differences between these three groups (NK1r+ non-retrograde, NK1r+ retrograde 
and NK1r- retrograde) were found to be significant (Kruskal–Wallis test, 
P<0.001). Post-hoc Mann–Whitney U-tests with sequential Bonferroni correction 
showed a highly significant difference between the soma sizes of the NK1r-
immunoreactive neurons that were not retrogradely labelled and those of both 
groups of retrogradely labelled neurons (P<0.001). However, there was no 
significant difference between the retrogradely labelled neurons that were 
NK1r-immunoreactive and those that were not immunoreactive (P=0.16).  
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Nearly all (895/900, 99.4%) of the NK1r-immunoreactive cells that were not 
retrogradely labelled had soma cross-sectional areas that were less than 200 
µm2. In contrast, only 43/441 (9.8%) of the retrogradely labelled NK1r-positive 
cells had cell bodies smaller than 200 µm2 (Figure 3-5 and Table 3-3). 
3.3.5 Morphology of NK1r-negative projection neurons 
In order to fulfill one of the aims of this part of the study regarding investigating 
lamina I pyramidal projection neurons that lacked the NK1 receptor, the 
morphology of all the projection cells that were NK1r-negative was examined. 
Within this population (n=101), 15 were classified as pyramidal, 36 as multipolar 
and 24 as fusiform. Of the remainder 26, 13 fell under the ‘unclassified’ group, 
while 13 could not be classified because of incomplete filling of primary 
dendrites. An example of a retrogradely labelled pyramidal cell that lacked 
NK1r-immunoreactivity is illustrated in Figure 3-4 (cell 3). Figure 3-6 shows 
drawings of the cell bodies and proximal dendrites of five of these cells. The 
pyramidal cells were characterized by a triangular cell body, and in most cases 
(11/15) this gave rise to three primary dendrites (one from each pole of the 
soma). Each of the remaining four pyramidal cells had four primary dendrites. In 
one of these cases, two of the dendrites arose from one pole, while in the other 
three cases an additional thin dendrite was given off from the soma (Figure 3-6). 
One of these travelled dorsally towards the dorsal columns. Although the 
morphology of the retrogradely labelled NK1r-immunoreactive neurons was not 
analysed systematically, many of these cells were also pyramidal (e.g. cells 1 
and 2 in Figure 3-4). In order to compare the soma sizes of NK1r-immunoreactive 
and non-immunoreactive pyramidal projection neurons, the results from the 15 
NK1r-negative pyramidal projection cells seen in this part of the project were 
pooled with data from a study of spinoparabrachial neurons in the L3 segment of 
the rat reported by Al-Khater and Todd (2009). This latter group consisted of 55 
retrogradely labelled pyramidal cells, of which 37 were NK1r-immunoreactive 
and 18 were non-immunoreactive. Soma sizes of the NK1r-immunoreactive 
pyramidal cells varied from 196 to 616 µm2 (median 333, n=37) while those of 
the non-immunoreactive cells ranged from 171 to 533 µm2 (median 285, n=33). 
Although the NK1r-immunoreactive cells tended to be larger than the non-
immunoreactive ones (Figure 3-7), this difference did not reach significance 
(P=0.07, Mann–Whitney U-test). 
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Figure 3-1 Drawings of Fluorogold and CTb injection sites in the three 
experiments.  
Injection sites in the three experiments (Fluorogold injected into LPb and CTb 
into CVLM). The drawings show the spread of tracer in each of these 
experiments. Each vertical column represents a single experiment, and the 
experiment number is shown at the bottom of the column. Numbers on the left 
correspond to the position of the section anterior or posterior (-) to the 
interaural plane. Drawings are based on those of Paxinos and Watson (2005). The 
upper four outlines in each column represent the Fluorogold injection, while the 
lower five show the spread of CTb.  
CnF, cuneiform nucleus; Cu, cuneate nucleus; IC, inferior colliculus; KF, 
Kölliker-Fuse nucleus; LPb, lateral parabrachial nucleus; LRt, lateral reticular 
nucleus; MPB, medial parabrachial nucleus; PAG, periaqueductal grey matter; 
py, pyramidal tract; scp, superior cerebellar peduncle; Sol, nucleus of the 
solitary tract; Sp5, spinal trigeminal nucleus. 
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Figure 3-3 Immunoreactivity of the NK1 receptor, CTb and Fluorogold.  
A horizontal section from the L4 segment of experiment 2. (a) shows a field 
scanned to reveal NK1r-immunoreactivity (green), (b) has been scanned for CTb 
(red) and Fluorogold (FG, blue), while (c) is a merged image. The NK1r-
immunoreactivity is associated with thin elongated profiles, which are dendrites, 
as well as with larger structures, which are cell bodies.  
This field contains the cell bodies of five NK1r-immunoreactive projection 
neurons (asterisks) that were retrogradely labelled from both CVLM and LPb, and 
therefore contain both tracers. In addition, several smaller NK1r-
immunoreactive cell bodies are visible, and these are not retrogradely labelled. 
Six of these cells are indicated with arrowheads. The images are projections of 
two optical sections at 2 µm z-separation. Scale bar=20 µm. 
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Figure 3-4 Examples of retrogradely labelled neurons.  
A horizontal section from L4 in experiment 1. (a) A projected image through the 
cell bodies of several retrogradely labelled cells, with CTb shown in red and 
Fluorogold in blue. Most cells have taken up both tracers and therefore appear 
pink, while the cell numbered 1 is labelled only with Fluorogold, and the one 
marked with an asterisk is labelled only with CTb. The three numbered cells are 
pyramidal in shape and single optical sections through the cell bodies of each of 
these are shown in (b–g).  
From these images it can be seen that cells 1 and 2 are NK1r-immunoreactive, 
while cell 3 is not. The image in (a) is a projection of eight optical sections at 2 
µm z-spacing. Scale bar=20 µm. 
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Figure 3-5 Frequency histogram showing the soma cross-sectional areas for 
different groups of lamina I neurons.  
The histogram shows all of the NK1r-immunoreactive cells (All NK1r+, n=1341), 
those that were NK1r-immunoreactive but not retrogradely labelled (NK1r+ non-
retrograde, n=900), those that were NK1r-immunoreactive and retrogradely 
labelled (NK1r+ retrograde, n=441) and those that were retrogradely labelled and 
not NK1r-immunoreactive (NK1r- retrograde, n=101).  
In each case, the y-axis represents percentage. The dashed line corresponds to a 
cross-sectional area of 200 µm2. The NK1r-immunoreactive neurons show a clear 
bimodal distribution, with the first and second peaks corresponding to the non-
retrogradely labelled and the retrogradely labelled populations, respectively. 
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Figure  3-6 Drawings of NK1r-negative retrogradely labelled pyramidal cells. 
Drawings showing five of the 15 retrogradely labelled pyramidal cells that were 
not NK1r-immunoreactive. Cell 1 corresponds to cell 3 in Figure 3-4. Three of 
these cells (1, 3 and 4) each give rise to three primary dendrites. Cell 2 has two 
primary dendrites originating from one pole of the soma, while cell 5 has an 
additional very fine dendrite originating from the soma. Scale bar=20 µm. 
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Figure  3-7 Box and whisker plot of the soma sizes of retrogradely labelled 
pyramidal cells.  
The plot shows the soma sizes of retrogradely labelled pyramidal cells that were 
NK1r-immunoreactive (NK1r+, n=37) or non-immunoreactive (NK1r-, n=33). The 
boxes represent the median and interquartile range, while the upper and lower 
error bars show the 90th and 10th percentiles and the filled symbols are values 
outside these ranges.  
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3.4 Discussion 
The main finding of this part of the study is that NK1r-expressing projection 
neurons can be distinguished from NK1r-expressing interneurons, in lamina I, 
based on their cell body sizes. The great majority of NK1r-expressing cells that 
were not retrogradely labelled from CVLM and/or LPb have soma cross-sectional 
areas of less than 200 µm2, while most of the retrogradely labelled cells are 
larger than this. 
3.4.1 Choice of the retrograde tracers and injection targets 
In this part of the study, a retrograde labelling technique was used in order to 
identify lamina I projection neurons. It was reported that this technique allows 
both quantitative and qualitative assessments of connections between various 
CNS areas (Vercelli et al., 2000). A combination of two retrograde tracers (CTb 
and Fluorogold), which were injected into two different supraspinal targets on 
one side, CVLM and LPb, enabled targeting almost all lamina I projection 
neurons on the contralateral side, for reasons that will be explained shortly.  
It has been shown from previous studies that both CTb and Fluorogold are 
sensitive markers, as evidenced by their ability to detect large numbers of 
retrogradely labelled cells, as well as their extensive filling of labelled neurons 
(Spike et al., 2003; Al-Khater and Todd, 2009; Polgar et al., 2010). They are also 
equally efficient, since Spike et al. (2003) reported that the injection of either 
Fluorogold or CTb into the LPb resulted in labelling almost the same number of 
cells. It was observed that Fluorogold may cause necrosis of the tissues to which 
it is injected, this is why it is preferable, that if used with another marker, for it 
to be injected to the more rostral target, which is the LPb in this case 
(Akintunde and Buxton, 1992; Bice and Beal, 1997b).  
It has been concluded from previous studies in our laboratory that the injection 
of tracers into both CVLM and LPb labels almost all lamina I projection neurons. 
Ikeda et al. (2006) suggested that lamina I spino-PAG neurons represent a 
distinct population, since they showed a functional difference compared to 
lamina I neurons that projected to the LPb. Their study provided evidence for a 
difference in the type of long-term potentiation between lamina I neurons that 
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were retrogradely labelled from the PAG and those that were labelled from the 
LPb. However, Spike et al. (2003) have shown that nearly all of the cells that 
projected to the contralateral PAG can also be labelled from contralateral LPb. 
This suggests that although spino-PAG neurons may represent a distinct 
functional population, they still can be labelled from the LPb. It was also 
reported that axons from the SDH that travel to the PAG pass through the LPb 
(Bernard et al., 1995; Feil and Herbert, 1995). Therefore, the tracers used in 
both studies (Spike et al., 2003; Ikeda et al., 2006) would have been taken not 
only by axon terminals, but also by fibres of passage. Regarding the thalamus as 
a potential distinct projection target of lamina I neurons, Al-Khater et al. (2008) 
reported that lamina I spinothalamic tract neurons make up only ~3–5% of the 
total number of projection cells in the mid-lumbar segments of the rat. Almost 
all of these cells send axon collaterals to the LPb (Al-Khater and Todd, 2009). It 
was also found that lamina I neurons can be labelled following injection of 
tracer into the dorsal part of the caudal medulla, which is an area that includes 
the DRt and NTS (Menetrey and Basbaum, 1987; Lima, 1990; Todd et al., 2000). 
However, it was recently shown that cells labelled from the dorsal part of the 
caudal medulla are also retrogradely labelled from the LPb (Polgar et al., 2010).  
Regarding the percentages of labelled cells, the present study showed that 
between 83 and 88% of the retrogradely labelled lamina I neurons contained 
Fluorogold and CTb, indicating that they had been labelled from both LPb and 
CVLM respectively. However, Spike et al. (2003), who used similar injection and 
immunostaining protocols, reported a lower percentage of these labelled cells. 
Their study found that 63–78% of labelled cells contained both tracers. This 
difference is mainly due to an increase in the number of cells labelled from the 
LPb (94–95% of all retrogradely labelled cells in the present study, compared to 
81–91% in the study of Spike et al. (2003). This may be attributed to a technical 
difference between those two studies, since the method of detecting Fluorogold-
positive cells in the present study seems to be more sensitive. It involved using a 
highly sensitive gallium arsenide phosphide photomultiplier tube to detect 
Fluorogold, which was conjugated to Cy5.  
One issue in this part of the study is that some of the retrograde labelling with 
CTb that was seen resulted from uptake of the tracer by fibres passing through 
the CVLM before reaching their targets (Spike et al., 2003). This might be 
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attributed to the fact that the CTb injections extended into the ventrolateral 
white matter, which contains many axons that ascend from the spinal cord 
(Zemlan et al., 1978). However, this did not affect the overall outcome of the 
study, since the purpose of it was to label all projection neurons regardless of 
their supraspinal projection targets.  
3.4.2 NK1r-mmunoreactive neurons 
The present findings strongly support what was hypothesized by Cheunsuang and 
Morris (2000) that lamina I NK1r-expressing neurons are divided into two 
populations based on their soma sizes. The present study has identified a 
population of large NK1r-immunoreactive neurons that are considered projection 
neurons, since virtually all (398/403, 99%) of those with soma areas >200 µm2 
were retrogradely labelled. In contrast, the size distribution for NK1r-
immunoreactive cells that were not retrogradely labelled indicates that these 
correspond to the population of small neurons. Neurons that were located in the 
most lateral part of lamina I were not analysed, since this part curves around 
the lateral margin of the dorsal horn leading to a different orientation of the 
neurons in this region, which makes it difficult to compare their soma sizes. 
However, it was observed that retrogradely labelled lamina I neurons in this 
region have a similar appearance to those elsewhere in the lamina. It is 
therefore unlikely that the lack of data from the lateral part of lamina I affects 
the validity of this conclusion.  
Lamina I contains a very large number of the small NK1r-immunoreactive 
neurons, and it was not possible therefore to include all of these in the sample 
that was used for analysis. These cells also had weak immunoreactivity, which 
would have made it very time-consuming to identify them all. However, it is 
most probably that the present study did not underestimate the extent of 
retrograde labelling within this group, since in all cases a search for retrogradely 
labelled cells was carried out after the sample of NK1r-immunoreactive neurons 
had been collected. Another possible explanation for the absence of retrograde 
labelling in the small cells may be the lack of time for transport of the tracers, 
since the animals were perfused three days after the tracer injection surgery. 
However, it was found (in our laboratory) that increasing the post-operative 
survival time does not result in any increase in the number of labelled cells or in 
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the appearance of smaller labelled cells (Todd and Polgar, unpublished 
observations). In addition, this absence of labelling is unlikely to be due to a 
tracer sensitivity issue, since there was a clear distinction between cells that 
were positive and negative for CTb and Fluorogold. For the reasons stated 
above, it is unlikely that the present study underestimated the extent of 
retrograde labelling in the small NK1r-immunoreactive neurons. Although 
Cheunsuang and Morris (2000) speculated that the small NK1r-immunoreactive 
cells might be projection cells, it is very unlikely. However, the possibility that 
they project to some other brain region, other than the CVLM, LPb, PAG, 
thalamus, DRt or NTS can not be ruled out, but it is more likely that these cells 
are intrinsic spinal interneurons. 
Of the 5 large NK1r-immunoreactive cells that were not retrogradely labelled, 3 
had cell bodies >300 µm2, and clearly these do not belong to the population of 
small neurons. Although it is possible that these cells are interneurons, it seems 
more likely that they are projection cells that were not retrogradely labelled 
from either of the injection sites used in these studies. The very low number of 
large (>200 µm2) NK1r-immunoreactive cells that were not retrogradely labelled 
(5/403, 1%) provides additional support for the suggestion that the two 
injections used in this study labelled the great majority of lamina I projection 
cells on the contralateral side.  
Although the small NK1r-immunoreactive cells were not quantified 
systematically, these appeared to be much more numerous than the large ones. 
This presumably accounts for the fact that ~45% of lamina I cells are NK1r-
immunoreactive (Todd et al., 1998) and that projection neurons (~80% of which 
express the NK1r) are thought to make up less than 10% of the total neuronal 
population in this lamina (Bice and Beal, 1997a, 1997b; Spike et al., 2003; Al-
Khater et al., 2008). Although these small cells outnumber the larger projection 
neurons, more research has been done on projection neurons, and even the 
studies that investigated lamina I interneurons did not distinguish the NK1r-
positive from the NK1r-negative smaller cells.    
Little is known about the function of the small NK1r-expressing cells in lamina I. 
However, since NK1r-immunoreactive cells in this lamina are not GABA-
immunoreactive (Littlewood et al., 1995), it is likely that they are glutamatergic 
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excitatory interneurons. In the next part of this project, it will be shown that 
some of these cells phosphorylate ERK following noxious stimulation. Since they 
only express low levels of the NK1 receptor, it is likely that these cells would not 
have been destroyed by intrathecal administration of SP-SAP, and this 
presumably explains why there is no detectable reduction in the number of 
neurons in lamina I following this treatment (Nichols et al., 1999). Additionally, 
A recent study by Choi et al. (2012) reported that after the pretreatment of the 
rats with SP-SAP, ~30% of the NK1r immunoreactivity, determined by pixel 
count, remained in the SDH, which may be attributed to the retained small 
NK1r-expressing interneurons.     
An important practical outcome from the above results is that soma size can be 
used to identify putative lamina I NK1r-expressing projection neurons in studies 
that have not used retrograde tracing. Although NK1r-immunoreactive cells that 
have soma areas between 150 and 200 µm2 cannot be classified with certainty, 
those with areas above 200 µm2 are very likely to be projection cells, while 
those below 150 µm2 are probably interneurons. A similar approach (without the 
need of retrograde labelling) can be used to identify the large laminae III-IV 
NK1r-immunoreactive cells as projection neurons, since virtually all of these 
were shown to be labelled from the CVLM, with some projecting to LPb and/or 
PoT (Todd et al., 2000; Al-Khater and Todd, 2009). This approach will be used in 
the next Chapter as a means of distinguishing responses of lamina I projection 
neurons from those of interneurons to various types of noxious stimulation.    
3.4.3 Projection neurons that lack the NK1r 
The present study shows that of the 542 retrogradely labelled cells from the 
CVLM and/or LPb, 101 lacked the expression of the NK1 receptor. Although some 
of these cells will correspond to lamina I giant cells that were described 
previously, there are only ~10 cells of this type on each side in the L4 segment in 
the rat, and they therefore constitute only ~3% of lamina I projection neurons 
(Polgar et al., 2008). 
Little is known about the morphology and function of the remaining lamina I 
NK1r-negative projection neurons. Although Almarestani et al. (2007) have 
reported that ~90% of these neurons that projected to the LPb were of the 
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pyramidal class, with some having a 4th dorsally-directed dendrite, the present 
study shows that this number may be over-representative. Out of the 88 lamina I 
NK1r-negative projection neurons that could be classified morphologically in the 
present study (13 cells had incomplete filling of their dendrites) only 15 (17%) 
were classified as pyramidal. The present study also shows that from the 15 
identified pyramidal cells only one had a 4th dendrite that travelled dorsally 
towards the white matter. Almarestani et al. (2009) provided evidence that 
these pyramidal cells can display novel expression of the NK1r (and also an 
increase in innervation by substance P-containing primary afferents) following a 
chronic inflammatory stimulus. However, there is also a population of large 
pyramidal NK1r-immunoreactive neurons (Cheunsuang and Morris, 2000) that are 
included in the spinoparabrachial population (Spike et al., 2003; Almarestani et 
al., 2007; Al-Khater and Todd, 2009; Almarestani et al., 2009). It may therefore 
be difficult to distinguish pyramidal cells that are normally NK1r-negative and 
up-regulate the receptor after inflammation from those that constitutively 
express the receptor. Almarestani et al. (2009) reported that the pyramidal cells 
that normally lack NK1r are smaller than the NK1r-immunoreactive type, and 
typically have a fourth dendrite that emerges from the dorsal aspect of the soma 
and travels towards the overlying white matter. However, the present study 
shows that there is a considerable overlap in the distribution of soma sizes of 
NK1r-immunoreactive and non-immunoreactive pyramidal neurons, and that the 
difference between the two populations is not significant. In addition, the 
fourth, dorsally-directed dendrite described by Almarestani et al. (2009) is only 
observed on one of the 15 non-NK1r-immunoreactive pyramidal neurons.  
Further experiments are needed to identify the function of the remaining 
projection neurons that lacked the NK1 receptor in lamina I.  
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4. ERK phosphorylation in NK1r-expressing dorsal 
horn neurons and lamina I giant cells after 
noxious stimulation 
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4.1 Introduction 
Superficial dorsal horn neurons respond specifically or preferentially to various 
forms of noxious stimuli. These neurons may receive a direct input from primary 
afferents (monosynaptic), and/or are indirectly activated through excitatory 
interneurons (polysynaptic). Lamina I is a major termination site for Aδ- and C-
fibre primary afferents. Neurons in this lamina receive input from cutaneous, 
visceral, muscle and joint primary afferents (Cervero and Connell, 1984; Mense 
and Prabhakar, 1986). The primary afferent input to lamina II is mainly from 
unmyelinated fibres innervating cutaneous tissues as well as from Aδ hair follicle 
afferents (Light and Perl, 1979b; Shortland et al., 1989). It was also revealed 
recently that many large afferent fibre terminals enter the inner part of lamina 
II (Woodbury et al., 2000). Much of the input to laminae III-IV is from large 
primary afferents that enter the cord and curve into the medial part of the 
dorsal horn (Hamano et al., 1978). Cells in lamina IV have been also reported to 
receive visceral (Pomeranz et al., 1968) and joint (Schaible et al., 1986) inputs. 
In addition, these cells commonly have an input from cutaneous and muscle 
receptors (Schaible et al., 1987).  
Christensen and Perl (1970) were the first to record the responses of lamina I 
neurons to noxious stimulation in the cat. The study divided lamina I neurons 
into 3 groups according to their excitatory input. Group I, which responded only 
to intense mechanical stimulation of high threshold myelinated primary 
afferents. The 2nd group, which received afferent input from both Aδ- and C-
fibres, was activated by both intense mechanical and noxious heat stimulation. 
The 3rd group responded to the above 2 stimuli as well as to innocuous 
temperature changes. Similar findings were seen in the monkey dorsal horn 
(Kumazawa and Perl, 1978). It was also reported that in the rat, the marginal 
zone (lamina I) contained cells that were only activated by noxious pinching or 
pin-pricking stimuli (Menetrey et al., 1977). Light and Willcockson (1999) 
recorded in vivo from a sample of 73 neurons in laminae I-II of the lumbar spinal 
cord of the rat. Of these, 39 were classified as nociceptive, responding to heat 
and/or mechanical noxious stimuli, and these were located mainly in laminae I 
and IIo. Most cells in lamina II, in both primates and cat, were activated by hair 
movement (single brush stimulus) or innocuous mechanical stimulation, but some 
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cells required more intense stimulation (Kumazawa and Perl, 1978; Wall et al., 
1979; Cervero and Iggo, 1980). Laminae III-IV was found to contain narrow- and 
wide-dynamic-range cells in primates and cats. Neurons in these laminae 
responded to both cutaneous stimulation and joint movements (Wall, 1967). 
Some of these neurons responded only to noxious stimuli (Kolmodin and 
Skoglund, 1960), while others were activated just by mechanical stimuli such as 
hair movement, touch, pressure and pinch (Wall, 1967; Brown and Franz, 1969).    
Receptive fields of SDH neurons usually vary in shape and size, and can also be 
modifiable. Excitatory neurons’ receptive fields are often ovoid and larger than 
the receptive fields of primary afferents. The central part of these receptive 
fields is usually the most sensitive, and the application of a strong stimulus to 
the skin adjacent to an excitatory receptive field could produce inhibition (Wall, 
1960). Receptive fields often vary from 1-1000 mm2 depending on the body part 
encoded. The smallest excitatory receptive field for lamina I neurons can be as 
small as that of a C-fibre nociceptor (<1 mm2). In contrast, lamina I neurons with 
A-fibre nociceptive inputs have more uniform, continuous receptive fields rather 
than spot-like ones, which indicate considerable convergence from primary 
afferent onto the lamina I neurons (Light and Lee, 2009). Further, noxious 
mechanical stimulation of the region that surrounded an excitatory receptive 
field caused inhibitory postsynaptic potentials in the recorded neuron, and this 
inhibitory field faded out gradually as the distance from the excitatory field 
increased (Light and Lee, 2009). Wall (1967) initially described a somatotopic 
organisation of the dorsal horn, with the toes being represented medially, while 
the lateral aspect of the foot and more proximal regions are represented 
laterally in the dorsal horn of the cat. It was also found that the receptive fields 
of some dorsal horn neurons are changeable in primates, cats and rats. For 
instance, it was reported that noxious stimulation caused an expansion of the 
receptive fields of dorsal horn neurons, mostly of the wide-dynamic-range class, 
to both innocuous and noxious mechanical stimulation as well as to noxious heat 
(Kenshalo et al., 1979, 1982; Laird and Cervero, 1989; Simone et al., 1989; 
Simone et al., 1991).       
The responses of dorsal horn projection neurons, which were identified by 
antidromic activation from contralateral supraspinal targets, to various noxious 
stimuli have been investigated. Many studies were done on STT neurons in the 
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cat and monkey. It has been shown that lamina I STT cells play an important role 
in transmitting both nociceptive and thermoreceptive information to the 
thalamus (Willis et al., 1974). It has also been reported that the receptive fields 
of STT cells in lamina I are generally smaller than those of STT cells in deeper 
laminae (IV-IV) (Apple Baum et al., 1975). Andrew and Craig (2002) studied the 
responses of lamina I spinothalamic neurons in the cat to various stimuli. Of the 
125 lamina I spinothalamic neurons recorded, 33 were classified as nociceptive 
specific, 43 were considered polymodal-nociceptive, since they responded to 
heat, pressure and cold and the remaining 49 neurons were classified as 
thermoreceptive specific, responding to cooling and innocuous warming. As 
described previously, there are not many lamina I STT neurons in the rat, 
compared their number in the cat and monkey (Al-Khater et al., 2008). Zhang et 
al. (2006) investigated the responses of 33 lamina I STT neurons in the rat. Of 
these, 30 neurons were activated by noxious, but not innocuous, mechanical 
stimuli applied to their cutaneous receptive fields. Half of the 17 thermally 
tested STT cells were activated by both innocuous cooling as well as noxious 
heat and cold, while the other half were nociceptive-specific. The study also 
reported a difference in the thalamic terminations of axons of cells that 
responded to innocuous cooling, compared to cells that responded to noxious 
heat and cold. 
The parabrachial area, which surrounds the superior cerebellar peduncle at the 
ponto-mesencephalic junction, has been reported to be one of the major targets 
of lamina I dorsal horn neurons in primates, cats and rats (Hylden et al., 1989; 
Craig, 1995; Spike et al., 2003). Bester et al. (2000) recorded from 53 lamina I 
spinoparabrachial neurons in anesthetized rats. Most of these neurons (75%) 
were nociceptive-specific, while the remainder responded to both noxious and 
innocuous thermal and mechanical stimulation. The majority of these neurons 
(92%) responded to two modalities of noxious stimuli (mechanical and thermal), 
and about a third of the neurons in this group also responded to noxious cold 
stimuli. Andrew (2009) also studied the responses of lamina I spinoparabrachial 
neurons of the rat to different stimuli. Of the 40 neurons studied, 28 were 
nociceptive specific, 6 were polymodal-nociceptive, 4 were wide-dynamic-range 
neurons and 2 were thermoreceptive-specific.   
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In addition to their responses to noxious and thermal stimuli, Andrew and Craig 
(2001) found that a class of lamina I spinothalamic neurons in the cat responded 
to pruritic stimulation, since they were selectively excited by iontophoretic 
histamine; an itch producing agent. However, recent studies in primates 
recorded from a group of spinothalamic neurons and reported that these were 
polymodal with respect to their excitation by pruritic and painful stimuli 
(Simone et al., 2004; Davidson et al., 2007).  
The function of substance P has been studied at both cellular and systemic 
levels. Henry et al. (1975) reported that substance P, when applied by 
iontophoresis into the vicinity of dorsal horn neurons, led to a prolonged 
excitation (lasting for several minutes) of almost half of the neurons tested in 
cats. Subsequently, Salter and Henry (1991) found that iontophoretic application 
of substance P in the cat activated most of nociceptive dorsal horn neurons, but 
not non-nociceptive ones. Substance P also led to a slow depolarisation of dorsal 
horn neurons, as shown by intracellular recordings in spinal cord slice 
preparation in the rat (Murase et al., 1982). The mechanism of action of 
substance P has been investigated by voltage clamp experiments on dorsal horn 
neurons in slice preparations. Substance P’s action was attributed to its 
augmentation of an inward Ca2+ current and its inhibition of the M-current, 
which is a voltage-sensitive K+ current, causing depolarisation accompanied by 
an increase in the membrane resistance (Murase et al., 1986). Substance P has 
also been reported to potentiate the action of glutamate on its NMDA receptor 
(Dougherty and Willis, 1991). This long lasting effect of substance P has been 
shown to play an important role in the generation of hyperalgesia and allodynia 
(Woolf, 1983; Dougherty et al., 1995).  
Intrathecal injection of substance P has been reported to induce nociceptive 
behaviours that were prevented by NK1 receptor antagonists. Substance P 
increased the gain of nociceptive flexion withdrawal reflexes (Ma and Woolf, 
1995), and decreased the latency of paw withdrawal following noxious heat 
(Malmberg and Yaksh, 1992). It also led to biting and scratching behaviours, 
which were similar to those induced by the peripheral injection of noxious 
chemicals (Wilcox, 1988; Bjorkman et al., 1994). NK1 receptor antagonists also 
prevented behavioural responses that were associated with noxious visceral 
stimulation and those related to the 2nd phase of formalin injection (Garret et 
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al., 1991; Seguin et al., 1995). This prevention of nociception-related behaviours 
was successful only if the NK1 receptor antagonist was given either before or 
during the process of stimulation. It is therefore assumed that substance P-
induced activation of the NK1 receptor contributes mainly to the generation, but 
not the maintenance, of hyperalgesia.  
A number of studies focused on the role of NK1r-expressing neurons in 
nociception. It was reported that following the injection of formalin into the rat 
hindpaw, the expression of the NK1 receptor gene was increased in the SDH, and 
this increase was blocked following the administration of a specific NK1 receptor 
antagonist (McCarson and Krause, 1996). It has been also shown that natural and 
electrical noxious stimulation, as well as the administration of substance P or 
NMDA led to internalisation of the NK1 receptor. This internalisation was 
stimulus intensity-dependent, occurred within 5-10 minutes, and the receptor 
returned to the cell membrane within 1 hour (Mantyh et al., 1995; Abbadie et 
al., 1997). This NK1 receptor internalisation can be prevented by NK1 receptor 
antagonists as well as by NMDA antagonists, but not by AMPA or kainite 
antagonists (Liu et al., 1997; Marvizon et al., 1997). This therefore suggests a 
role of NMDA in controlling internalisation of the NK1 receptor, which is initiated 
by substance P. Afrah et al. (2001) also reported that capsaicin-induced 
substance P release (capsaicin in the perfusion fluid for 30 min, a microdialysis 
study) into the dorsal horn of the rat spinal cord was partially dependent on an 
action of NMDA receptors. Their study suggest that capsaicin may activate the 
release of glutamate from primary afferents, which in turn acts on presynaptic 
NMDA receptors located on substance P-containing primary afferents leading to 
the release of substance P. Although it was reported that GABAB agonists 
reduced the release of substance P from primary afferents, these failed to 
reduce NMDA-induced NK1 receptor internalisation (Marvizon et al., 1999). 
Trafton et al. (1999) reported that morphine alone produced a modest decrease 
in noxious-pinch induced internalisation of the NK1 receptor in the rat, but when 
combined with an NK1 antagonist, internalisation was almost prevented. Their 
study suggests that opioid analgesia may involve controlling non-substance P 
primary afferents. However, Kondo et al. (2005) showed that the administration 
of spinal µ- and δ-opioid agonists prevented afferent-evoked NK1 internalisation 
both in vivo and ex vivo. More recently Beaudry et al. (2011) reported that 
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capsaicin- and formalin-induced NK1 receptor internalisation, which can be used 
as an indication of substance P release, as well as fos up-regulation were 
inhibited by selective spinal activation of the µ- and δ-opioid receptors in the 
mice SDH.  
The involvement of NK1r-expressing neurons in nociception has been also studied 
by using markers of neuronal activity, such as fos and pERK. For instance, it was 
reported that the number of chemical- or electrical-induced dorsal horn neurons 
that up-regulated fos was significantly reduced after the pretreatment of rats 
with selective NK1r antagonists (Chapman et al., 1996; Tao et al., 1997; 
Redburn and Leah, 1999). Similarly, De Felipe et al. (1998) reported that in NK1 
receptor-knock-out mice, which were injected with formalin, the number of fos-
positive neurons in the SDH was reduced by 30% compared to the wild type. Lu 
et al. (1995) also found that 2 hours after the injection of formalin into the 
urinary bladder of the rat, fos was up-regulated in NK1r-expressing neurons, 
which were found mainly in the medial aspects of lamina I and in the dorsal 
commissural nucleus and sacral parasympathetic nucleus of the lumbosacral 
cord. This suggests that these neurons receive nociceptive input from the urinary 
bladder through substance P-containing afferents. Subsequently, Seki et al. 
(2005) reported that instillation of capsaicin into the urinary bladder of the rat 
up-regulated fos in the SDH of the lumbosacral cord. The study also reported 
that this capsaicin-induced fos expression was reduced after the pretreatment of 
the rats with SP-SAP, indicating an important role of the NK1r-expressing 
neurons in conveying nociceptive afferent information from the bladder to 
supraspinal relay centres.  
In contrast to the several studies that showed fos up-regulation in NK1r-
expressing neurons after noxious stimulation, little is known about the types of 
neurons that contained pERK. For instance, Ji et al. (2002) reported that 24 
hours after the injection of CFA into the rat hindpaw, most neurons in lamina I 
that contained prodynorphin or expressed the NK1 receptor were pERK-
immunoreactive. Ji et al. (2002) suggested that the contribution of pERK in pain 
hypersensitivity may be attributed to activation of the MAPK/ERK pathway, 
which then regulates the expression of the NK1 receptor and prodynorphin, as 
well as other target genes. It was also reported that pERK expression in the SDH 
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of adult rat spinal slice preparations was increased by 8 to 10 fold after C-fibres 
activation, and that this expression was decreased by blocking the NK1 receptor 
(Kawasaki et al., 2004). Choi et al. (2005) also found that intrathecal injection 
of substance P led to pERK expression in laminae I and II of the spinal cord of the 
mice. This expression was attenuated after the pretreatment with a MEK1/2 
inhibitor in a dose dependent manner, suggesting that ERK plays a role in 
substance P-induced nociception. Moreover, and in agreement with studies that 
reported fos up-regulation after the stimulation of the urinary bladder, Yoo and 
Hwang (2007) reported that pERK was expressed in lamina I neurons of the rat 
after both mechanical (distension) and chemical (mustard oil) noxious 
stimulation of the bladder. Their study also showed that the majority of pERK-
positive cells were NK1r-immunoreactive, and received contacts from TRPV1-
positive primary afferents, suggesting that these fibres may mediate ERK 
phosphorylation in the SDH. 
It was described above that some of lamina I giant cells up-regulated fos after 
either formalin injection into the rat hindpaw (Puskar et al., 2001), or exposing 
it to noxious heat (Polgar et al., 2008). Laminae III-IV NK1r-expressing neurons 
also showed NK1 receptor internalisation as well as ERK phosphorylation after 
mechanical, thermal and chemical stimulation in the rat (Polgar et al., 2007). 
Polgar et al. (2007) reported that almost all laminae III-IV NK1r-expressing 
neurons contained pERK 5 minutes after repeated pinching of the skin of the 
hindpaw, immersion of the hindpaw in hot water or subcutaneous injection of 
formalin into the hindpaw. The majority of these cells also showed 
internalisation of the NK1 receptor following noxious stimulation, particularly 
following thermal and chemical stimulation. 
Work done in the previous Chapter showed that lamina I NK1r-expressing 
projection neurons can be distinguished from interneurons, as they were 
generally larger. In this part, the responses of lamina I NK1r-expressing 
presumed projection neurons and interneurons to cutaneous, deep and visceral 
noxious stimuli were investigated, using pERK as the marker of neuronal activity. 
Responses of lamina I giant cells to cutaneous and deep noxious stimuli were 
also studied. The responses of laminae III-IV NK1r-expressing neurons to deep 
and visceral noxious stimuli were investigated, since their responses to 
cutaneous stimulation have already been demonstrated.  
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4.2 Experimental procedures 
The first part of the study (Chapter 3) showed that NK1r-expressing projection 
neurons in lamina I could be distinguished from interneurons based on their soma 
sizes. Specifically, it showed that 99% of the cells with soma cross-sectional 
areas >200 µm2 are projection neurons, while the great majority (~95%) of those 
below this size are interneurons. Therefore, the investigation regarding 
responses of lamina I NK1r-expressing neurons to different noxious stimuli was 
carried out on rats that had not received injections of retrograde tracer, and 
soma size was used to identify NK1r-immunoreactive cells as putative projection 
neurons or interneurons.  
 
4.2.1 Animals and noxious stimulation 
Thirty adult male Wistar rats (250–280 g; Harlan, Loughborough, UK) were used 
for this part of the study. The rats were deeply anaesthetized with 10% urethane 
(1.3 g/kg ip) and the depth of anesthesia was sufficient that the animals did not 
respond to gentle touching of the cornea (negative corneal reflex). Body 
temperature was maintained at 38.0 ± 0.5°C with an electric blanket and was 
controlled by a body thermometer. They then received one of the following 
noxious stimuli:                                                                       
(1) Pinching of folds of skin at 12 points on the left hindpaw (six each on the 
dorsal and ventral surfaces, applied with forceps for 5 s at each point; n=3).                         
(2) Injection of 25 µl of 1% capsaicin* (Sigma-Aldrich, Poole, UK) into the 
plantar surface of the left hindpaw (n=3).                                                                                    
(3) Immersion of the left hindpaw in water at 52°C for 20s (n=3) or 45s (n=3).                     
(4) Injection of 20 µl of 10% mustard oil* (95% Allyl isothiocyanate, Sigma-
Aldrich, Poole, UK) into the left knee joint (n=6), followed by flexion and 
extension of the knee joint (3-5 times).                                                                                                             
(5) Injection of 30 µl of 10% mustard oil to the left gastrocnemius muscle (n=6).               
* 1% capsaicin is made by adding 800 µl of solution A to solution B and mixing well,  
Solution A: 700 µl Tween80 added to 9.3 ml saline and stirred on a magnetic stirrer  
Solution B: 10 mg capsaicin dissolved in 200 µl ethanol  
The dissolved solution is heated for 1hr at 50°C with the lid off to evaporate the alcohol, optional. 
 
* 10% mustard oil is made by dissolving 10.5 µl of 95% Allyl isothiocyanate in 89.5 µl paraffin oil.   
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(6) Distension of the rectum and colon (colorectal distension, CRD) with a 6-7 cm 
latex balloon at 80 mmHg for 20s (n=3), since CRD at 80 mmHg for 20s has been 
demonstrated behaviourally to be noxious (Ness et al., 1991). The balloon was 
made by connecting the finger of a surgical glove with tygon tubing, using a tight 
ligature. The pressure was monitored and maintained with a handheld 
manometer attached to the balloon. Three additional rats were considered 
controls as a balloon was inserted into their colon but not inflated. The rats that 
underwent visceral stimulation were fasted with unlimited access to water for 
24 hours prior to distension.    
In each case, the animals were maintained under general anaesthesia for 5 
minutes after the end of the stimulus, and were then perfused through the heart 
with 4% formaldehyde. The first three stimuli were considered cutaneous, while 
mustard oil into joint and muscle was a means of deep stimulation, and CRD was 
the visceral stimulus.  
4.2.2 Tissue processing and immunocytochemistry 
Thoracic, lumbar and sacral spinal segments (T13, L1-L6, S1-S2) were removed, 
post-fixed at 4°C overnight. Apart from the spinal segments from rats that were 
exposed to visceral stimulation, all other segments were notched on the right 
side, in order to distinguish it from the left (stimulated) side.          
4.2.2.1 Lamina I NK1r-expressing neurons and giant cells 
To investigate the responses of lamina I NK1r-expressing neurons and giant cells 
to various noxious stimuli, the appropriate spinal segments (Table 4-1) were cut 
into 60 µm thick horizontal sections with a Vibratome. They were then treated 
for 30 minutes in 50% ethanol and processed immunocytochemically. The 
sections were incubated in mouse monoclonal antibody (mAb) against gephyrin 
(mAb 7a, 1:100,000), which was detected with a TSA kit (PerkinElmer Life 
Sciences, Boston, MA), see below. The mouse mAb 7a was combined with rabbit 
anti-NK1r (1:10,000) followed by incubation in mouse monoclonal antibody 
against pERK (1:1000). Sections were incubated in species-specific secondary 
antibodies raised in donkey and conjugated to either Cy5 or Alexa 488.  
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The TSA method was performed by applying one primary antibody, which is the 
mAb 7a in this case, at a level that is too low to be detected with a fluorescent 
labelled secondary antibody, yet sufficient for detection with the tyramide 
system. This first primary antibody will then be effectively neglected during 
application of a second primary antibody that will be detected by conventional 
fluorescently labelled secondary antibodies (Shindler and Roth, 1996). 
4.2.2.2 Laminae III-IV NK1r-expressing neurons 
To investigate the responses of laminae III-IV NK1r-expressing neurons to various 
noxious stimuli, deep horizontal 60 µm thick sections as well as parasagittal 60 
µm thick sections from the left side of the appropriate segments (Table 4-1) 
were treated with 50% ethanol for 30 minutes. The sections were then incubated 
for 72 hours in a mixture of primary antibodies: rabbit anti-NK1r (1:10,000) and 
mouse monoclonal antibody against pERK (1:1000). Sections were incubated for 
24 hours in species-specific secondary antibodies conjugated to either 
Rhodamine Red or Alexa 488.  
For reactions that did not involve TSA, antibodies were diluted in PBS containing 
0.3 M NaCl and 0.3% Triton® X-100. For those involving TSA, antibodies were 
diluted in PBS that contained 0.15 M NaCl, together with a blocking serum, 
which was supplied by the manufacturer. Sections were mounted in anti-fade 
medium and stored at -20°C.The primary antibodies that were used in this part 
of the study, and their characterisations are described in Chapter 2. 
4.2.3 Confocal microscopy and analysis 
4.2.3.1 Lamina I NK1r-expressing projection neurons and interneurons 
To investigate the responses of lamina I NK1r-expressing projection neurons and 
interneurons to noxious cutaneous, deep and visceral stimuli, horizontal sections 
from the ipsilateral side of the appropriate segments were analysed. Sections 
were initially scanned through the confocal microscope (Bio-Rad Radiance 2100) 
at 20× objective lens, and the regions of lamina I that contained numerous pERK-
immunoreactive cells were identified.  
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These regions were then scanned through a 40× oil-immersion lens to produce 
overlapping fields of image stacks, with a z-separation of 2 µm. Confocal image 
stacks were were analysed with Neurolucida for Confocal software. A sample of 
NK1r-immunoreactive cells was selected, and the outlines of their cell bodies 
and proximal dendrites were drawn by examining all of the optical sections 
through each cell. For each of the selected cells, cross-sectional area of its cell 
body was measured and its morphology was assessed. When all of the selected 
cells in a field had been analysed, the files containing pERK-immunostaining 
were then viewed and the presence or absence of pERK in each of the selected 
cells was determined. Based on the results from Chapter 3, NK1r-
immunoreactive lamina I neurons with soma areas >200 µm2 were assumed to be 
projection cells, and those with somata <200 µm2 were putative interneurons. 
4.2.3.2 Lamina I giant cells 
To investigate the responses of lamina I giant cells to noxious cutaneous and 
deep stimuli, horizontal sections from the ipsilateral side of the appropriate 
segments were analysed. Initially, the region of lamina I that contained 
numerous pERK-positive cells was determined using 20× objective lens, and then 
all of the giant cells that were present within this region were identified by the 
presence of numerous gephyrin puncta on their cell bodies and dendrites. These 
cells were then scanned through a 40× lens to reveal gephyrin, NK1r, and pERK 
immunoreactivity. They were also examined for their NK1 receptor expression. 
The presence or absence of pERK immunoreactivity in the selected cells was 
determined.  
4.2.3.3 Laminae III-IV NK1r-expressing neurons 
To investigate the responses of laminae III-IV NK1r-expressing neurons to noxious 
deep and visceral stimuli, parasagittal and deep horizontal sections from the 
ipsilateral side of the appropriate segments were analysed.  
Parasagittal sections were initially scanned through a 10× lens to reveal pERK-
immunoreactivity and the sections from each animal that showed maximal 
staining in the superficial laminae were selected for further analysis. At this 
magnification it was possible to identify the band of pERK-immunoreactivity in 
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the superficial dorsal horn, but individual pERK-positive neurons in deeper 
laminae were not well seen. This was not applicable for the deep horizontal 
sections from the rats that had received noxious visceral stimulation, since 
lamina I was absent in these sections. However, unlike joint and muscle 
stimulation, CRD produced diffuse, bilateral pERK immunoreactivity in lamina I. 
It is therefore unlikely to select deep horizontal sections from an area that had 
minimal pERK immuoreactivity in lamina I.  
Selected sections were then examined through a 20× lens and all of the NK1r-
immunoreactive neurons with cell bodies in laminae III or IV and dendrites that 
could be traced dorsally into superficial laminae (either in the same section or 
by following the dendrites through serial sections) were identified. Care was 
taken to avoid double-counting neurons with cell bodies that appeared on two 
adjacent sections. For all of the selected cells, the presence or absence of pERK 
staining in the soma and dendrites was recorded. In this way, the proportion of 
laminae III-IV NK1r-immunoreactive cells in each animal that showed pERK-
immunostaining was determined.  
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4.3 Results 
4.3.1 pERK in lamina I NK1r-expressing neurons 
After the application of cutaneous and deep noxious stimuli, numerous pERK-
positive cells were seen in lamina I, in the medial part of the dorsal horn on the 
left side (ipsilateral to the stimulus) in the lumbar cord, while very few were 
present on the contralateral side. Following CRD, pERK-positive cells were seen 
in both sides of lamina I of the lumbosacral spinal cord. Table 4-1 shows the 
appropriate spinal segments that were analysed in regard to the stimuli applied.  
 
Most of the NK1r-immunoreactive cells with soma cross-sectional areas >200 µm2 
were pERK-positive following the pinch stimulus. When data from the three rats 
were pooled, pERK was found in 68% (228 out of 335 cells) of the NK1r-positive 
cells >200 µm2, and only 28% (109/393) of the cells that were smaller than 200 
µm2 were pERK-positive. In the three rats that had received the capsaicin 
injection, 81% (229/283) of NK1r-positive cells with cell bodies >200 µm2, and 
39% (135/344) of those with somata <200 µm2 contained pERK. In rats that were 
stimulated with noxious heat (immersion of the hindpaw in 52°C for 20s), almost 
all (97%, 289/299) of the NK1r-immunoreactive cells >200 µm2 were pERK-
positive, as were 72% (236/327) of the cells <200 µm2. After injection of mustard 
oil into the joints and muscles, 77% (61/79) and 74% (75/101) of the NK1r-
immunoreactive cells with soma cross-sectional areas >200 µm2 were pERK-
positive, respectively. However, only 34% (28/83) and 33% (30/82) of the smaller 
cells, <200 µm2, were pERK-positive following deep noxious stimulation of the 
joints and muscles, respectively. Following CRD, but not tubal insertion, pERK 
was found in 75% (80/106) of the large NK1r-positive cells (>200 µm2) while only 
16% (29/180) of the NK1r-immunoreactive cells <200 µm2 phosphorylated ERK. 
Chi-square tests revealed that the expression of pERK differed significantly 
between cells with somata >200 µm2 and cells smaller than 200 µm2 following all 
6 noxious stimuli (P<0.05). Figure 4-1 shows the percentages of pERK+ NK1r-
immunoreactive small and large neurons after the exposure to different types of 
noxious stimuli. 
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There was no significant difference in the frequency of pERK expression between 
the three morphological classes (fusiform, multipolar and pyramidal) of lamina I 
NK1r-presumed projection neurons after the exposure to different types of 
noxious stimuli (P>0.05, Chi-square tests, Table 4-2).  
 
After each type of noxious stimulation, many of the NK1r-immunoreactive cells 
showed extensive internalisation of the receptor, which gave rise to numerous 
endosomes in their cells bodies and dendrites, and the great majority of these 
cells were pERK-positive. In some cases, NK1r-expressing neurons that did not 
appear to have significant internalisation showed pERK immunoreactivity, and 
most of these were presumed to be interneurons (soma size <200 µm2). In rare 
occasions, NK1r-expressing cells that showed clear signs of internalisation did 
not appear to be pERK-immunoreactive. Examples of pERK and lamina I NK1r-
immunostaining are shown in Figures 4-2 and 4-3. 
 
4.3.2 pERK in lamina I giant cells  
After application of cutaneous and deep noxious stimuli, a clear band of pERK-
positive cells was observed in the medial part of lamina I on the ipsilateral sides 
of the appropriate segments (Table 4-1). Giant cells lateral to this band were 
also often pERK-immunoreactive, suggesting that they may have large receptive 
fields. For this reason, in addition to the fact that these cells are scarce, all 
giant cells identified were included in the analysis.  
In the rats that had received the pinch stimulus, the percentages of giant cells 
that were pERK-positive varied from 80 to 92% (mean of 85%). After the injection 
of capsaicin, the mean percentage of giant cells that contained pERK was 84% 
(77-88%). Noxious heat (immersion of the hindpaw in 52°C for 45s) led to the 
phosphorylation of ERK in 74% of the giant cells (67-88%). After the injection of 
mustard oil into the knee joint, 44% of the giant cells were pERK-positive (33-
60%) and only 13% contained pERK after the injection of mustard oil into the 
gastrocnemius muscle (0-33%). Table 4-3 shows the proportions of giant cells 
that expressed pERK after the exposure to the different noxious stimuli. 
Examples pERK-positive giant cells are shown in Figures 4-4, 4-5 and 4-6. The 
intensity of pERK-immunostaining in the giant cells varied but mostly was 
moderately strong. 
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4.3.3 pERK in laminae III-IV NK1r-expressing neurons 
The number of large laminae III-IV NK1r-immunoreactive cells that were 
identified in parasagittal sections from the ipsilateral side of the appropriate 
segments (Table 4-1) in each of the 6 rats that received mustard oil injections 
into their joints and muscles varied from 6 to 15. In each of the 3 rats that 
underwent CRD, the number of large laminae III-IV NK1r-expressing neurons that 
were identified in deep horizontal sections (both sides) of the lumbosacral cord 
varied from 38 to 41. The dorsal dendrites of all identified cells could be 
followed to at least as far as lamina II.  
After the injection of mustard oil into the left knee joint, 8 of the 35 large 
laminae III-IV NK1r-expressing neurons identified contained pERK (mean of 23%). 
Following the injection of mustard oil into the left gastrocnemius muscle, 8 of 
the 27 identified large NK1r-expressing cells in laminae III-IV were pERK-positive 
(mean of 30%). Of the 118 large laminae III-IV NK1r-expressing neurons identified 
in the 3 rats that underwent CRD, but not tubal insertion, only 13 were pERK-
immunoreactive (mean of 11%). Table 4-4 shows the proportions of pERK-positive 
laminae III-IV NK1r-expressing cells after the exposure to deep and visceral 
noxious stimuli. Figure 4-7 shows 2 pERK-positive laminae III-IV NK1r-expressing 
cells after the injection of mustard oil into the knee joint. Figure 4-8 shows a 
laminae III-IV NK1r-expressing cell that did not contain pERK after the injection 
of mustard oil into the knee joint.  
The intensity of pERK-immunostaining in these cells varied from very weak to 
moderately strong. In most of the pERK-positive laminae III-IV NK1r-expressing 
neurons, pERK-immunoreactivity was detected in both cell body and dendrites. 
However, in few of these cells, pERK staining was seen clearly only in their 
dorsal dendrites. pERK staining was often considerably stronger in the distal 
parts of the dorsal dendrites compared to the cell bodies of these neurons.  
Most of the laminae III-IV NK1r-expressing neurons showed internalisation of the 
NK1 receptor, mainly of their dorsal dendrites. However, pERK-immunoreactivity 
was not restricted to dendrites that showed internalisation. 
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Figure 4-1 Histogram showing the percentages of pERK+ NK1r-expressing 
small and large cells in lamina I after noxious stimulation. 
The histogram shows the percentages of pERK+ NK1r-immunoreactive cells that 
had soma cross-sectional areas <200 µm2 and those that had somata >200 µm2 in 
lamina I following various noxious stimuli. 
The percentages of pERK+ NK1r-immunoreactive presumed projection neurons 
were significantly higher than those of pERK+ NK1r-immunoreactive interneurons 
following noxious cutaneous, deep and visceral stimuli (*P<0.05, **P<0.001, Chi-
square tests). In each case, the y-axis represents the total percentage of pERK+ 
NK1r-immunoreactive cells from the three experiments, and the upper and lower 
error bars show the higher and lower percentages after pooling the results from 
the three animals. 
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Figure 4-2 Examples of pERK-immunoreactivity in lamina I NK1r-expressing 
cells following noxious pinch.  
This Figure shows a projected confocal image stack from a horizontal section 
through the ipsilateral side of the L5 segment. Two large NK1r–immunoreactive 
cells with somata >200 µm2 cross-sectional area are marked with asterisks. 
These two cells were positive for pERK and showed internalisation of the 
receptor.  Five small NK1r–immunoreactive cells with somata <200 µm2 are 
marked with arrowheads, and these were not immunoreactive for pERK. Images 
are projections of 2 optical sections at 2 µm z-spacing. Scale bar=20 µm. 
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Figure 4-7 Examples of pERK-immunoreactivity in lamina III NK1r-expressing 
cells after the injection of mustard oil into the knee joint.  
This figure shows a projected confocal image stack from a parasagittal section 
through the ipsilateral side of the L2 segment. It shows 2 large lamina III NK1r-
immunoreactive neurons that are also weakly pERK-positive. The Image is a 
projection of 12 optical sections at 2 µm z-spacing. Scale bar=20 µm. 
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Figure 4-8 Example of the lack of pERK-immunoreactivity in a lamina III NK1r-
expressing cell after the injection of mustard oil into the knee joint.            
This figure shows a projected confocal image stack of 15 optical parasagittal 
sections at 2 µm z-spacing through the ipsilateral side of the L2 segment. It 
shows a large lamina III NK1r-immunoreactive cell that is negative for pERK. The 
inset shows a more limited projection of 5 optical sections through a lamina I 
NK1r-expressing cells that is pERK-positive. Scale bar=25 µm. 
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4.4 Discussion 
Several studies have used immunocytochemistry or electrophysiology to 
investigate the responses of dorsal horn neurons to various noxious stimuli. 
However, few of these studies attempted to identify the specific population of 
neurons that responded to these noxious stimuli. This part of the project shows 
that a proportion of lamina I NK1r-expressing neurons, both putative projection 
neurons and interneurons, phosphorylated ERK within 5 minutes of noxious 
cutaneous, deep and visceral stimulation. The study also reports that the 
responses of different morphological classes of lamina I NK1r-expressing 
projection neurons did not differ significantly following noxious stimulation. 
These projection cells were more likely to phosphorylate ERK than the presumed 
NK1r-expressing interneurons after the exposure to noxious stimuli. Additionally, 
following noxious deep and visceral stimulation, few of the large laminae III-IV 
NK1r-expressing projection neurons contained pERK. Regarding the giant cells, a 
varying proportion of them developed pERK-immunorectivity after noxious 
cutaneous and deep stimulation. 
4.4.1 pERK as a marker of neuronal activity  
As described previously, stimuli of different nature have been used to induce the 
phosphorylation of ERK in the spinal cord, and to further study the causes and 
effects of this activation. pERK expression in the SDH was first studied by Ji et 
al. (1999) after the exposure of the rat to different noxious stimuli (thermal, 
mechanical, chemical and electrical). Ji et al. (1999) tested the time course of 
capsaicin-induced ERK phosphorylation, and for how long this phosphorylation 
lasted. The study reported that ERK was initially activated at 1 minute after 
stimulation and this activation peaked at 2 minutes, was maintained for 5 
minutes, but decreased at 10 minutes, and finally reached its basal level at 2 
hours. The study also showed that pERK induction is intensity dependent, since 
the number of pERK expressing neurons increased as the noxious temperature 
increased from 45 to 55°C. Fukui et al. (2007) reported that electrically 
stimulating C-fibres at different frequencies induced pERK expression in the SDH 
of the rat in a frequency dependent manner. 
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In this part of the project, and based on the findings of Ji et al. (1999) as well as 
on the findings from our laboratory (Polgar et al., 2007), the animals were 
perfused 5 minutes after the exposure to noxious stimulation. The short time 
course of ERK phosphorylation, compared to that of fos up-regulation, is one of 
the advantages of using pERK as the marker of neuronal activity. The time 
course of fos up-regulation after noxious stimulation was studied by Herdegen et 
al. (1991). Their study investigated the expression of different proto-oncogene 
proteins, including fos, after electrically stimulating the sciatic nerve of the rat 
at Aδ/C-fibre intensity. Fos expression reached its maximal level in both 
superficial and deep spinal dorsal horn 1 hour after the electrical stimulus. Fos 
immunoreactivity decreased to basal levels between 8 and 16 hours after 
applying the stimulus, with its expression persisting longer in the deeper 
laminae. Another technical reason, for preferring pERK over fos, is that pERK 
immunoreactivity occurs in the cell bodies and dendrites of the cells, while fos is 
up-regulated in the nucleus only. The cellular morphology of pERK-positive 
neurons can therefore be easily identified.  
4.4.1.1 Spinal ERK phosphorylation following noxious stimulation  
Several studies have reported the effect of various types of noxious stimuli 
(cutaneous, deep and visceral) on spinal ERK activation. Ji et al. (1999) were the 
first to show that phosphorylation of ERK in the spinal cord is stimulus-specific 
and is also activity-dependent. ERK was activated by noxious cutaneous stimuli 
as well as by electrical stimulation of primary afferents at the C- and Aδ-fibre 
range, but not after Aβ-fibre stimulation. The study reported that 2 minutes 
after the application of an intense punctate mechanical stimulus to the hindpaw 
of the rat, pERK was expressed in the SDH. The injection of either capsaicin or 
formalin into the hindpaw of anesthetised or awake rats respectively, also 
induced pERK mainly in the medial half of laminae I and IIo of the L4-L5 spinal 
segments. In addition, Ji et al. (1999) examined the effect of noxious heat on 
pERK expression in the SDH, and reported that ERK phosphorylation was stimulus 
intensity dependent, since it varied with the water bath temperature. Few 
pERK-immunoreactive cells appeared at the threshold of activating heat-
sensitive nociceptors (45°C), and the number increased with increasing 
temperature from 48°C to 55°C. This pERK expression was only partially inhibited 
by an NMDA antagonist, suggesting that the activation of ERK may be initiated 
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through the action of glutamate on non-NMDA (AMPA, mGlu) glutamate 
receptors, or through the action of neuropeptides or growth factors such as 
substance P, CGRP or BDNF. Galan et al. (2002) showed that intraplantar 
injection of carrageenan into both hindpaws of the rat evoked a peak five-fold 
activation of ERK in the SDH of the lumbar spinal cord at 30 minutes, compared 
to saline injection, which resulted in a two-fold activation. Saline-treated 
animals showed a higher level of ERK activation compared to control animals, 
suggesting that the process of injection itself may be sufficient to activate ERK.  
The involvement of the MAPK/ERK cascade in central (spinal cord) and 
peripheral (DRG) processing of chronic inflammatory articular pain has been 
reported (Cruz et al., 2005; Seino et al., 2006). The above studies showed that 
passive movement of the inflamed ankle or knee joints (induced by the injection 
of CFA) of anesthetized rats increased pERK-immunoreactivity in both superficial 
and deep dorsal horn of the L3-L5 spinal segments, as well as in the DRG. 
Additionally, intrathecal and intra-articular injection of a MEK inhibitor reduced 
the joint movement-induced pain behaviour in monoarthritic rats, and decreased 
pERK labelling in the DRG neurons. This suggests that ERK phosphorylation in the 
spinal cord or in the DRG may play a role in decreasing mechanical pain 
threshold. Recently, Tsujimura et al. (2011) reported that the MAPK/ERK 
cascade was activated following noxious muscle stimulation in the rat. It was 
shown that following the injection of capsaicin into the muscles of mastication, 
a large number of pERK-positive cells were seen in the SDH of the upper cervical 
cord. The study also showed a significant reduction in the number of pERK-
positive cells following the intrathecal administration of a MEK1/2 inhibitor, 
further supporting the involvement of this cascade in muscle pain.   
Regarding visceral pain, Zhang et al. (2009) reported that noxious CRD evoked 
pERK expression in the SDH of the lumbosacral cord of rats. This suggests the 
involvement of ERK in CRD-induced neuronal responses in the spinal cord. Lai et 
al. (2011) also studied the effects of noxious distention of the urinary bladder of 
anaesthetized mice with or without a 10-day treatment with cyclophosphamide 
to pre-sensitize the bladder. The study reported that after distending the 
bladder, pERK was expressed in both superficial and deep laminae of the L6-S1 
cord, and this expression was more profound in the cyclophosphamide-treated 
animals. Intrathecal injection of a MEK inhibitor attenuated distention-induced 
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bladder pain, suggesting that ERK activation may contribute to the development 
of inflammatory bladder painful conditions. 
4.4.2 Lamina I NK1r-expressing projection neurons 
The present study shows that following noxious cutaneous mechanical, chemical, 
or thermal stimulation, the majority of lamina I NK1r-expressing presumed 
projection neurons (with somata >200 µm2) phosphorylated ERK. It also shows 
that after the injection of mustard oil into the knee joint or the gastrocnemius 
muscle, as well as after noxious visceral stimulation, three-quarter of these 
presumed projection neurons contained pERK. Noxious CRD, compared to tubal 
insertion without inflation, led to a large number of bilateral pERK-
immunostaining in the SDH of the lumbosacral cord mainly, with some labelling 
in the thoracolumbar area. 
4.4.2.1 Input to lamina I NK1r-expressing neurons 
Lamina I NK1r-expressing projection neurons represent 80% of the projection 
neurons in this lamina (Todd et al., 2000; Spike et al., 2003; Al-Khater et al., 
2008). These NK1r-expressing projection neurons receive selective monosynaptic 
input from substance P-containing primary afferents (Todd et al., 2002). They 
also receive glutamatergic input (Todd, 2010), presumably from Aδ primary 
afferents (Andrew, 2010), as well as from lamina II vertical interneurons (Lu and 
Perl, 2005). Uta et al. (2010) showed that these vertical interneurons receive 
peripheral inputs from TRPA1-expressing C-fibres, which can be activated by 
formalin (McNamara et al., 2007), and from C-fibres that express TRPV1, on 
which capsaicin acts (Pingle et al., 2007). Labrakakis and MacDermott (2003) 
used fluorescence-conjugated substance P to label NK1r-expressing neurons in 
lamina I of the rat spinal cord in a slice preparation. They reported that 
capsaicin increased the frequency of excitatory postsynaptic currents in 73% of 
these neurons, suggesting that these cells also receive a direct input from 
capsaicin and heat sensitive nociceptors. Consistent with the above finding, the 
present study shows that 81% of lamina I NK1-expressing neurons contained pERK 
after the injection of capsaicin. Torsney and MacDermott (2006) also reported 
that lamina I NK1r-expressing neurons receive monosynaptic input mainly from 
high-threshold C- (52%) and Aδ- (29%) fibres.  
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4.4.2.2 Responses of lamina I projection neurons to noxious stimuli; 
electrophysiological studies 
It has been shown in electrophysiological studies that many lamina I projection 
neurons in the rat responded to one or more noxious stimuli. These studies did 
not distinguish between neurons that expressed the NK1 receptor from those 
that did not. However, since the NK1 receptor is expressed on 80% of lamina I 
projection neurons, the majority of neurons in these studies would presumably 
have been NK1r-positive. As described previously, Bester et al. (2000) showed 
that almost all of the spinoparabrachial neurons were activated by noxious 
stimuli; of these 75% were nociceptive specific (responding only to stimuli of the 
noxious range). The study also showed that 92% of these projection neurons 
responded to both noxious thermal and mechanical stimuli. Further, Andrew 
(2009) showed that 70% of the spinoparabrachial neurons were activated by 
noxious thermal and/or mechanical stimulation (nociceptive specific). Zhang et 
al. (2006) also reported that almost all lamina I STT neurons were activated by 
noxious mechanical stimuli, and half of those neurons that were activated by 
thermal stimulation were nociceptive specific (activated only by noxious heat). 
Consistent with the above findings of physiological studies, which suggested that 
almost all STT and spinoparabrachial neurons were excited by noxious 
mechanical and/or thermal stimuli, the present study shows that ERK was 
phosphorylated in almost all NK1r-expressing projection neurons after noxious 
heat, and in the majority of these cells following noxious pinch or capsaicin 
injection. This higher proportion of cells that responded to noxious heat, 
compared to the other noxious modalities, may be attributed to the fact that in 
case of thermal stimulation, the whole hindpaw is immersed in hot water 
covering a larger skin area. In contrast, pinching is a punctate stimulus that is 
not applied to the entire hindpaw and therefore, cells with receptive fields 
outside this area would not be activated.  
The present study shows the responses of NK1r-expressing neurons to individual 
noxious stimuli, and therefore avoids the phenomenon of sensitisation, by which 
one stimulus may affect the neuronal responses to a 2nd stimulus (Campbell and 
Meyer, 1983). It also shows that the majority of the NK1r-expressing projection 
cells are heat or capsaicin or pinch activated, therefore, they are presumed to 
respond to all three stimuli.    
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4.4.2.3 Responses of lamina I NK1r-expressing neurons to noxious stimuli; 
activation of fos and ERK  
Doyle and Hunt (1999) studied the effects of noxious stimuli on fos expression, 
specifically in NK1r-immunorective neurons in both superficial (laminae I, III-IV) 
and deep (laminae V-X) dorsal horn of the rat. It was found that in the SDH, but 
not in deeper laminae, the number of fos+ NK1r-expressing neurons positively 
correlated with the intensity of the noxious stimulus. Their study therefore 
suggests the involvement of laminae I and III-IV NK1r-expressing neurons in 
intensity discriminative aspects of pain. Regarding lamina I NK1r-expressing 
neurons, their study showed that 70-80% of these neurons up-regulated fos 
following topical application of mustard oil onto the hindpaw, injection of 
formalin and immersion of the hindpaw in water at 52°C for 10s. Results from 
the present study show that almost all lamina I NK1r-expressing projection 
neurons activated ERK following noxious heat (immersion of the hindpaw in 
water at 52°C for 20s). The higher proportion of pERK+ NK1r-expressing neurons 
following noxious heat in this study, compared to the proportion of fos+ NK1r-
expressing cells seen by Doyle and Hunt (1999), may be attributed to more than 
one reason. First of all, Doyle and Hunt (1999) did not distinguish between the 
responses of small and large NK1r-expressing neurons, therefore their sample 
could have included a proportion of small NK1r-expressing cells that did not up-
regulate fos. The number of fos+ large NK1r-expressing (projection) neurons may 
be therefore underestimated. Secondly, in the present study, a longer duration 
of the stimulus was used: 20s compared to 10s, and Ji et al. (1999) reported that 
pERK expression is intensity-dependent. It has also been found that the number 
of lamina I NK1r-expressing neurons that internalized the receptor, as well as 
the number of endosomes within each NK1r-expressing neuron, was increased as 
the intensity of noxious heat  increased (from 43 to 55°C) (Allen et al., 1997). 
Although Todd et al. (2005) used a similar method to what has been used in the 
present study (immersion of the rat hindpaw in water at 52°C for 20s), 57-69% of 
lamina I spinoparabrachial NK1r-expressing neurons up-regulated fos, compared 
to 97% pERK+ NK1-expressing neurons in the present study. The overall higher 
number of NK1r-expressing neurons that responded to noxious heat in the 
present study, compared to Doyle and Hunt (1999) and Todd et al. (2005) studies 
may be attributed to the difference in the markers of neuronal activity that 
were used in these studies; fos versus pERK. It therefore seems that ERK 
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phosphorylation is more sensitive, at least in detecting the activity of NK1r-
expressing neurons after noxious heat. The present study also shows that 
following noxious pinch and capsaicin injection, 68 and 81% of lamina I NK1r-
expressing projection neurons contained pERK, respectively. In support of the 
above finding, Mantyh et al. (1995) found that 5 minutes after the exposure of 
rats to similar noxious mechanical and chemical stimuli, 67-70% of lamina I NK1r-
expressing cells internalised the NK1 receptor.  
Doyle and Hunt (1999) also reported that after the injection of mustard oil into 
either the gastrocnemius muscle or the knee joint, 20% or 45% of lamina I NK1r-
expressing neurons up-regulated fos, respectively. The present study shows that 
~75% of the large cells contained pERK after noxious deep stimulation, which 
was of similar quantity and quality to what was used by Doyle and Hunt (1999). 
However, for the reasons described above, the comparison between the present 
study and that of Doyle and Hunt (1999) in regard to the responses of lamina I 
NK1r-expressing neurons to noxious stimuli is not straightforward, because of the 
many variables between the two studies. In support of the present study, it has 
been reported that the gastrocnemius muscle afferents [mostly of the 
unmyelinated class, (Langford, 1983)] distribute collaterals to lamina I and 
deeper laminae (IV-IV) in cats and rats (Cervero et al., 1976; McMahon and Wall, 
1985; Mense and Craig, 1988). It was also reported that 50% of the gastrocnemius 
muscle afferents in the L5 DRG contained substance P in the rat, suggesting the 
importance of the NK1 receptor in muscle pain transmission (Perry and Lawson, 
1998). Further, Craig and Kniffki (1985) recorded from lamina I STT neurons in 
the cat and reported that some of these neurons responded either specifically to 
deep noxious stimulation of the gastrocnemius muscle (algesic chemical and 
noxious mechanical stimulation), or to cutaneous noxious and innocuous stimuli 
(polymodal). Responses to noxious knee joint stimulation have also been 
recorded from lamina I neurons in the cat (Schaible et al., 1986), consistent with 
the termination pattern of nociceptive knee joint afferents in the spinal cord; 
laminae I and VI-VI (Craig et al., 1988). Langford (1983) also reported that ~50% 
of the cat knee joint afferents are group IV axons (unmyelinated).  
Previous studies have shown that lamina I neurons can also be activated by 
visceral stimulation. Traub et al. (1992) showed that after repetitive distension 
of the colon of anesthetised rats to 80 mmHg, more fos-immunoreactive neurons 
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were observed in laminae I-II, V-VII and X of the lumbosacral cord, compared to 
what was seen after the distension of the colon to 20 mmHg only. In a 
subsequent behavioural study, Traub et al. (2002) confirmed that CRD at 80 
mmHg is a noxious stimulus, since it caused avoidance behaviours in rats. In 
contrast, distending the colon at 20 mmHg was considered innocuous, since 
there was no difference in the behaviour of these animals compared to the non-
distended controls. Honore et al. (2002) reported that internalisation of the NK1 
receptor was seen in lamina I neurons in the T13 and S1 spinal segments after 
noxious CRD in awake rats. Further, Gamboa-Esteves et al. (2004) specifically 
reported that ~70% of lamina I NK1r-expressing neurons that projected to the 
NTS up-regulated fos after the exposure to noxious visceral stimulation (formalin 
injection into the urinary bladder). The present study shows that 75% of lamina I 
NK1r-expressing neurons phosphorylated ERK following noxious CRD, and that a 
large number of these cells showed internalisation of the receptor. Fewer pERK-
positive cells were seen following tubal insertion, compared to CRD, and these 
were scattered in laminae I and II of the lumbosacral cord.  
It has been suggested that the spinal phosphorylation of ERK may be due to a 
direct action of substance P on the NK1 receptor, as well as the co-release of 
glutamate from primary afferents and excitatory interneurons. For instance, 
Choi et al. (2005) reported that the intrathecal injection of substance P, 
presumably acting on the NK1 receptor, induced pain behaviour in the mouse 
and led to the expression of pERK in laminae I and II of the spinal cord at 10 
minutes. This substance P-induced pain behaviour was attenuated after the 
blockade of ERK activity by the pretreament of the mice with PD98059. Anderson 
and Seybold (2000) reported that the phosphorylation of cAMP response element 
binding protein (CREB), which is required for the transcription of many neuronal 
genes and long-term synaptic plasticity (Ji and Rupp, 1997), was increased in 
NK1r-expressing neurons in the SDH 30 minutes after the injection of formalin 
into the rat hindpaw. Their study speculated that phospho CREB (pCREB) may 
regulate the expression of the NK1 receptor gene as well as other genes such as 
c-fos (Ji and Rupp, 1997), suggesting an indirect role of pCREB in regulating the 
expression of the NK1 receptor mRNA through the up-regulation of fos. Kawasaki 
et al. (2004) reported an additional indirect evidence of the involvement of 
NK1r-expressing neurons in the activation of ERK. They showed that the 
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activation of C-fibre primary afferents, in adult rat spinal slice preparation, by 
brief exposure to capsaicin led to an 8 to 10 fold increase in pERK in the SDH 
neurons. This pERK immunoreactivity was reduced by blocking the NK1 receptor. 
Their study also showed that C-fibre stimulation led to ERK-dependent 
phosphorylation of CREB, suggesting that the MAPK/ERK cascade may contribute 
to the production of long-lasting changes in sensory processing. Recently, Choi 
et al. (2012) reported that the carrageenan-induced phosphorylation of Akt, 
which is a serine/threonine kinase that plays an important role in various 
cellular processes including nociception, in the deep dorsal horn of the rat is 
dependent on the prior activation of the NK1r-expressing neurons in the SDH. It 
is therefore likely that NK1r-expressing projection neurons, most of which 
phosphorylated ERK following noxious stimulation, play an important role in 
conveying nociceptive information to higher brain centres through pathways that 
involve activation of ERK.  
4.4.2.4 Morphology of lamina I NK1r-expressing projection neurons  
Previous attempts to classify lamina I projection neurons based on their 
morphology have been controversial. It was suggested that morphology of these 
cells is related to their function; since Han et al. (1998) reported that in the cat, 
pyramidal cells specifically responded to innocuous cooling only, in comparison 
to the other two morphological classes, which were mostly nociceptive-specific. 
Yu et al. (2005) and Almarestani et al. (2007) also reported that lamina I 
pyramidal neurons that projected to the thalamus or to the parabrachial area 
were seldom NK1r-immunoreactive in the rat. However, it is unlikely that all 
lamina I pyramidal projection neurons in the rat respond to innocuous cooling for 
the reasons stated below. Although it has been reported that spinoparabrachial 
neurons of the pyramidal class make up 23-30% of this population (Almarestani 
et al., 2007; Al-Khater and Todd, 2009), Bester et al. (2000) did not find cells 
that responded to innocuous cooling in a sample of 53 lumbar lamina I 
spinoparabrachial neurons in the rat. In addition, out of the 40 spinoparabrachial 
cells that were studied by Andrew (2009), only 2 were identified as cooling-
specific, while the majority of those (70%) were nociceptive specific. Further, 
although Zhang et al. (2006) identified cervical spinothalamic lamina I cells that 
were activated by cooling, these cells also responded to noxious stimuli. Todd et 
al. (2002, 2005) also showed that lamina I NK1r-expressing projection neurons of 
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all three morphological classes up-regulated fos after the exposure to noxious 
chemical (formalin) and thermal (noxious heat and cold) stimulation, with the 
responses of these neurons to noxious cold being more common in the multipolar 
class. The present study shows further evidence that morphology of lamina I 
NK1r-expressing projection neurons does not correlate with their function. There 
is also no significant difference between the responses of fusiform, multipolar or 
pyramidal lamina I NK1r-expressing cells to various noxious cutaneous (pinch, 
capsaicin or heat), deep or visceral stimuli. 
4.4.3 Lamina III-IV NK1r-expressing projection neurons 
Immunocytochemical studies have revealed a population of large laminae III-IV 
NK1r-expressing neurons of the rat spinal cord that have prominent dorsal 
dendrites entering the superficial lamina (Bleazard et al., 1994; Brown et al., 
1995; Littlewood et al., 1995; Mantyh et al., 1995). These are also known to be 
projection neurons, since virtually all of them projected to supraspinal targets 
as described previously (Al-Khater and Todd, 2009). There are approximately 20 
cells of this type on each side of the L4 segment in the rat (Todd et al., 2000). 
These cells receive a large input from substance P-containing primary afferents, 
which form numerous synapses on their cell bodies and dendrites (Naim et al., 
1997). They therefore provide a route through which information transmitted by 
nociceptive primary afferents can be conveyed to deeper laminae and to 
supraspinal areas in the CNS. Torsney and MacDermott (2006) recorded from 
laminae III-IV NK1r-exressing neurons in spinal cord slices, and were unable to 
demonstrate monosynaptic input from Aδ- or C-fibres on the majority of these 
cells. However, they attributed this to the possibility of recording from neurons 
that did not posses long dorsal dendrites, or to not being able to retain the 
afferent input to these cells during the slice preparation.  
The involvement of laminae III-IV NK1r-expressing neurons in transmitting 
nociceptive information from cutaneous tissues has been demonstrated by 
internalisation of the NK1 receptor on these cells after the injection of capsaicin 
(Mantyh et al., 1995) or formalin (Honor et al., 1999) into the rat hindpaw. 
Doyle and Hunt (1999) also reported that 40% of laminae III-IV NK1r-expressing 
cells up-regulated fos following the injection of formalin into the rat hindpaw. In 
contrast, a lower proportion of these cells were fos-positive following the topical 
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application of mustard oil onto the skin or noxious heat (immersion of the 
hindpaw in water at 52°C for 10s). However, Polgar et al. (2007) showed that 
almost all laminae III-IV NK1r-expressing neurons phosphorylated ERK after more 
intense noxious heat (immersion of the hindpaw in water at 52°C for 60s), 
noxious pinch or the injection of formalin. 
The involvement of substance P and laminae III-IV NK1r-expressing cells in the 
spinal processing of nociceptive information from the knee joint of the rat has 
been suggested. Neugebauer et al. (1994) recorded from a sample of deep dorsal 
horn (laminae IV-VI) neurons, which may include some of lamina IV NK1r-
expressing cells, that responded to pressure applied to the knee joint. Although 
the SDH contained neurons with inputs from the knee, the above study was done 
on deeper laminae neurons, since it was not easy to distinguish neurons with 
joint input from those with input from the skin in the SDH. Their study reported 
that the administration of substance P and neurokinin A led to a transient 
increase in the responses of neurons to both innocuous and noxious joint 
stimulation. However, the application of a specific NK1r inhibitor blocked the 
excitatory effects of substance P on neurons that were exposed to noxious, but 
not innocuous, stimuli.  
The present study shows that after the injection of mustard oil into the knee 
joint or the gastrocnemius muscle, less than one-third of the large laminae III-IV 
NK1r-expressing projection neurons contained pERK. Doyle and Hunt (1999) also 
reported that less than 5% of all laminae III-IV NK1r-expressing neurons up-
regulated fos following deep noxious stimuli of the joint and muscle. This lower 
proportion of fos-positive cells that was seen in Doyle and Hunt (1999) study, 
compared to the present study, following noxious deep stimulation may be due 
to the difference in the criteria of selection of laminae III-IV NK1r-expressing 
neurons. Doyle and Hunt (1999) included in their sample both the large neurons 
that had dorsal dendrites reaching the superficial laminae as well as the smaller 
non-projection ones, which were not included in the present study. This may 
have led to an increase in the sample size of Doyle and Hunt (1999), and a 
subsequent decrease in the proportion fos+ NK1r-expressing projection cells in 
laminae III-IV. 
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The present study also reports a lower proportion of laminae III-IV NK1r-
expressing neurons that phosphorylated ERK after noxious deep and visceral 
stimulation, compared to what was seen following noxious cutaneous stimulation 
(Polgar et al., 2007). In addition, the responses of laminae III-IV NK1-expressing 
neurons to noxious deep and visceral stimulation differed from the responses of 
lamina I NK1r-expressing neurons to the same noxious stimuli. This suggests a 
difference in the type of information (cutaneous versus deep and visceral) that is 
transmitted to supraspinal areas through populations of NK1r-expressing 
projection neurons in laminae III-IV versus those in lamina I. Hu and Zhao (2001) 
also reported that the injection of turpentine oil into either the hindpaw or the 
gastrocnemius muscle of anesthetised rats led to fos expression in the superficial 
(laminae I-IIo) and deep (laminae V-VI) dorsal horn of the of the L4-L5 spinal 
segments. Their study showed that the number of fos-positive cells, induced by 
the intramuscular injection, was significantly decreased after the pretreatment 
of the animals with an AMPA and kainate receptor antagonist. In contrast, an 
NMDA receptor antagonist decreased the number of fos-positive cells that were 
induced only by intraplantar injection into the hindpaw. This suggests that the 
transmission of nociceptive information from various tissues (deep versus 
cutaneous) may be mediated by different glutamate receptors in the spinal cord.   
4.4.4 Lamina I giant cells 
The giant cells represent a distinct population of very large lamina I projection 
neurons that either lack or weakly express the NK1 receptor. These cells can be 
identified by the presence of high density of gephyrin (the glycine and GABA 
receptor-associated protein) puncta on their cell bodies and dendrites (Puskar et 
al., 2001). These giant cells receive inhibitory input from lamina II nNOS-
containing GABAergic neurons, which provide around one quarter of their 
GABAergic input (Puskar et al., 2001; Todd, 2010). They are also densely 
innervated by VGLUT2-immunoreactive boutons that are associated with GluA4-
containing puncta. This glutamatergic input is thought to be derived from 
excitatory interneurons, since the giant cells receive little direct synaptic input 
from peptidergic or Aδ primary afferents, compared to the NK1r-expressing 
neurons, which are densely innervated by peptidergic primary afferents as 
described earlier (Polgar et al., 2008).     
124 
The giant cells have extensive, radiating dendritic trees, as seen in the present 
study and also reported by Puskar et al. (2001). It is therefore more likely that 
these cells have large peripheral receptive fields. In agreement with the above 
finding, results from the present study shows that following noxious pinch, 85% 
of the giant cells phosphorylated ERK, and even those giant cells lateral to the 
band of pERK immunolabelling were often pERK-positive. The present study also 
shows that a large number of the giant cells (74-85%) contained pERK following 
all three noxious cutaneous stimuli (pinch, capsaicin, heat). This, together with 
the fact that the giant cells form a small population that project mostly to the 
parabrachial area (Polgar et al., 2008), suggests that these cells are involved in 
transmitting nociceptive information that alerts about the presence of a noxious 
stimulus, rather than providing accurate (discriminative) information about the 
noxious stimulus itself. These cells, in relation to their projection target, may 
also play a role in the affective and autonomic responses to pain. The fact that 
the giant cells lack, or weakly express, the NK1 receptor makes them resistant 
to being ablated by SP-SAP (Mantyh et al., 1997). Although Mantyh et al. (1997) 
reported a dramatic reduction in hyperalgesia following SP-SAP treatment, 
responses to acute noxious stimuli remained intact. It is therefore likely that the 
giant cells are involved in transmitting nociceptive signals that led to the 
responses observed by Mantyh et al. (Mantyh et al., 1997).  
The involvement of giant cells in nociception was first shown by Puskar et al. 
(2001). Their study reported that that 87% of the giant cells up-regulated fos 
after the injection formalin into the rat hindpaw. The present study shows a 
similar percentage of giant cells (84%) that contained pERK after the injection of 
capsaicin. Regarding the responses of the giant cells to noxious heat, Polgar et 
al. (2008) reported that 38% of these cells up-regulated fos following thermal 
stimulation (immersing the hindpaw in water at 52°C for 45s). However, the 
present study shows that following noxious heat, of similar intensity and 
duration, 74% of the giant cells phosphorylated ERK. This discrepancy between 
the sensitivity of pERK and fos may be due to the possibility that in order for fos 
to be up-regulated, it requires a certain threshold of pERK activity to be reached 
(if it is assumed that spinal fos activation is ERK-dependent). It is likely 
therefore that the occasional lower levels of pERK expression, which are 
manifested as weak pERK immunolabelling, in this study, are insufficient to 
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subsequently up-regulate fos. In agreement with this, noxious heat also led to a 
higher proportion of pERK+- compared to fos+-NK1r-expressing neurons. 
Results from the present study show that a lower proportion of the giant cells 
were activated by noxious stimulation of the joint or muscle, in comparison to 
the responses of lamina I NK1r-expressing neurons to noxious deep stimulation. 
This may be attributed to the observation that these cells receive less direct 
input from primary afferents, including those innervating joints and muscles. 
This also suggests that different populations of projection neurons in lamina I 
convey different messages to higher brain centres.  
Puskar et al. (2001) found that most of the giant cells were located in the mid-
lumbar spinal cord in the rat (~10 cells on each side of the L4 segment). In the 
present study, the pERK-immunostaining that was seen after noxious CRD was 
concentrated mainly in L6-S1 spinal segments, with some staining seen in T13-L1 
segments. It was not applicable therefore to assess the responses of giant cells 
to visceral stimulation due to the rarity of these cells in the area that showed 
the highest pERK labelling after noxious CRD.  
4.4.5 Lamina I NK1r-expressing interneurons 
It was described previously that projection neurons in lamina I make up ~5% of 
the neuronal population in this lamina. It is therefore assumed that most lamina 
I cells (~95%) are interneurons. Twenty-five percent of these interneurons are 
found to be GABAergic (Polgar et al., 2003), suggesting that the majority of 
lamina I neurons are excitatory interneurons. Todd et al. (1998) reported that 
45% of neurons in lamina I express the NK1 receptor. From the above data, it 
could be calculated that 60% of all excitatory interneurons express the NK1 
receptor. Despite the large number of interneurons in lamina I, knowledge of 
their organisation and function is very limited. Prescott and De Koninck (2002) 
reported a clear correlation between morphology and firing pattern for a sample 
of small neurons (presumably interneurons) in lamina I. However, little is known 
about the relation between morphology, function and the neurotransmitter 
phenotype for lamina I interneurons.  
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Although Doyle and Hunt (1999) reported that lamina I NK1r-expressing neurons 
up-regulated fos after exposure to various noxious stimuli, the interpretation of 
their findings is complicated, since they did not distinguish between the 
responses of NK1r-expressing projection neurons from those of NK1r-expressing 
interneurons. However, the present study shows the responses of both the large 
and small (with somata <200 µm2) NK1r-expressing neurons to various noxious 
cutaneous, deep and visceral stimuli. Following pinch, capsaicin or noxious heat, 
28%, 39% and 72% of these putative interneurons contained pERK, respectively. 
One-third of these cells were pERK-positive after the injection of mustard oil 
into the joint and muscle, and only 16% phosphorylated ERK after noxious CRD.  
The first part of the project showed that the NK1 receptor was weakly expressed 
on this interneuronal population, while most of the larger NK1r-positive 
projection neurons expressed the NK1 receptor more strongly. This suggests that 
these smaller cells may not have been killed by SP-SAP, and may contribute to 
the normal behavioural responses to noxious heat that were seen in rats after 
the treatment with SP-SAP (Mantyh et al., 1997). They may provide excitatory 
input to neighboring giant cells or even to other NK1r-expressing projection 
neurons that had survived SP-SAP treatment. Overall, the results from the 
present study suggest that this population of excitatory interneurons in lamina I 
plays a role in modulating and fine tuning nociceptive information before it is 
transmitted to higher brain centres.  
4.4.6 Technical considerations and future directions 
4.4.6.1 Noxious deep stimulation 
One of the technical issues in the present study is the possibility that introducing 
a needle into the skin, rather than the noxious deep stimulus itself (mustard oil), 
may be the cause of activating the large numbers of lamina I NK1r-exressing 
neurons that were seen after deep noxious stimulation. Panfil et al. (2006) 
investigated the expression of fos in the SDH of the mice after the injection of 
NGF into the semispinal neck muscle, which was exposed surgically. Following 
the injection, fos-immunoreactivity was increased significantly in laminae I and 
II of the cervical cord, compared to sham-operated and saline injected controls. 
Although NGF was injected into a surgically exposed neck muscle, the number of 
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fos-positive cells was significantly higher in those operated animals compared to 
the sham group, on which a cannula needle was only inserted without any 
injection. In the present study, mustard oil was injected into the gastrocnemius 
muscle without the need to surgically expose it and risk the activation of 
additional cutaneous afferents.  
4.4.6.2 Use of anaesthetics  
The validity of the use of anaesthetics in experiments that investigates the 
responses of neurons to various noxious stimuli has been questioned. Banks et al. 
(1988) reported that although anaesthesia may influence the responses of 
neurons, it succeeded in minimizing the effects of intra-individual variability, 
which occurred while measuring these responses in awake rats. The study also 
showed a difference in the effects of pentobarbital, urethane and ketamine on 
the responses of mice to noxious thermal stimulation, assessed by measuring 
their tail flick latency. Although pentobarbital had no effect on latencies, in 
comparison with awake mice that received saline, if used in higher doses, which 
resulted in very deep level of anaesthesia, it led to an increase in the latencies. 
Urethane increased the mice tail flick latencies (decreased their levels of 
nociception), while ketamine decreased the latencies leading to more positive 
responses to noxious heat.  
Anaesthesia may also affect the number of fos/pERK-positive neurons that are 
seen after noxious stimulation, since it was shown that it may dampen the 
responses of these neurons; resulting in false negative data. For instance, 
Willcockson et al. (1995) reported that the use of anaesthetics (a combination of 
ketamine-xylazine) increased the threshold of fos expression in the SDH as 
evidenced by the requirement of higher intensities of electrical stimulations in 
order to up-regulate fos in a pattern similar to the pattern of fos expression in 
un-anesthetised rats. It was also reported that the number of formalin-induced 
fos-positive neurons in the SDH of the lumbar cord was decreased in rats that 
were anaesthetised with halothane or isofluorane, compared to awake ones 
(Fukada et al., 1999; Sommers et al., 2008; Liu et al., 2011). However, a 
number of studies reported that inhalational anaesthesia had failed to decrease 
the number of formalin-induced fos-positive cells in the SDH in rats (Sun et al., 
1996; Hagihira et al., 1997). 
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In the present study, urethane was used as the anaesthetic, and a large number 
of pERK-positive neurons were seen in the SDH after the exposure of urethane-
anesthetized rats to various noxious stimuli. Specifically, noxious heat induced 
the expression of pERK in almost all large lamina I NK1r-expressing neurons. This 
suggests that urethane is less likely to lead to under-estimation of the number of 
neurons that are activated following noxious stimulation, at least at spinal 
levels. Abbadie et al. (1994) also showed that under urethane anaesthesia, the 
temperature threshold that induced a consistent fos expression in the SDH of the 
rat was ~46°C. This threshold is similar to the threshold that led to heat-induced 
nociceptive reactions in awake rats, and that also activated C nociceptors.  
Anaesthesia has also been reported to cause unexpected false positive results. 
However, these fos-positive neurons were found in supraspinal areas rather than 
in the spinal cord. Bullitt (1990) showed that prolonged inhalational anaesthesia 
led to the appearance of fos-positive cells in unexpected areas such as the 
olfactory cortex in the rat. Additionally, it was reported that after urethane 
anaesthesia without stimulation, numerous fos-positive cells were seen in the 
NTS and in the intermediate reticular formation in the rat (Strassman and Vos, 
1993). Lanteri-Minet et al. (1993) also reported that controlled volatile 
anaesthesia alone did not cause fos labelling in the spinal cord of the rat, while 
it was effective in evoking fos in discrete hindbrain regions such as the rostral 
ventrolateral medulla, nuclei of the parabrachial area and the NTS. In the 
present study, pERK-positive cells were found mostly in the dorsal horn, 
ipsilateral to the  stimulus, while the contralateral side showed minimal pERK 
labelling, suggesting that urethane alone has no effect in, at least, evoking 
spinal false positive cells.  
Although carrying out experiments on awake rats may seem to prevent unwanted 
effects of anaesthesia, exposing the animals to noxious stimuli without the use 
of anaesthetics raises ethical issues. It has also been reported that 
experimenting on awake rats may indirectly lead to false negative results. For 
instance, Fukuda et al. (2009) showed that, in awake rats, the number of pERK-
positive cells after the injection of formalin was decreased by the ‘analgesic’ act 
of licking, compared to the number of these cells in restrained awake rats, 
which were unable to lick their hindpaws.  
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Work from the present study sheds light on specific populations of dorsal horn 
neurons, as important contributors in conveying (projection neurons) or 
modulating (interneurons) nociceptive information, received from cutaneous, 
deep and visceral tissues. Future work to further investigate the effects 
inhibiting specific cascades that activated these neurons is recommended.  
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5. Responses of mGlu5-expressing neurons to 
spinal application of DHPG 
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5.1 Introduction 
Glutamate, which is released by primary afferents and local excitatory neurons, 
is the principal excitatory neurotransmitter in the CNS. It acts on both ionotropic 
and metabotropic receptors. Metabotropic glutamate receptors (mGlus) are G 
protein-coupled receptors. Their binding to glutamate regulates a series of 
cellular activities including phosphorylation of ion channels and/or gene 
transcription. There are 8 cloned mGlus, which are broadly classified into 3 
groups based on their sequence homology, pharmacology and association with 
intracellular effector systems (Conn and Pin, 1997). Group I mGlus (mGlu1 and 
mGlu5) are linked to phospholipase C, an enzyme which hydrolyzes 
phosphoinositide leading to calcium release from intracellular stores. Groups II 
(mGlu2 and mGlu3) and III (mGlu4, mGlu6, mGlu7, and mGlu8) mGlus are linked to 
adenylate cyclase, an enzyme which catalyses the production of cyclic adenosine 
monophosphate (Simeone et al., 2004). Each mGlu is composed of seven 
transmembrane-spanning domains with a large N-terminal domain.  
mGlus are expressed on spinal dorsal horn neurons as well as on primary 
afferents. For instance, Ohishi et al. (1995) found that some axon terminals of 
primary afferent fibres, which terminated in the SDH, expressed mGlu7. 
Although primary afferent terminals may contain mGlus, Jia et al. (1999) 
suggested that most of these receptors were typically in dendrites and cell 
bodies of neurons within the dorsal horn. These mGlus work synergistically 
and/or antagonistically with ionotropic receptors to control the release of 
glutamate from primary afferents and interneurons.  
Localization of mGlus subtypes in the spinal cord has been investigated. 
Regarding group I mGlus, it was reported that SDH neurons strongly express 
mGlu5a and mGlu5b (two alternative splice variants), while deep dorsal horn 
neurons predominantly express the mGlu1a subtype (Valerio et al., 1997; Boxall 
et al., 1998; Berthele et al., 1999; Alvarez et al., 2000). Additionally, in lamina 
II of the rat dorsal horn, mGlu5 was found either at the postsynaptic densities of 
asymmetrical synapses, which have thickened postsynaptic densities and are 
thought to be excitatory (Gray, 1959), or localized extrasynaptically at dendritic 
and somatic membranes (Vidnyanszky et al., 1994; Jia et al., 1999; Alvarez et 
al., 2000). Tao et al. (2000) also identified a synaptic relationship of mGlu5–
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containing neurons in the SDH of the rat with nociceptive primary afferents and 
GABAergic terminals of presumed interneurons. Regarding group II mGlus, it was 
reported that the antibody against mGlu2/3 was found mainly in laminae IIi, III 
and IV (Young et al., 1998; Jia et al., 1999). Additionally, Boxall et al. (1998) 
and Berthele et al. (1999) reported the absence of mGlu2 mRNA from the spinal 
cord of rat. In regard to group III mGlus, it was reported that mGlu4 mRNA was 
expressed in a disperse manner over the grey matter, while mGlu6 mRNA was not 
expressed in the spinal cord (Boxall et al., 1998; Berthele et al., 1999). Their 
studies also showed that mGlu7 mRNA was localized with a high concentration in 
the SDH, in comparison to its lesser expression in deeper laminae.    
Fisher and Coderre (1996a) reported that the application of group I mGlus 
agonist DHPG to the rat spinal cord induced spontaneous nociceptive behaviours. 
These behaviours were attenuated after the treatment of rats with antagonists 
acting on groups I and II mGlus, as well as on NMDA. Mechanical and thermal 
thresholds were also increased after the application of group I mGlu antagonists 
to the rat spinal cord (Young et al., 1997). It was also reported that activation of 
groups I and II mGlus enhanced the excitatory responses of spinal neurons to 
ionotropic glutamate receptor (AMPA, kainite and NMDA) agonists both in vivo 
and in vitro (Bleakman et al., 1992; Bond and Lodge, 1995; Budai and Larson, 
1998). The excitability of dorsal horn neurons of the rat was also increased after 
the activation of group I mGlus (Zhong et al., 2000; Park et al., 2004). Park et 
al. (2010) recently reported that the bath application of DHPG enhanced the 
number of fos-immunoreactive neurons in the spinal trigeminal subnucleus 
caudalis in vitro (brainstem slices). The study also showed that the neuronal 
expression of fos was significantly decreased after the application of an NMDA 
receptor antagonist, as well as protein kinase C (PKC) and ERK inhibitors. This 
facilitatory effect of group I mGlus is either attributed to their interaction with 
ionotropic receptors (Fisher and Coderre, 1996b), or to their direct effect of 
increasing neuronal excitability (Jones and Headley, 1995). However, the role of 
group I mGlus in modulation of nociception is still poorly understood.  
ERK is expressed in dorsal horn neurons and is phosphorylated by noxious stimuli, 
as described in the previous Chapter. It has been reported that nociceptive 
behaviour, which resulted from the activation of spinal group I mGlus, was ERK-
dependent (Karim et al., 2001). Karim et al. (2001) also showed that DHPG-
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induced activation of group I mGlus led to ERK phosphorylation in mice dorsal 
horn neurons, identifying the ERK/MAPK cascade as a potential mediator of 
mGlu-induced enhancement of nociception. Hu et al. (2007) also reported that 
ERK activation was induced pharmacologically by activating group I mGlus in 
mouse spinal cord.  
The role of mGlu5 in modulating nociception is not yet clear. Karim et al. (2001) 
reported that nociceptive behaviours resulting from the activation of spinal 
group I mGlus is ERK-dependent. In this part of the study, phosphorylation of 
ERK in mGlu5-expressing neurons after the administration of DHPG into the 
lumbar spinal cord was investigated. The study also examined the phenotype of 
these pERK+ mGlu5-expressing neurons by investigating the colocalisation of pERK 
and mGlu5 with excitatory and/or inhibitory neurochemical markers.  
5.2 Experimental procedures 
5.2.1 Animals and DHPG application 
Eight adult male Wistar rats (250–280 g; Harlan, Loughborough, UK) were used 
for this part of the study. The rats were deeply anaesthetized with 10% urethane 
(1.3 g/kg ip). They were then placed on a heating pad in order to maintain their 
body temperature. The depth of anaesthesia was monitored throughout the 
procedure by occasionally pinching the forepaw and observing the appearance of 
any withdrawal reflexes. A midline incision was made over the back, the 
paraspinous muscle was dissected, and a dorsal laminectomy was performed at 
T13 and L1 to expose the mid-lumbar spinal cord. Connective tissue and muscle 
were dissected from the dorsolateral surfaces of T12 and L2 to enable placement 
of vertebral clamps. DHPG [165 nmol (3.3 mM, 30 µg/50 µl), Tocris Cookson, 
Ballwin, MO, (Karim et al., 2001)] was applied to the exposed mid-lumbar spinal 
cord and maintained for 8 minutes (n=3). 100 µl of normal saline was applied to 
the lumbar cord of the remaining 5 rats for 8 minutes. The rats were then 
perfused with 4% formaldehyde. 
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5.2.2 Tissue processing and immunocytochemistry 
Lumbar spinal cord was dissected out and post-fixed at 4°C for 24 hours. Mid-
lumbar (L3-L5) spinal segments were cut into 60 µm thick transverse sections 
with a Vibratome. The transverse sections were cut sequentially into 5 bottles 
and were then treated for 30 minutes with 50% ethanol. Spinal sections from one 
of the bottles were reacted for 3 days in rabbit anti-mGlu5 (1:500), and mouse 
monoclonal antibody against pERK (1:1000). Sections from the 2nd, 3rd and 4th 
bottles were reacted in both rabbit anti-mGlu5 and mouse anti-pERK, as well as 
in one of the following primary antibodies: (1) goat anti-calretinin (1:1000) (2) 
goat anti-calbindin (1:500) or (3) guinea pig anti-GABA (1:1000), respectively. 
Sections were then incubated overnight in appropriate species-specific 
secondary antibodies raised in donkey and conjugated to either Alexa 488, 
Rhodamine Red, or DyLight 649. They were then rinsed 3 times with PBS, 
mounted and stored at -20°C. Characteristics and suppliers of the antibodies 
used in this part of the study are described in Chapter 2.    
5.2.3 Confocal microscopy and analysis 
5.2.3.1 ERK phosphorylation in mGlu5-expressing neurons 
To investigate the proportion of pERK+ mGlu5-expressing neurons after the 
application of DHPG, transverse sections from the mid-lumbar (L3-L5) spinal cord 
were analysed. For this part of the study, Zeiss LSM710 confocal microscope was 
used. Sections from the L3, L4 and L5 spinal segments were initially examined 
with a 20× lens using fluorescence microscopy for the presence of pERK. Three 
sections from each of the 2 segments that showed the most numerous pERK 
immunoreactive neurons were selected for further analysis. These were then 
scanned throughout the depth of the section using a 40× oil-immersion objective 
lens to produce z-series consisting of 24 to 26 optical sections at 2 µm z-
separation. Between 4 and 6 contiguous fields were scanned for each section in 
order to cover the entire cross-sectional area of lamina I and II on one side. Files 
corresponding to pERK-immunostaining were opened with Neurolucida for 
Confocal software and every pERK-immunoreactive cell in lamina II was 
selected. The files containing mGlu5-immunostaining were then viewed and the 
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presence or absence of mGlu5 in each of the selected pERK–positive cells was 
determined. 
5.2.3.2 mGlu5-expressing excitatory and inhibitory neurons 
The proportions of lamina II mGlu5-expressing neurons that were positive for 
calretinin, calbindin or GABA were investigated. Three sections from each 
segment were scanned with the confocal microscope through a 40× oil-
immersion objective lens to produce z-series at 2 µm z-separation that covered 
the entire area of lamina II on one side. Sections were then analysed with 
Neurolucida. The mGlu5 channel was initially viewed, and mGlu5-immunoreactive 
cells were selected from 4 optical sections at the start of the z-series. The 
selection was performed by applying a 5 µm × 5 µm grid and choosing the cell 
nearest the lower right hand corner of each grid square. It started at the most 
dorsal part of the lamina working from dorsal to ventral (1st 4 optical sections) 
and then from left to right. Once the cells had been selected, the calretinin, 
calbindin or GABA channel was viewed, and the presence or absence of 
calretinin-, calbindin- or GABA-immunostaining in each of the selected mGlu5-
positive cell was recorded. 
5.2.3.3 Colocalisation of pERK with calretinin, calbindin and GABA in mGlu5-
expressing neurons 
To investigate the proportion pERK+ mGlu5-expressing neurons that were 
assumed to be excitatory, sections from the L3-L4 or L4-L5 spinal segments that 
were incubated to reveal pERK, mGlu5 and calretinin or calbindin were analysed. 
Initially, colocalisation of calretinin or calbindin with mGlu5 in pERK-positive 
neurons was investigated. All the pERK+ mGlu5-expressing neurons were selected 
throughout the depth of the section. Files containing calretinin- or calbindin-
immunostaining were then viewed and the presence or absence of calretinin or 
calbindin in each of the selected pERK+ mGlu5-expressing cells was determined. 
To investigate the proportion pERK+ mGlu5-expressing neurons that were GABA-
immunoreactive, sections from the L3-L4 and L4-L5 spinal segments that were 
incubated to reveal pERK, mGlu5 and GABA were analysed. Three sections from 
each segment were scanned with the confocal microscope through a 40× oil-
immersion objective lens to produce z-series at 2 µm z-separation that covered 
136 
the entire area of lamina II on one side. Since penetration of the GABA-
immunostaining was extremely limited, only the superficial parts of each section 
were scanned. Sections were then analysed with Neurolucida. The pERK-positive 
neurons that were at the surface of the section were selected and the files 
containing mGlu5- immunostaining were then viewed and the presence or 
absence of mGlu5 in each of the selected pERK–positive cells was determined. 
The GABA channel was then revealed, and the presence or absence of GABA 
immunoreactivity in each of the selected pERK+ mGlu5-expressing cells was 
recorded. 
In order to determine whether differences in the sizes of GABA+ and GABA- 
neurons could have led to a bias in selection, the distance in the z-axis between 
the upper surface of the Vibratome section and the bottom of the nucleus for a 
sample of pERK-positive neurons was estimated, by counting the number of 
optical sections between these levels. The presence or absence of GABA-
immunostaining was then recorded.  
5.3 Results 
5.3.1 pERK+ mGlu5-expressing neurons  
mGlu5 staining was localized in the SDH, mostly in lamina II, consistent with 
previous studies that showed that mGlu5 expression was concentrated in the 
superficial laminae of rats and mouse. mGlu5 immunoreactivity was present as 
numerous granules forming distinct annuli that occupied cellular membranes.  
Following DHPG (but not saline) application, numerous pERK-positive cells were 
seen in the SDH, particularly in lamina II (Figure 5-1). Of the 606 lamina II pERK-
positive cells analysed, 531 (88%, range 81-94%) were mGlu5-immunoreactive.  
Animals that received saline showed variable results. In the first two rats, 
scattered pERK-positive cells were seen in both laminae I and II, with more of 
these cells in lamina I. In addition to the difference in the laminar distribution of 
these cells, compared to cells that activated ERK after DHPG, their rostrocaudal 
distribution differed too. They were mainly concentrated at one end of the 
exposed lumbar cord: L3 or L5 spinal segment and this segment corresponded to 
137 
an external swelling of the cord, which was induced by the laminectomy itself. 
These pERK-positive cells were also larger than those seen after DHPG, and were 
seldom mGlu5-immunoreactive. The other three animals that received saline 
showed minimal pERK expression, and this may be attributed to the laminectomy 
procedure after which less swelling of the cord was seen.      
Results of the quantitative analysis of pERK in mGlu5-expressing neurons in 
lamina II, after DHPG application, are shown in Table 5-1, and an example of 
pERK and mGlu5-immunostaining is seen in Figure 5-2.   
5.3.2 Neurochemistry of mGlu5-expressing cells 
5.3.2.1 Calretinin and calbindin 
In the sections reacted to reveal calretinin, which is expressed by excitatory 
neurons, calretinin-immunostaining was present in the superficial dorsal horn, 
mostly in lamina II. The percentage of calretinin+ mGlu5-immunoreactive neurons 
in lamina II was 38% (37-39%, Table 5-2). Additionally, of the 578 pERK+ mGlu5-
immunoreactive cells analysed, only 58 cells (10%, 6-15%) contained calretinin 
(Table 5-2 and Figure 5-3). Table 5-2 also shows a significant difference between 
the expression of calretinin in mGlu5-immnuoreactive cells compared to its 
expression in pERK+ mGlu5-expressing cells (P<0.001, Chi-square test). 
In the sections reacted to reveal calbindin, a marker for excitatory neurons, 
calbindin-positive cells were seen in the SDH, mostly in lamina II. Fifty-seven 
percent (51-64%) of the mGlu5-expressing neurons in lamina II contained 
calbindin (Table 5-3). Additionally, of the 674 pERK+ mGlu5-immunoreactive cells 
analysed, 138 cells (20%, 13-30%) were calbindin-positive (Table 5-3 and Figure 
5-4). Chi-square test shows that there is a significant difference between the 
expression of calbindin in mGlu5-immnuoreactive cells and its expression in 
pERK+ mGlu5-expressing cells (P<0.001, Table 5-3). 
5.3.2.2 Gamma-aminobutyric acid (GABA) 
In sections reacted to reveal GABA, which is expressed exclusively by inhibitory 
interneurons, the distribution of GABA immunostaining was very similar to that 
reported previously in the rat dorsal horn. Staining was particularly dense in 
138 
laminae I-III, and this region contained numerous immunoreactive cell bodies. 
Non-immunoreactive cells were seen as dark areas, surrounded by strongly 
immunoreactive structures in the neuropil, which presumably corresponded to 
dendrites and axonal boutons of GABAergic neurons. However, as reported 
previously, the penetration of GABA-immunostaining was extremely limited in 
formaldehyde-fixed tissues compared to glutaraldehyde-fixed ones (Somogyi et 
al., 1985; Sardella et al., 2011a), and only cells for which the nucleus appeared 
on the top surface of the section were examined.  
The percentage of GABA+ mGlu5-expressing neurons in lamina II was 35% (31-43%, 
Table 5-4). However, GABA-immunoreactivity was seen in 79% (74-84%) of the 
pERK+ mGlu5-expressing cells. Results of the quantitative analysis of GABA 
expression in both mGlu5-expressing neurons and pERK+ mGlu5-immunoreactive 
neurons in laminae II are shown in Table 5-4. Table 5-4 also shows a significant 
difference between GABA expression in pERK+ mGlu5-immnuoreactive cells 
compared to its expression in mGlu5-expressing cells (P<0.001, Chi-square test). 
An example of GABA, pERK and mGlu5-immunostaining is seen in Figure 5-5.  
Since only pERK-positive neurons that were located in the surface of the section 
were selected for further analysis, and both GABA+ and GABA- pERK-
immunoreactive neurons were found in laminae II, it was unlikely to avoid a 
selection bias towards the larger pERK-positive cells. However, the present study 
did not show any significant difference between the sizes of the pERK-positive 
neurons that expressed GABA (8.97 µm, range 6-12 µm, median 9 µm, n=114) 
and those that were GABA-negative (9.01 µm, range 6-13 µm, median 9 µm, 
n=74) (P=0.984, Mann-Whitney U-test). It is therefore unlikely that the estimate 
of the proportion of pERK-positive neurons that were GABA-immunoreactive was 
influenced by this selection bias.  
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5.4 Discussion 
This part of the study reports that following spinal activation of group I mGlus, 
numerous pERK-positive cells were seen in lamina II of the spinal cord, and the 
great majority of these (88%) were mGlu5-positive. It also shows that while 38% 
of lamina II mGlu5-positive neurons contained calretinin, only 10% of these cells 
phosphorylated ERK after DHPG. Additionally, more than half of the mGlu5-
positive cells (57%) in lamina II are double-labelled with calbindin, but only 20% 
were also positive for pERK following DHPG. Despite the finding that 35% of the 
mGlu5-expressing neurons were GABA-immunorective, a high proportion (79%) of 
the pERK+ mGlu5-expressing neurons was positive for GABA after DHPG. Overall, 
lamina II mGlu5-expressing neurons contain various proportions of calretinin, 
calbindin and GABA. However, activating these cells phosphorylated ERK in a 
lower proportion of mGlu5-expressing excitatory interneurons (calretinin+ and/or 
calbindin+), and in a higher proportion of mGlu5-expressing inhibitory 
interneurons (GABA+). This suggests that mGlu5-expressing cells, when activated, 
play a complex role in processing nociceptive information. 
5.4.1 Spinal mGlu5-expressing neurons  
Although it has been well established that ionotropic glutamate receptors are 
involved in the transmission and mediation of spinal nociception (Yamamoto and 
Yaksh, 1992; Kristensen et al., 1994; Meller et al., 1996), the role of spinal 
mGlus in processing nociceptive information is not yet fully understood.   
The involvement of spinal mGlus in nociception was initially supported by 
pharmacological studies that demonstrated the effects of applying non specific 
AMPA/mGlu agonists such as quisqualic acid into the lumbar spinal cord 
(Aanonsen et al., 1990; Sun and Larson, 1991). Subsequently, selective mGlu 
agonists and antagonists were available, and these helped in exploring the 
specific roles of mGlu groups, as well as the roles of each member of these 
groups. For instance, it has been reported that intrathecal application of DHPG 
(mGlu1/5 receptor agonist) in rats induced spontaneous nociceptive behaviours 
and enhanced formalin-evoked nociception in the 2nd phase of the formalin test 
(Fisher and Coderre, 1996a, 1996b). DHPG also led to thermal hyperalgesia 
(persistent decrease in noxious heat response latency), mechanical hyperalgesia 
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(vigorous nociceptive responses to tail pinch) and mechanical allodynia (a 
reduction in the 50% response threshold to von Frey hairs) in rats (Fisher and 
Coderre, 1998). In addition, it was reported that the application of relatively 
selective group I mGlu antagonists [(S)-4-carboxyphenylglycine or (S)-4-carboxy-
3-hydroxyphenylglycine] reduced nociceptive responses in the 2nd phase of the 
formalin test (Fisher and Coderre, 1996b). Furthermore, antisense knockdown of 
spinal mGlu1 in rats decreased neuronal responses to topical mustard oil 
application (Young et al., 1998), and also attenuated thermal hyperalgesia and 
mechanical allodynia in a rat model of chronic inflammation (Fundytus et al., 
2002). Together, the above findings suggest a role of group I mGlus in spinal 
modulation of nociception.  
As described previously, one of the established cellular mechanisms of action of 
group I mGlus are through their activation of phospholipase C, which leads to the 
release of intracellular calcium and subsequently the activation of PKC (Masu et 
al., 1991; Abe et al., 1992). Recent studies also showed that group I mGlus can 
activate other pathways such as the ERK/MAPK cascade, which has been shown 
to be involved in nociception (Ji et al., 1999; Karim et al., 2001; Adwanikar et 
al., 2004). Karim et al. (2001) reported that intrathecal application of DHPG into 
the mouse spinal cord led to spontaneous nociceptive behaviours, which were 
attenuated by the administration of selective mGlu1 or mGlu5 antagonists. 
Immunoblot analysis of the mouse spinal cord after DHPG administration showed 
a dose-dependent increase in phosphorylation of ERK1 and ERK2, with stronger 
activation of ERK2. The doses of DHPG that were required to activate ERK were 
similar to those that induced nociceptive behaviours, suggesting that group I 
mGlu activation leads to an ERK-dependent nociceptive behaviour in mice. This 
suggestion was further confirmed in a subsequent study by Adwanikar et al. 
(2004) that showed that DHPG-induced nociceptive behaviours were attenuated 
after the pretreatment with a MEK inhibitor, which blocks the activation of ERK.     
Karim et al. (2001) also reported that mGlu5 colocalised with pERK in the SDH 
after DHPG administration, however, they did not attempt to quantify these 
pERK+ mGlu5–expressing neurons. The present study, on the other hand, 
demonstrates the proportion of these cells and further confirms the involvement 
of group I mGlus as an upstream activator for ERK in rats. Results from this study 
show that the spinal application of DHPG led to the expression of high levels of 
155 
pERK, mostly in lamina II. The majority (88%) of these pERK-positive cells were 
mGlu5-immunoreactive, suggesting a direct involvement of mGlu5 in activating 
ERK, rather than mGlu5 indirectly acting on other dorsal horn receptors and 
subsequently activating ERK.  
The present study also reports that a low proportion (12%) of the pERK-positive 
cells did not express mGlu5 after DHPG. One possible technical reason for this is 
that the mGlu5 antibody used in this study detects only one splice variant of 
mGlu5: mGlu5a or mGlu5b, suggesting that some mGlu5-expressing cells were not 
detected. However, this possibility is ruled out since it is found that the mGlu5 
antibody used detects the last 28 amino acids from the C terminal, which are 
the similar in both splice variants: mGlu5a and mGlu5b (Joly et al., 1995). Another 
explanation for the presence of these pERK-positive cells that lacked mGlu5 is 
that they could be activated by nearby pERK+ mGlu5–expressing interneurons. It 
can also be attributed to the fact that DHPG is a non-specific group I agonist, 
which activates both mGlu1 and mGlu5, and therefore, suggests that these pERK+ 
mGlu5-negative cells may express mGlu1. This suggestion is further supported by 
the finding of Karim et al. (2001), who showed that both mGlu1 and mGlu5 
antagonists attenuated DHPG-induced pain behaviours. However, the 
distribution of mGlu1a and mGlu5a/b has been described above, and mGlu1a is 
found mainly in deep dorsal horn, compared to the expression of mGlu5a/b which 
is concentrated in the SDH (Valerio et al., 1997; Alvarez et al., 2000). It is 
therefore unlikely that those mGlu5 lacking pERK-positive cells express mGlu1a. 
In support of the above finding, Karim et al. (2001) reacted mouse spinal cord 
sections with a selective antibody against mGlu1a and reported no detectable 
mGlu1a-immunostaining in the SDH. Another explanation for these pERK-positive 
cells that neither expressed mGlu5a/b nor mGlu1a is that they express other 
known splice variants of mGlu1 such as mGlu1b and mGlu1d. Alvarez et al. (2000) 
also reported the expression of low levels of mGlu1b in lamina II in the rat. 
Additionally, Karim et al. (2001) reported the presence of 2 RNA splice variants 
of mGlu1 in the spinal cord dorsal horn of the mouse: mGlu1b and mGlu1d.  
Recent studies have demonstrated the involvement of activated ERK in 
phosphorylating the pore-forming subunit of the potassium channel Kv4.2, which 
is a major contributor to A-type K+ currents (Adams et al., 2000; Hu et al., 2003; 
Ji et al., 2003; Hu et al., 2006). The down regulation of these A-type currents is 
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known to enhance neuronal activity (Hu and Gereau, 2003; Hu et al., 2003). 
Subsequently, Hu et al. (2007) showed that ERK-mediated phosphorylation of 
Kv4.2 is downstream of mGlu5 activation. Their study examined the effects of 
DHPG on action potentials evoked by depolarising current injection in spinal cord 
dorsal horn neurons in culture and in acute slices from mice. DHPG application 
decreased first spike latency and increased spike frequency. Their study also 
showed that DHPG decreased A-type currents in dorsal horn neurons from wild-
type mice, but not in those from Kv4.2 knock-out mice. This DHPG-induced 
inhibition of A-type currents was blocked by ERK inhibitors. Additionally Hu et 
al. (2007) reported that 71% of DHPG-induced pERK+ neurons from three 
different cultures were also positive for Kv4.2, and all Kv4.2-expressing neurons 
contained pERK. It was also found that the blockade of mGlu5, but not mGlu1, 
activation completely abolished the modulation of A-type K+ currents and 
neuronal excitability that were seen following DHPG application. Their study 
concluded that mGlu5, but not mGlu1, modulates A-type currents in the SDH, 
while the mechanism that explains the contribution of mGlu1 to nociceptive 
behaviour remains unclear.  
It has been reported (Ji et al., 1999; Polgar et al., 2007) and also shown in the 
previous Chapter that ERK is phosphorylated in the SDH following noxious 
stimulation. The present study shows that many of the mGlu5-expressing neurons 
in the SDH did not phosphorylate ERK following DHPG. The reason for the 
presence of these pERK- mGlu5-expressing neurons is not clear. It may be duo to 
the possibility that these cells express non-functioning mGlu5, or that DHPG 
activates these pERK- mGlu5-expressing cells through different pathways other 
than the MAPK/ERK cascade. 
5.4.2 pERK in mGlu5-expressing excitatory and inhibitory neurons 
Lamina II contains both inhibitory and excitatory interneurons, and these play an 
important role in modulating nociception, by their action on neighbouring 
interneurons or on projection neurons in neighbouring laminae (I and III-IV). 
Calcium binding proteins have been used as markers for excitatory (calretinin, 
calbindin) or inhibitory (parvalbumin) neurons, as described in the first Chapter.  
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The present study is the first to report that one-third of lamina II mGlu5-
expressing neurons contain calretinin, and more than half of the mGlu5-positive 
cells in lamina II are double-labelled with calbindin. Both calretinin and 
calbindin are expressed by excitatory neurons, and Albuquerque et al. (1999) 
reported that the majority of calbindin- calretinin-containing neurons were not 
reactive for either GABA or glycine. Antal et al. (1991) also showed that most of 
the calbindin-positive cells in the SDH were not GABAergic, which further 
confirms that these calretinin- calbindin-expressing mGlu5+ neurons are more 
likely to be glutamatergic.  
Polgar et al. (2003) reported that one-third of lamina II interneurons of the rat 
were inhibitory, containing GABA. The present study shows that 35% of the 
mGlu5-expressing neurons are also GABA-immunoreactive, suggesting that mGlu5 
is expressed on both excitatory and inhibitory neurons in lamina II. Jia et al. 
(1999) used electron microscopy to investigate colocalisation of GABA and mGlu5 
in SDH neurons of the rat. They reported that about half of the vesicle-
containing profiles immunostained for mGlu5 were stained for GABA.  
Hu and Gereau (2011) recently showed that only 16% of mGlu5-expressing cells 
also expressed GAD67-GFP (inhibitory cells marker) in cultured neurons. This 
discrepancy between the present study and that of Hu and Gereau (2011) may be 
attributed to the different inhibitory markers used, since an unknown proportion 
(estimated between 35% and 67%) of GAD67-GFP neurons represent GABAergic 
neurons (Heinke et al., 2004; Dougherty et al., 2009). However, GABA, which is 
the marker of choice in this study, presumably labels all inhibitory neurons. 
Another reason of this difference is that Hu and Gereau (2011) results were 
based on a study done in cultured neurons, which may differ in their responses 
compared to the responses of dorsal horn neurons of rats (in vivo).    
Regarding the phenotype of these DHPG-induced pERK+ mGlu5-expressing cells, 
results from the present study show that 10 and 20% of these cells contained 
calretinin and calbindin, respectively. The majority (79%) of pERK+ mGlu5-
expressing neurons were GABAergic. The above percentages add up to more than 
a 100%, however, it has been shown that calretinin and calbindin expression 
patterns in the SDH partially overlap (Albuquerque et al., 1999). The finding 
from the present study that a proportion of pERK+ mGlu5-expressing cells were 
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excitatory is in agreement with the results by Huang et al. (2005) and Hu and 
Gereau (2011). Huang et al. (2005) reported that almost all Kv4.3-positive cells 
(which also express Kv4.2) in lamina II of the rat expressed mGlu5, and Kv4.3 was 
expressed in a subset of lamina II calretinin+ (calbindin- and PKCγ-) excitatory 
neurons. Hu and Gereau (2011) recently showed in cultured dorsal horn neuron 
that Kv4.2-containing potassium channels, which were modulated by mGlu5-ERK 
signalling as described above, were found primarily in excitatory cells, since 
these cells expressed VGLUT1/2, PKCγ and NK1r.  
Results from the present study suggest that the pronociceptive effect of 
activating mGlu5 in the spinal cord is likely to involve a direct action of a subset 
of mGlu5-expressing excitatory interneurons on projection neurons. This effect 
may also involve an indirect inhibition of local inhibitory interneurons by mGlu5-
expressing inhibitory cells, a process of disinhibition. However, the finding that 
DHPG induced pERK expression in a high proportion of mGlu5-expressing 
inhibitory cells speculates that this group of cells may be involved in inhibiting 
other spinal pathways such as itch, rather than their indirect involvement in 
nociception (Ross et al., 2010; Ross, 2011). This part of the project helps in 
understanding the various mechanisms that underlie the role of mGlu5 in the 
spinal cord. It also shows that there is a balance in the dorsal horn between 
inhibition and excitation, resulting in accurately modulating nociceptive 
information. Further studies investigating other mechanisms of actions of group I 
mGlus in the spinal cord are required. 
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6. Concluding remarks 
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This thesis highlighted some important aspects regarding different populations of 
spinal cord dorsal horn neurons and their role in nociception. Initially it aimed to 
assess whether NK1r-expressing projection neurons can be distinguished from 
NK1r-expressing interneurons, in lamina I of the spinal cord, based on their soma 
sizes. It showed that cell bodies of NK1r-immunoreactive neurons in lamina I had 
a clear bimodal size distribution that is related to the presence or absence of 
retrograde labelling from CVLM and/or LPb. It found that nearly all of the NK1r-
immunoreactive cells that were not retrogradely labelled had soma cross-
sectional areas that were less than 200 µm2. In contrast, less than 10% of the 
retrogradely labelled NK1r-positive cells had cell bodies smaller than 200 µm2. 
An important practical outcome from the above results is that soma size can be 
used to identify putative lamina I NK1r-expressing projection neurons in studies 
that have not used retrograde tracing.  
Results from the 1st part were then used to assess the responses of putative 
lamina I NK1r-expressing interneurons and projection neurons (cell bodies >200 
µm2) to various noxious stimuli. It reported that both lamina I NK1r-expressing 
projection cells and interneurons phosphorylated ERK after noxious cutaneous, 
deep and visceral stimulation with significantly more of the projection neurons 
were pERK-positive compared to the interneurons. It also showed that there was 
no significant difference in the responses of various morphological classes of 
lamina I NK1r-expressing projection cells to different types of noxious stimuli. 
The 2nd part of the project also showed that other populations of projection 
neurons (laminae III-IV NK1r-expressing neurons and lamina I giant cells) in the 
SDH phosphorylated ERK following noxious stimulation. Few laminae III-IV NK1r-
expressing cells were pERK-positive after noxious deep and visceral stimulation 
and these were very weakly labelled. Most of lamina I giant cells contained pERK 
after noxious cutaneous stimulation, and a lower proportion of these cells 
phosphorylated ERK after noxious deep stimulation. These results indicate that 
different types of projection neurons have different roles in conveying 
nociceptive messages. 
The 3rd and final part investigated ERK phosphorylation in mGlu5-expressing cells 
following spinal DHPG application. It showed that following spinal activation of 
group I mGlus, numerous pERK-positive cells were seen in lamina II of the spinal 
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cord, and the great majority of these were mGlu5-positive. It also reported that 
lamina II mGlu5-expressing neurons contained various proportions of calretinin, 
calbindin and GABA. However, activating these cells phosphorylated ERK in a 
lower proportion of mGlu5-expressing excitatory neurons (calretinin+ and/or 
calbindin+), and in a higher proportion of mGlu5-expressing inhibitory cells 
(GABA+). This suggests that mGlu5-expressing cells, when activated, play a 
complex role in processing nociceptive information.  
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